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Living with the unpredictable nature of epilepsy is difficult. Not knowing when the next seizure 
will occur is grim enough, moreover when combined with further complexities associated with 
the disease epilepsy can become debilitating and often fatal. 
Many current studies of epileptic seizure management disclose that an ultimate solution to drug-
resistant epilepsy is still lacking. Also, although a variety of epilepsy devices exist the prevailing 
knowledge still resounds that epilepsy is not easily managed, this being due to its sheer complex 
nature. 
An emerging approach is to personalise healthcare and this is known to be facilitated by the 
Internet of Things (IoT). Therefore, focusing upon personalised parameters that make epilepsy 
patients distinct from each other this thesis proposes that with IoT technologies there is a more 
accurate and refined way of remotely monitoring and managing the ‘individual’ patient. This is 
achieved by using classification techniques such as ontology development tools and clustering 
analysis to develop a Patient Profile Description Language (PPDL) and generate meaningful 
groups to categorize epilepsy patients.  Ultimately a monitoring framework is developed to 
capture this personalised seizure data obtained from an IoT sensor-based device, which is 
positioned on different parts of the patient’s body.  
This thesis discloses that it is ‘the individual profile’ that makes the difference in which IoT 
sensor-based device to choose and therefore the results used from this study are used to form a 
typical model or a PMP (Personalised Monitoring Plan) which recommends which IoT sensor-
based device to use based on those very individual, personal characteristics of a given patient.  
By integrating IoT sensor-based devices deployed remotely and personalised patient data into a 
combined monitoring framework the vision of personalisation is realised. Further revealed is 
some irrefutable evidence derived from patient profile analysis and experimental data that 
seizure detection using sensors positioned on different parts of a patents body ultimately makes 
an impact on the monitoring of epilepsy, endorsing that modern computer science is providing a 
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   Introduction 
 
1.1 Motivation 
A number of epilepsy and healthcare monitoring systems have been proposed by researchers 
to detect seizures and monitor the patient. The majority of these methods of management 
focus solely on how we can improve ‘seizure detection and prediction’. For example, epilepsy 
specific platforms include and Sareen and EpiCare. Sareen gathers data from EEG, 
(electroencephalogram, which records brain activity) using Mobile Cloud Computing (MCC) 
for storage and for sending notifications to the family and clinicians [1]. Whereas EpiCare, 
whilst also using MCC is used in home settings specifically to assist epilepsy diagnosis [2] 
and portable EEG are used to detect the seizures. 
Other body measurements in addition to EEG have been recommended i.e. signals obtained 
from sensors have been proposed in many academic studies and commercial sectors to detect 
epileptic seizures. For example, gyroscopes, accelerometers, pulse rate, temperature sensors, 
magnetometers, galvanic skin response sensors (GSR), implanted advisory system, 
electromyography, video detection systems, mattress sensor, and audio systems [3]. Body 
sensor networks placed on the body together with MCC has been proposed for epilepsy 
detection [1] such as pulse rate which can be worn as a wrist band.  
Yet none of these approaches to manage epilepsy recognises that each epilepsy patient is 
unique in their specific characteristics of epilepsy. The fact is that epilepsy is complex and 
seizures are a not easily managed due to being a very diverse group of disorders, [4] just 
because someone has epilepsy it does not tell you the nature of their epilepsy or what seizure 
behaviours they have, seizures can be different for each person [5]. A question that needs 
addressing is whether epilepsy monitoring can benefit from personalised approach.  
 
1.1.1 Background 
Epilepsy is a chronic neurological disorder characterized by recurrent and unprovoked 
seizures. The epileptic seizures occur from electrical instabilities in the brain which can range 
from brief lapses of attention or muscle jerks to severe and prolonged convulsions [6].  
The patient’s quality of life is dramatically impacted and there are about 65 million people 
affected by this disorder worldwide. 
Epileptic seizure monitoring and management is challenging. Most current studies of epileptic 
seizure detection disclose drug resistant epilepsy still lacks an ultimate solution, despite the 
increase in anti-epileptic drugs [7]. 
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Epilepsy is not a single disease, but a family of syndromes that share the feature of recurring 
seizures. In some instances, it may be related to a genetic aetiology, or it can occur in 
association with metabolic disorders, structural abnormalities, infection or brain injury [8]. 
In the United Kingdom epilepsy affects 3 million people and in the United States it is the 4th 
most common neurologic disorder, only migraine, stroke, and Alzheimer’s disease occurs 
more frequently [9]. There are around 60 different types of seizure and a person may have 
more than one type. Seizures vary depending on where in the brain they are happening. Some 
people remain aware throughout, while others can lose consciousness [10]. 
Aside from their unpredictability, the worst part of having seizures is their utter complexity. 
The complex nature of epilepsy is noticeable in the variation of seizures types and symptoms 
between one patient and another. Distinguishing or classifying an individual epilepsy patient 
makes it difficult to manage and monitor. The negative impact of uncontrolled seizures 
spreads beyond the individual to affect their family, friends, and society. Chronic anxiety is 
experienced by the families and friends of people with epilepsy and many lives are adjusted 
to ensure the safety of their loved one. Novel approaches to epilepsy treatment are still 
greatly needed [11] novel therapies that better manage and monitor seizures as well as 
technology can help to handle the consequences of seizures. 
Insufficient knowledge about epilepsy, which is a very common disorder, has a great and 
negative impact on people with epilepsy, their families and communities, and the healthcare 
systems. There is need for a better understanding of the disease to make way for new 
approaches to monitor it. 
In the modern day of personalised medicine and rapid advancements in IoT a question that 
needs addressing is whether epilepsy monitoring can benefit from personalised approach. Can 
the IoT have the potential to significantly improve the ‘patients’ daily lives whose seizures 
cannot be controlled by either drugs or surgery? [12] 
 
1.1.2 Sensor-Based IoT Device Experiments 
One of the challenges in using sensor-based IoT devices to achieve a personalised approach 
is the barriers found in the use of them in hospital settings. EEG monitoring is the chief gold 
standard method used within hospitals to detect and monitor seizures. EEG is an 
electroencephalogram is a recording of brain activity. There is limited evidence found how 
sensor-based IoT devices and experiments are used in hospital settings. 
Recently an epilepsy patient described what a more connected system might have been able 
to do, in an article; ‘Where is the internet of healthcare things?’ and stated; “I could have a 
different result if I (my device) was connected to the correct APP/Web Portal” [13]. Generic 
smart devices are being recommended to patients without any precision. Even though there is 
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much hype about new healthcare sensor based IoT devices in today’s digital world; many 
clinicians presume they should be up to date with latest wearable technology or should be 
recommending them to their patients, but they don’t have this knowledge in fact it is quite 
uncommon to find a doctor so well versed and confident in technology [14]. Yet the impact 
of technology on ‘future’ healthcare is mammoth and if these changes hit healthcare 
professionals unprepared; “they will wash away the medical system we know and leave it a 
purely technology-based service without personal interaction. [14]. 
Here the ‘personal’ element of technology is identified; it is with this aspect in mind that the 
next logical step in digitalising healthcare must be embraced. This next step coming around 
is a more ‘personalised’ approach to healthcare and current research is identifying this as a 
new trend in medicine focusing on patient-centered care [15].  
There is evidence that sensor-based IoT devices prescribed for individual patients are not yet 
fully fit for purpose. Once such study looked at some significant unintended consequences 
relating to new security vulnerabilities and modifications of behaviour together with use of 
big data sets and unanticipated challenges faced by regulatory authorities thus making it 
difficult to keep pace with recent innovations [16]. Currently there are epilepsy sensors and 
apps that track medication, send reminders to take medication, some are for emergency with 
buttons to press before losing consciousness with a seizure and some detect a seizure based 
on the pattern of jerks [17]. However, there is a danger that epilepsy patients and their Doctors 
who are confronted with a bewildering range of devices [18] may have difficulty in coming 
to a sound understanding of the device. 
Therefore, it is vital to choose the most appropriate sensor, to find evidence on device 
reliability for a particular seizure type, and specifically to avoid any false alarms which can 
be troublesome for carers or family. It is beneficial for epilepsy patients where possible to  
discuss with their doctors the advantages and disadvantages of each device [19]. Tailoring the 
approach to patient sensors is noteworthy. The main factor of a devices value may ultimately 
be its ability to provide meaningful, accurate, and timely information [20] and as observed: 
[21] address the vital purpose of improving patient outcomes by providing guidance to the 
user. Therefore, preparations need to be in place to realise these goals. There is still time and 
measures that can be taken to ‘guide’ clinicians to choose the most precise device. 
Sensor-based IoT devices are in popular demand for healthcare providers since there is a  
constant need for patient monitoring, this drives the sensor usage, therefore patients need to 
be monitored pre-hospital, in-hospital (before, during, and after procedures), at home, in long-
term care, and in other locations [22] yet it is argued that there is limited information about 
the actual patient care-related tasks that physicians perform on these devices [23]. 
Furthermore, time is vital for hospital-based physicians to have the ability to obtain the right 
information at the right place [23]. Hence medical devices and apps are already proving 
invaluable tools for healthcare professionals, but as their features and uses expand, there is a 
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danger that because they are becoming even more widely incorporated into nearly every 
aspect of clinical practice [24] there may not be the knowledge or tools to match the correct 
device with the correct patient. 
There are very few experiments with sensor-based IoT devices that have been endorsed by 
the NHS and a large problem is poor information when caring for people with epilepsy or 
doing epilepsy clinical trials [25] yet there is great potential to vastly increase the efficacy of 
epilepsy management using biomedical devices that can improve the quality of information. 
As available devices and sensors grow, if clinicians could be provided with more guidance in 
understanding and choosing which sensor suits which situation then a personalised approach 
can be achieved and hence the management and monitoring of epilepsy can be improved. 
Even now seizure detection devices are at a relatively early stage of development and so far 
it is difficult to find large-scale studies that compare the effectiveness of one device against 
another [26]. This highlights that more experimental evidence is needed. 
 
1.1.3 Complexity of Epilepsy and Sensor-Based Devices 
With so many existing sensor-based IoT devices for epilepsy devices, together with associated 
factors and with so many eventualities in capturing a seizure at home, it is difficult to know 
the best device to implement. For example, the patient could be in the bath, in bed, or watching 
the TV when the seizure occurs and it could be that a Smart Watch used for monitoring 
shaking may not be comfortable to wear in bed, so a Smart Mattress would take its place. 
Likewise, a Companion Monitor which monitors bed movement and sound but would not be 
fitting in the shower [27]. Another variant is that different types of seizures will present 
themselves and there aren’t always the solutions at the clinician’s fingertips; devices are just 
not suitable for all the different environments we live in. 
It is so difficult to ultimately ‘monitor’ epilepsy because of these complexities. A demand for 
a more personalised approach to monitor the ‘individual’ patients’ characteristics is needed. 
This personalised approach is addressed in this thesis with the creation of the PPDL. Here 
the ‘terminology’ of epilepsy is investigated so that an ‘individual’ seizure type patient profile 
can be formed. To enable the health carers to define a ‘type’ of epilepsy patient, this thesis 
also recommends  distinct groups of epilepsy patients that share similar characteristics using 







1.2 Research Goals 
The principal aim of this thesis is to investigate whether a personalised approach to the remote 
monitoring and management of epilepsy is achievable. Initial research in the area of epilepsy 
and healthcare monitoring systems has identified the complex facets of epilepsy, also the use 
of IoT sensor-based devices has identified that experimental evidence is limited. 
However, little focus has been placed on how a personalised (individualised) patient-specific 
approach to managing epilepsy could be feasible to managing epilepsy. This is investigated 
in this thesis. 
This research attempts to address the remote personalised monitoring of individual patients 
using an IoT approach, highlight the essential IoT sensor-based devices that can monitor 
epilepsy and show how the typical seizure patient profiles be represented. 
Most of the challenges in seizure management lie in its complex nature. This thesis focuses 
on utilising computing in particular IoT technology to investigate, unravel and decipher some 
of its many facets. 
To begin this journey and realise if a personalised approach can benefit, epilepsy 
‘terminology’ was first investigated; existing seizure type classifications must be understood 
so that an individual seizure type patient profile can be formed and thus an ontology 
developed to model this concept. 
In addition to the individual patient profile another approach in this thesis was to see if distinct 
group of patients sharing similar characteristics could be identified so that ultimately patients 
could receive distinct recommendations per group. In order to achieve this Clustering 
techniques were analysed and carried out. 
Finally, by use of experiments the assumption that an individual patient profile or distinct 
group of patients sharing similar characteristics can make a difference in which IoT device 
to use will be evaluated. For example, can an IoT sensor-based device with an accelerometer 
sensor worn on the left ankle detect a seizure on ‘Patient Profile 1’? Or an IoT sensor-based 
device worn on the right wrist detect a seizure on ‘Patient Profile 5’? 
 
1.2.1 Research Questions  
The main questions this thesis has attempted to answer are outlined below. 
RQ 1. How can remote monitoring of individual patients be personalised using an 
IoT approach? 
RQ 1a. Can IoT sensor-based devices support the essential sensors in the reading 
of bio-signals for epilepsy monitoring? 
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RQ 1b. How can an understanding of typical seizure patient profiles be achieved? 
 
1.2.2 Research Aims & Objectives 
Following the related concepts previously introduced in this chapter the research aims and 
objectives for this thesis are outlined below: 
Aim: The aim of this research is to develop an IoT driven Framework for remote 
personalised monitoring and managing of epilepsy 
OB1: Investigate ontologies for seizure types/classifications  
OB2: Develop a language PPDL (Patient Profile Description Language) using a 
Semantic Ontology 
OB3: Perform a clustering technique to discover distinct groups of patients that share 
similar characteristics. 
OB4: Investigate IoT sensor-based devices that can support the essential sensors in 
the reading of bio-signals for epilepsy monitoring. 
OB5: Design and develop a conceptual framework which will support a Personalised 
Monitoring Plan  (PMP). 
OB6: Test and validate the framework with epilepsy scenarios.  
 
1.2.3 Research Contributions 
The main contributions this research makes are: 
• New ontology language; Patient Profile Description Language (PPDL). This 
language will support the need of the healthcare process to transmit, re-use and share 
individual patient profile data related to their seizures. 
This has been achieved by the investigation of epilepsy ‘terminology’; existing seizure type 
classifications/categories were analysed so that an ‘individual’ seizure type patient profile 
could be formed. A close collaboration with clinicians helped to build a data model fit for 
real-world adoption inside hospital settings and thus an ontology was developed to model the 
concept of the epilepsy patient profile, namely ESO ‘Epilepsy Seizure Ontology’. This was 
a driving force for the ultimate PMP Framework and a critical aspect for this concept. In 
order to make ESO useable for HCPs (Health Care Professionals) the ontology was 
transformed into a language that is understandable by humans and machines, this was 





• Distinct groups of epilepsy patients that share similar characteristics using Clustering 
Analysis. This will enable the health carers to define a ‘type’ of epilepsy patient. 
This has been achieved by performing clustering analysis techniques. Different clustering 
techniques were initially analysed to find the most appropriate approach for the acquired 
epilepsy data and an in-depth focus upon ‘clustering considerations’ was undertaken to 
confirm validity. The outcome was a set of 6 distinct ‘clustering’ groups, these 6 cluster 
groups revealed six completely different categories of patients each with their distinct seizure 
related information. 
• A novel IoT framework to realise “Personalised” monitoring of patients. 
This has been achieved by informed experimental results in the development of the 
conceptual PMP Framework which evaluated the assumption that an individual patient 
profile or distinct group of patients sharing similar characteristics can make a difference in 
which IoT device to use. The experiments were performed to capture seizure data, obtained 
from sensors, which were positioned on different parts of the patient’s body. The experiment 
outcomes revealed that difference is observed due to sensor ‘position’ on the body and that 
sensor ‘types’ are suited to different patient profiles.  
• An original  ‘Research Design Framework’  
Incorporating a sequential strategy, the research design approach used in this thesis originated 
on findings from the literature review, however it is a new and novel way to achieve the type 
of ‘personalisation’ described in this thesis. The framework is shown in the Methodology, 
Chapter 3 (Figure 3.1) and this design approach is transferrable to other studies aiming to 
achieve personalisation within alternative domains or can be applied to other health 
conditions such as diabetes, asthma or a condition with many characteristics.  
 
1.2.4 Thesis Structure 
The rest of this thesis is structured as follows:  
Chapter 2, ‘State of the Art’ presents an in-depth review of the literature context of this study 
on several areas including epilepsy and healthcare monitoring systems, technologies to help 
‘detect’ seizures and the challenges identified with epilepsy detection and monitoring 
systems. The concept of Personalised Healthcare is introduced with an in-depth discussion 
on methods to make epilepsy patients distinct from one another. 
Furthermore, this chapter will progress with a critical investigation of the literature of the 
concept of using semantic ontologies and its relevance to matching a patient profile with a 
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device profile. Finally, the chapter ends with a detailed understanding of why the modern 
trend is toward the personalised healthcare. 
Chapter 3 presents the research methodology of this study. It explains the research design 
and methods selected in order to achieve the aim. Methods and techniques adopted to extract 
the data, create the ontology, perform K-means Clustering are discussed. A framework of the 
research design containing the study objectives is systematically discussed at each stage and 
the various methods tools and techniques used discussed in detail. 
Chapter 4 presents the steps taken to gather the knowledge to inform the PPDL (Patient 
Profile Description Language). To do this the development of the ontology: ESO ‘Epilepsy 
Seizure Ontology’ is discussed. From the knowledge discovery process right through to the 
ontology implementation and evaluation this chapter presents the authentication of the ESO 
demonstrating its features and how it is used to create an individual representation of a seizure 
type patient, and ultimately enlighten the PPDL ‘Patient Profile Description Language.’  
Chapter 5 begins with an overview of clustering analysis and discusses the justification to 
fulfil Objective 3 and hence cluster the patient profiles. This chapter proceeds to 
systematically discuss the steps described in the research design framework to perform K-
means Clustering. From preparing the data needed right through to its visualisation and 
evaluation this chapter describes in-depth how the clusters are constructed and finally reveals 
a list of typical seizure type patients and which cluster they belong to.  
Chapter 6 discusses the experiments performed to test the thesis hypothesis. The results from 
the experiments will be used to inform the framework discussed in the next chapter. This 
chapter will discuss and analyse the results from the test carried out. 
Chapter 7 is where the evaluation takes place. It will focus on the development and of the 
proposed PMP framework to do this. The chapter will continue to outline and discuss the 
components of the proposed PMP framework then finally test the framework with ‘epilepsy 
scenario’ use-cases taking the user through each step of the framework. 
Chapter 8, ‘Conclusion and Future Work’ summarises the overall research work that has been 
done to achieve the aims and objectives that where originally identified in this study. With 
recommendations based on the findings of this research, also an understanding and 
justification of how an “IoT Approach to Remote Personalised Monitoring and Management 
of Epilepsy” successfully works with clear measurable attributes found in the use of the PMP 
framework. 
1.3 List of Publications 
Conference: The Second International Workshop on Mobile Technology for Healthcare 
(MT4H2017) 
Paper: An IoT Approach to Personalised Remote Monitoring and Management of Epilepsy 
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  State of The Art 
 
2.1 Introduction 
The emphasis of this chapter is to introduce relevant concepts and challenges that are 
considered to be influential and important to the development of this research. It begins by 
discussing approaches to healthcare monitoring systems, particularly recent ‘smart 
environment’ approaches. The next section focuses on monitoring specifically for epilepsy 
and technologies to help ‘detect’ seizures together with an in-depth discussion of the 
challenges identified. A summary table is presented with an overview of the all the ‘smart’ 
approaches discovered in this chapter. Finally, this chapter analyses the concept introduced 
in Chapter 1 on making epilepsy patients distinct from one another by introducing 
‘Personalised Healthcare’, continuing with focus on methods such as ‘clustering analysis’ to 
address patient individual parameters, following which there is a review on methodologies 
for ontology development. 
 
2.2 Healthcare Monitoring Approaches     
In the history of time it is only relatively recently that computers began to assist healthcare 
monitoring, in 1950s’ patients began to be continuously monitored by computerised 
machines [28] and clinical monitoring was first envisaged in the home [29]. For computer 
assistance to epilepsy it was not until 1972 in the field of imaging, when computerized 
tomography (CT) was invented by the British engineer Godfrey Hounsfield [30]  and only in 
recent decades where specific epilepsy healthcare ‘monitoring systems’ have been proposed 
by researchers, some of which are discussed in this chapter and shown Table 2.2. Smart 
Approaches to Monitoring in Healthcare and Epilepsy. 
Much of this recent growth being due to the advent of current IoT technology whereby the 
rise of ‘smart environment’ approaches to healthcare monitoring is witnessed. Such smart 
environment approaches are also shown in Table 2.2 where approaches are summarised 
accordingly following discussion, under: ‘Healthcare Monitoring’, ‘Epilepsy Monitoring’, 
‘Epilepsy Apps’ and ‘Epilepsy Sensors’. These recent ‘smart’ approaches in healthcare 
demonstrate the trend toward ‘sensor use’ and ‘remote monitoring’. 
Researchers are bounding toward the new generation of smart technology and IoT (Internet 
of Things). Novel devices such as smart watches, smart bands & smart clothing are all 
competing for the ultimate solution. Yet it is found there is limited research which focuses 
upon the concept of a more holistic, personalised approach to help manage epilepsy. 
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One study deemed the significance of attention on smart technologies and its potential to 
identify early indicators of cognitive and physical illness [19] and observed that researchers 
have argued and predicted that assessing individuals in their ‘everyday environment’ will 
provide the most ‘valid’ information about everyday functional status [31].  Indeed, there is 
evidence recently of this indication as several IoT platforms to manage & monitor healthcare 
remotely, are observed. For example, one IoT paradigm comprising of Wireless Health 
Sensors (WHS) permits the continuous monitoring of biometric parameters such as pulse 
rate, pulmonary functional quality, blood pressure and body temperature [32]. This IoT 
paradigm is being used to assist predictive analysis via smart healthcare systems by a medical 
practitioner. Using sensors connected to Arduino patient status is tracked, and by a Wi-fi 
connection data is collected and transmitted and can receive user requests. This data is shared 
with doctors through a website where the doctor can analyse the condition of the patient and 
provide further details online and intimate patient about future severity well in time [32]. 
There are several monitoring approaches specifically for Epilepsy which are discussed in 
section 2.3, but first this literature review will focus upon approaches which manage other 
health conditions: for example one study examines a Smart Environment for children with 
Autism and theirs was the vision of the school clinic seamlessly embedded and connected 
through advanced communication technologies creating a highly interactive physical world 
furnished with sensors, actuators, and novel displays [12]. This Autism experiment identified 
the sustained use of smart environments, focusing on models for predicting behaviour 
through the proposed generation of rich databases required for the continuous tuning and 
personalisation of classifiers. This study is a good example of one of the early smart 
environments used in healthcare and identifies that personalisation can be used to predict 
behaviour. 
Finding accuracy in predicting, diagnosing and recommending are the desired goals as 
observed in one study whereby an ontology-based model for diagnosis and treatment of 
diabetes patients in remote healthcare systems (OMDP) was proposed and experimental 
findings suggested more accurate findings for management of diabetes compared to other 
medical applications [10]. 
Another noteworthy system is ROCHAS (Robotics and Cloud-assisted Healthcare System 
for Empty Nester) [33] which recommends the monitoring of disabled patients in their own 
home, this provided them with robotic assistance but also allows them to live as 
independently as possible. Similarly, an assistant platform for elderly people was proposed 
in a study [34] whereby open software platforms are analysed to work together. 
The use of ‘sensor data’ in many more healthcare systems is becoming widespread, for 
example body temperature is captured in weblogs to monitor unhealthy children in ‘The 
Chinese CMTHC’ project, a Children’s medical treatment and healthcare system [35]. 
Wearable devices with embedded sensors are becoming more commonplace notably: 
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AIWAC which proposes affective interaction through wearable computing and cloud 
technology [36] this analyses the affective needs of the patients based on the measurements 
obtained from a wearable device.  
Allergy and Asthma Care in the Mobile Phone Era (or known as AACMPE ) [37] makes use 
of gravity sensors and controls the allergies and asthma evolution of the patients by means of 
Mobile Cloud Computing to determine several variables: the peak exhalation flow and the 
peak nasal inhalation flow and some breath parameters and sounds. 
Other computing studies conducted in healthcare vary; i.e. how to wirelessly transmit patient 
data from a device into the existing healthcare systems [38] whilst others simply discuss the 
positive effects of this synergy between Semantic Web and healthcare processes [39]. 
Furthermore, it was unfortunately discovered that instead of using semantic technologies 
many existing datasets in healthcare environments are still stored in relational databases [40] 
making data mapping a difficult process. 
The development of semantic technologies is emerging in popularity for healthcare, by 
combining real-time user-generated data and domain expert knowledge they are used for 
modelling relevant information, and for fostering reasoning activities. Many researchers are 
proposing the use of Semantic Web technologies to build a system for supporting and 
motivating people in following healthy lifestyles [41]. 
Consequently, as medical data is rapidly growing [42] the idea of using Semantic 
interoperability can provide a positive and meaningful exchange in the use of clinical data 
between many healthcare systems [43]. Yet some obstacles with healthcare data are known 
to slow this growth since healthcare data is generally heterogeneous, distributed, and non-
structured because each data element can have its own schema, structure, standard, format, 
coding system, level of abstraction  [42]. 
Another challenge coming from healthcare applications is the handling of all the information 
from the flourishing data created by IoT devices, [44] thus Carbonaro et al present an 
ontology-based system for the ehealth domain which provide semantic interoperability 
among heterogeneous IoT devices and facilitates data integration and sharing [44]. 
 
2.3 Epilepsy Detection & Monitoring Systems  
In 2010 ‘A Knowledge Management System’ [45] was developed for supporting creation, 
capture, storage and dissemination of ‘information’ about Epilepsy and Epileptic Seizures. 
The ontology on Epilepsy and web-based prototype to create the KMS (Knowledge 
Management System) is interesting as the issue of adding new concepts to the ontology was 
identified during the development, whereby the significance of continual communication 
with medical doctors was highlighted signifying the importance of understanding the 
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respective meaning of ontology concepts and to try to find new applications for the ontology, 
serving the patients, doctors and researchers [45]. This highlights a gap and calls for new 
applications for the epilepsy ontology, could new evidence found in more recent studies, 
hence ‘personalised healthcare’ contribute? As depicted, the ontology should reflect this 
evolution since the field of epilepsy and epileptic seizures is continually evolving [45]. 
More recently one study focus on Epilepsy symptoms particularly those that ‘lead’ to the 
seizures, are identified as being quite uncertain and there is the possibility they can 
unfortunately go undetected [46]. A Transition Model between the different phases of 
epilepsy to be adopted by decision-making systems used by people who are diagnosed with 
the specific disorder is proposed. Based on the whole model’s transitions information, 
epilepsy is represented by a health caring ontology which contains all the useful aspects of it 
[46]. 
University of Freiburg’s Cluster of Excellence BrainLinks-BrainTools studied smart devices 
to interface with the brain, were a “Closed Loop Stimulation System for Epilepsy Therapy” 
was proposed and a promise of new chances for patients suffering from pharmacoresistant 
epilepsy. The study used animal experiments  and obtained an insight into optimal parameter 
settings since identifying that electrical brain stimulations are complex and poorly 
understood, this is a good example of how prediction methods were tested [47]. 
EEG, an electroencephalogram is a recording of brain activity. This is the chief gold standard 
method used within hospitals to detect and monitor seizures. Several approaches have been 
reported with the aim to embed this method in other settings and platforms. Developments in 
some topics have been published, such as modelling the recorded signals [48] [49]or the 
design of portable EEG devices to deploy such models. As an alternative and sometimes 
supplement  to EEG there exist many sensors embedded in clothing or worn on the body to 
obtain bio-signals such as gyroscopes, accelerometers, pulse rate, temperature sensors, 
magnetometers, galvanic skin response sensors (GSR), implanted advisory system, 
electromyography, video detection systems, mattress sensor, and audio systems [50].    
The epilepsy specific platform such as Sareen (mentioned in Chapter 1) also makes use of 
data from EEG and uses Mobile Cloud Computing (MCC) for storage and for sending 
notifications to the family and clinicians [51]. MCC is being embraced in other epilepsy 
platforms such as EpiCare, where it is used in home settings specifically to assist epilepsy 
diagnosis [2], whilst body sensor networks placed on the body together with MCC has been 
proposed for epilepsy detection whereby [1] body sensors such as pulse rate which can be 
worn as a wrist band in a recent platform: ‘An IoT Platform for Epilepsy Monitoring and 
Supervising’ [1]. 
At the time of writing this chapter an initial review was done to discover existing sample 
devices for epilepsy. Variation in the available devices and their purpose was observed, i.e. 
in diagnosis, prevention, detection or monitoring. The sample devices are noted in Table 2.1. 
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Diversity in Epilepsy Devices, some devices are already in use in the home: i.e. mattress 
sensor devices whereas EEG, VNS (Vagus Nerve Stimulation) and brain stethoscope devices 
are used in hospital setting only and need medical training to use. Not all the devices use IoT 
technology or sensors. These initial findings highlighted the diversity in management of 
epilepsy and indicate how different devices suit specific needs in different epilepsy scenarios. 
Also noted were the benefits and limitations for each device, see Table 2.1. Diversity in 
Epilepsy Devices. 
A large amount of apps have been published more recently especially in the commercial 
sector for the detection and management of seizures using either the Smartphone sensors or 
external sensors, for example Epdetec [52] and Myepipal [53] and web logging which 
facilitates the way a patient records daily information concerning her/his epileptic events, 
medication, and news, My Epilepsy Diary [54] and Epidiary [55]. Another app attracting 
attention and recently reviewed in the press is the Alert App by Empatica. This app sends 
caregivers an automated SMS and phone call when it detects unusual patterns that may be 
associated to a convulsive seizure [56] yet it is only designed to work with the Embrace 
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An excellent performance comparator of epilepsy related apps is proposed by Ranganathan 
et al [58] and this study even goes as far to demonstrate the ideal monitoring system for 
epilepsy and indeed deems the system in Figure 2.1 [58] to be the “Holy Grail of 
Epileptology”. 
 
Figure 2.1 Holy Grail of Epileptology 
This system above encompasses a holistic approach: sensors are embedded on the patients 
either clothing or within the smart phone to capture all manner of data from galvanic skin 
responses, to location, blood pressure and even real-time EEG monitoring. The mass variety 
of information captured in the phone feeds back to the patient, career and neurologist alike 
and the drug delivery system is administered. This envisaged system goes some way to 
painting a picture of the individual epilepsy patient, but it does not distinguish between one 
epilepsy patient or from the other nor address the types of seizures or the frequency of 
seizures from the patient. 
Table 2.2. Smart Approaches to Monitoring in Healthcare and Epilepsy 
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2.4 Personalised Healthcare and IoT (Internet of Things) 
Instead of being handed a leaflet from your clinician which explains your condition in general 
what if you could be presented with an individualised personalised plan? This plan could be 
made up specifically for your specific strand of the condition, tailor made based on your 
characteristics, patients could walk out of the surgery with a personalised assessment of their 
health and have their own personalised disease management plan [43]. Researchers are 
recognising there are changes coming in healthcare, which can endorse the meaningful use 
of electronic health care data, and patient-centered outcomes, even in 2013 the need for 
personalisation was becoming recognised noting that the timing has come about for this kind 
of  research direction [43]. 
Recently personalised healthcare is known to be facilitated by Internet of things (IoT). As 
endorsed by one of the major mobile providers in the UK identified is that IoT devices could 
provide patients suffering with long-term illnesses with access to more personalised treatment 
[59]. Hence these wearable devices which allow physiological signals to be continuously 
monitored at home can help to resolve the problem of occasional visits to the surgery that can 
only offer a transitory ‘window’ into the physiological status of the patient [60]. 
Personalised healthcare and IoT is becoming popular emphasised again with the recent 
advancements of wearable devices and smartphone, this is since the fast explosion of 
wearable devices, smartphone and IoT enabled technology. This technology is evolving 
healthcare from old fashioned hub based systems to more personalised healthcare systems 
(PHS) Personalised Healthcare Systems [61]. Therefore, IoT can be deemed as game changer 
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by endorsing personalised healthcare, because with these connected devices we can also 
achieve self-tracking whereby make way for a future where individuals will be more involved 
in the management of their own health and data will be generated that can benefit clinical 
decision making and research [62].  As key players in the move toward personalised 
healthcare IoT devices are thus attracting keenness from medical and public health 
professionals [63]. 
The idea that health conditions should be treated by recognising the ‘multiple factor’ 
elements, or the strands of the condition is beginning to come to light. For example in recent 
years it is becoming more apparent to treat organ monitoring systems by providing care by 
organ specialty. A healthcare delivery model that is personalised to achieve individual health 
outcomes is needed since chronic disease involves multiple health factors with complex 
interactions between them over a prolonged period of time [63]. Another technique in line 
with personalised monitoring deemed immensely useful for the management of important 
chronic health conditions, such as diabetes, obesity, depression, ageing and mental health is 
to determine the ‘parameters’ of the individual, this is achieved by the personalised 
monitoring of health by the determination of weight, activity, sleep, heart-rate, blood glucose 
diet and other parameters [64]. 
A further aspect of personalised healthcare identified is systems which provide tailored 
recommendation capabilities. Work done Ivanović M et al uses agent technologies to support 
healthcare cases and found this revealed ways to discover new applications such as 
personalised and socialised healthcare platforms and interestingly systems with tailored 
recommendation capabilities [65]. In order to discover the patient individually these new 
technologies enable opportunities to discover the patient’s preferences, traits, and states. This 
highlights the trend toward the focus of the patient as an individual, and requests healthcare 
plans which are specially tailored for these preferences, traits and states. 
 
2.5 Personalised Healthcare for Epilepsy 
Certainly the very complex nature of Epilepsy can lend itself to a personalised approach; 
because there are over 40 different types of seizure [66], in addition there is an enormous 
‘variety’ of behaviours that may occur in different types of seizures and furthermore seizures 
are usually; ‘Stereotypic’ meaning symptoms are similar whenever they occur [66]. An 
individual ‘seizure type profile’ or an individual ‘patient dataset’ can be realised and hence a 
personalised approach to treating epilepsy is assumed viable. 
Accordingly, the concept of providing personalised tailored recommendation capabilities 
could be applied to epilepsy. If the precise IoT smart device is matched to the precise 
‘particulars’ (based on their seizure indication and type) of the patient profile and 
continuously monitored then not only are the chances of capturing seizure data greater, but a 
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tailored healthcare plan could be provided to the patient which recommends that device. 
Ultimately, such a personalised environment could help those who might occasionally miss 
an epileptic event and make enhancements for carers performing their overall monitoring 
scheme [67]. 
As noted previously in this chapter personalised healthcare also embraces determining the 
‘parameters’ of the individual [68]. Therefore, it is appropriate to focus upon the parameters 
that make epilepsy patients distinct from each other in this thesis, this is addressed in the 
ontology development in Chapter 4.  One example is ‘seizure types’. The two most common 
types of seizure are generally described in two major groups generalised seizures and focal 
seizures (or partial seizures), the difference between the two is in how and where they begin 
in the brain [69]. Another parameter particular to an individual epilepsy patient is whether 
there is any movement during a seizure, when no motor symptoms happen, it is known as a 
non-motor seizure [70]. These parameters are just a few amongst many that can be used to 
identify the individual, the sheer diversity of epilepsy is commonly known and it is 
recognised that it is not one singular condition and that seizures occur frequently with a  an 
essentially wide range of seizure types, frequency and severity [68]. 
Similarly, during a survey on current seizure detection and classification technologies, 
Bidwell et al also found a need for better distinguishing between patients exhibiting 
generalised and partial seizure types and in turn achieving more accurate seizure counts [71]. 
Another study recognised that there was little available information on which combination of 
bio-signal or bio-signals is the best for individual seizure types and for each individual patient 
[72]. Here it is evident that ‘seizure types’ are addressed; these observations provide further 
evidence and endorse the fact that epilepsy patients are so different from each other and how 
there is a need to focus upon each individual and their ‘seizure type’ and to actually 
individualise the seizures. 
In addition to academic research, some non-academic sources suggest personalised 
monitoring of epilepsy [73]. For example, Niesm, an Australian company reveal a 
personalised epilepsy monitoring system. As with other gurus, they recognise that the current 
way of managing epilepsy is as in UK with video monitoring in hospital settings and with the 
gold standard EEG. They propose a solution using their devices whereby patients wear a 
watch device and seizures are captured continuously and data is recorded at their NIESM 
portal. 
Niesm highlight the current trend towards personalisation in their proposal where they deliver 
a personalised epilepsy monitoring system combines the latest advances in wearable 
technology with quantitative data analysis [73]. The personalisation aspect characterizes 
patient seizure activities over extended times, and their holistic approach uses machine 
learning to create personal patient profiles. This is a good method to achieve personalised 
healthcare using machine learning. These perceptions which find specific solutions for 
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Figure 2.2. Competitive Sensor Landscape  
seizure types [73] and recognise that other products do not embrace this, see Figure 2.2 which 
provides a good opportunity for researchers to find other methods to achieve this.   
 
 
2.6 Addressing Current Gaps 
Studies discussed in this chapter have revealed many IoT approaches for the monitoring and 
management of epilepsy many of which encompass a network of connected smart devices 
which are equipped with sensors either embedded in clothing or smart phones, to either 
detect, predict or manage epilepsy. Discoveries disclose how IoT is utilised to support the 
ever-growing trend of personalised healthcare. 
However, the monitoring approaches and systems uncovered in this review do not focus on 
the embracing of a truly personalised approach for epilepsy. Even though the ‘diversity’ of 
epilepsy is acknowledged and has been identified in other studies, i.e. by highlighting the 
importance of distinguishing each ‘seizure type’, there is still a gap to address such 
parameters. The ‘seizure type’ is just one of many parameters that can distinguish one seizure 
patient from another. Therefore, these very individual characteristics can be further identified 
to address the challenge to achieve a truly personalised approach to managing epilepsy. 
More so recently researchers are recognising, that devices should specially take into account 
the user’s seizure types and personal preferences, [74] focus should be shifting not only on 
the desires of the users but seizure detection devices should be able to ‘adapt’ to the patient’s 
characteristics and seizures [74]. Regrettably, there are few specific sensor detection options 
for each specific seizure type, this is an imminent requirement for patients and their carers. 
Ideally when choosing a seizure detection device, the patient-specific seizure semiology’s 
should be considered [3]. Thus, highlighting the need for a type of monitoring that 
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distinguishes one patient from another and depicting the need for devices to pinpoint the 
patient-specific signs and symptoms. 
Primed from the literature analysis this thesis will begin with a focus upon the parameters 
that make epilepsy patients distinct from each other. In addressing the challenge to achieve 
this ‘personalised’ approach to remote monitoring system for epilepsy, other parameters must 
be found, so that the individual patient profile can be realised. Furthermore, it is important 
that specific sensor-based devices are identified to detect the individual parameters. 
To achieve this objective firstly the domain in question which is the ‘epilepsy patient’ must 
be understood, this will be achieved by developing an ontology.  
To begin the ontology development a suitable methodology should be selected which should 
begin with a ‘knowledge acquisition stage’ [75]. Part of this initial literature review aims to 
survey and discover the best methodology to use for the development of the ontology 
language. Section 2.6.1 shows selection process for a suitable method. 
Another aid toward personalisation is the concept of clustering. Recent discoveries in 
literature unveil focus upon clustering patient profiles. For example, in 2019,  Boeva et al 
focus on, the selection of a personalised treatment plan for a patient by using a split-merge 
evolutionary clustering algorithm, that can be used for maintaining patient profiles in 
healthcare [76]. In using clustering techniques, it was discovered that in associating patient-
specific disease characteristics the person’s increased risk for cardiovascular disease can be 
identified [77]. 
Similarly, a cluster-based approach is highlighted recently for patients with insomnia and 
considered a possibility to enhance patient care by guiding tailored patient-centered 
management of patients presenting with insomnia [78]. 
A mental health clustering tool released 2019  is used as a needs assessment tool designed to 
rate the care needs of a patient,[79] it uses rating scales, yet clinical human judgment is still 
needed, as observed in the NHS improvement publication when addressing HCP’s; they 
recommend that  the final clustering decision is still the clinicians based on their assessment 
results in applying this guidance (derived from clustering) [80], thus demonstrating user 
intervention is still needed. 
The prevalence of clustering patient profiles in different domains in healthcare is becoming 
apparent particularly in recent times:  another 2019 study is noticed for use in detecting drug 
use patterns and Klaid et al observe that in their knowledge this is the first study proposing 
cluster analysis for detecting drug utilisation patterns from electronic healthcare records [81]. 
Another clustering analysis study is discovered on acute decompensated heart failure 
(ADHF) where authors found that their results may be superior to bedside classifications [82]. 
This indicates the recent success of clustering. 
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Yet the only real value and purpose for clustering patient profiles is so that their treatment 
can be personalised, since every patient is capable of showing a different response to standard 
treatment procedures even for a well-defined clinical condition [83]. Likewise, as witnessed 
by Payne-Murphy and Beacham in 2014 when profiling chronic pain patients, the research 
pathway of tailoring personalised interventions based on the cluster profiles is highlighted 
when they identify clusters with significant differences among them [84] thus indicating the 
relevance of clustering in personalised healthcare. 
Yet there is limited evidence on clustering for epilepsy patient profiles and hence the 
discovery of profiles for epilepsy patients is an open question that needs addressing. 
Consequently, this thesis will address this gap drawing on knowledge from the ontology 
development in Chapter 4. Deeper analysis of the concept of clustering analysis is undertaken 
in Chapter 5 of this thesis. 
 
2.6.1 Ontology Development Methods 
In finding the ideal method to use for ontology development, this investigation/exploration 
of the literature demonstrates that there is no gold standard method for developing an 
ontology as witnessed by Noy & McGuinness in the claim that there is no single correct 
ontology-design methodology [75]. 
In the publication “Guide to Creating your First Ontology” [75] the focus is upon a simple 
knowledge engineering approach and uses ‘a good rule of thumb’ to provide a guide. It is 
discovered that the best solution almost always depends on the application that you have in 
mind and the anticipated extensions [85] this makes good sense due to the fact that each 
domain and scope of project is so different. 
Most methodologies achieve the same goals with a first stage usually named ‘data gathering’ 
whereby key terms or keywords are identified. Noy & McGuinness call this the ‘Textual 
Analysis Approach’ and  such initial decisions should be made which consider the key terms 
to be talked about and their associated properties. Whereas another study phrase this stage as 
‘Information Extraction’ [86] and claim this stage is not a mere keyword filtering method; 
they use more precise steps and bring in linguistic analysis derived from Hobbs et al. [86]:i.e. 
text pre-processing, whose level ranges from mere text segmentation into sentences and 
sentences into tokens to a full linguistic analysis. 
Some researchers focus on Knowledge Acquisition Techniques used for ontology 
development [87]. Data gathering here involves interacting with domain experts to extract all 
of the required knowledge; gaining the vocabulary required for assisting in ontology model 
development [88]. Also defining a Glossary of Terms (GT), a group of tables to encompass 
types, classes, associations, attributes, and instances. 
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Boicu et al aptly describe ontology development as building a knowledge base and they assert 
that it is always a difficult task to start from scratch. Consequently, it would make more sense 
to try to reuse knowledge than to recreate knowledge [89]. Moreover, this reuse should also 
facilitate the communication between the systems because of their shared knowledge. 
 
2.6.2 Text Mining Approach 
Continuing the focus on the data gathering phase and the extraction of key terms a study by 
Tsoi et al looks at a text mining approach to ontology development in Bio-medical Science. 
It is identified that it still poses significant challenges developing such high-quality 
ontologies, as a wide range of domain experts need to be involved [90]. To aid ontology 
development they survey numerous methods that have been developed to extract terms from 
literature automatically. Tsoi et al find that these automatic extraction methods are hardly 
ever used despite these efforts, and that it is still widely recognized that ‘manual curation’ is 
the most reliable method for ontology development, therefore the chosen methodology for 
this research will adopt this approach as observed later in Chapter 3, Methodology. 
Tsoi et al acknowledge (as do  researchers identified above) that it is a substantial challenge 
to determine which terms should be used as the basic building blocks to develop the ontology; 
interestingly they acknowledge that some objective method and measure is used without 
either a preliminary or confirmatory test conveying that the term selection process really 
relies on the expertise of individual curators,  and they endorse that a quantitative approach 
to evaluate whether terms are suitable to develop an ontology for a particular domain would 
provide this objective method and measure, improve the usefulness of the resulting ontology, 
and lessen the amount of work imposed on curators [90]. 
A similar approach to text mining is text clustering which is adopted by Rajput 2017 [91] 
although it does enable text-mining and some text extraction techniques. Rajput present a 
clustering ontology based text mining for grouping paper or proposals and assigning that 
grouped proposal to reviewers systematically. Again the challenging nature it is advocated; 
in the issue to find accurate knowledge, information (or features) in text documents to help 
users to find what they want and what data they want. Rajput find that most existing text 
mining methods adopted term-based approaches suffer from the problems of polysemy and 
synonymy and that generally traditional text mining has a problem with polysemy and 
synonymy. Yet the popularity of text mining is growing due the fact it can automatically 
discover the knowledge assets buried in unstructured text [91]. 
2.6.3 Sequential Ontologies 
Indeed, there is a significant challenge in constructing a well-developed and sharable 
ontology to address the research questions.  
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Since investigating many authors, it is apparent that there is range in the way ontologies are 
designed. Some of these methodologies and approaches have been reported in the literature 
regarding ontology building methodologies. However, there is ongoing argument within the 
ontology community about the best method to build them [92]. 
A study in 2015 [93] adapted methodologies to suit the purpose of coding historical 
documents, in this study the ontology building process was divided into the following stages: 
• Identifying the purpose, scope, and users 
• Domain analysis and knowledge acquisition 
• Building a conceptual (informal) ontology model 
• Formalization 
• Evaluation In our method, we focus on an evolving prototype of the ontology 
This sequential (step by step) process will be utilised and adapted for this research, to ensure 
robustness it is observed that at every stage of the development process there is specific 
criteria that must be adhered to such as clarity, coherence, extensibility, minimal encoding 
bia and Minimal ontological commitment [94]. 
Another sequential methodology used by Sampalli in 2011 [95] uses a generic framework for 
the development of an ontology and is divided into three important phases: a specification 
phase, a conceptualization phase, and an implementation phase. The generic steps and the 
variations that are involved in the development of an ontology in a heterogeneous domain 
such as a controlled vocabulary and involvement of domain experts is key to ontology 
development. 
Further sequential methodologies exist again demonstrating the stages of ontology 
development, this time comprising of with 4 phases: data gathering, data analysis, ontology 
development and testing [96]. Similarly, stages are similar to other methodologies used such 
as and stages can be adapted to suit its purposes and built from scratch if necessary [97]. 
 
2.7 Summary 
Evidence provided in this chapter showed that personalised healthcare is facilitated by IoT 
within industry yet there are very few experiments and limited evidence of how IoT sensor-
based devices are used in hospital settings. Consequently, could IoT be a game-changer in 
endorsing a personalised approach to epilepsy healthcare in hospital settings? Could the 
individual characteristics found in each unique patient profile be matched to a specific IoT 






This chapter explains in detail the research design and methods selected in order to achieve 
the aim. Methods and techniques adopted to extract the data, create the ontology, perform K-
means Clustering are discussed. Figure 3.1 shows a framework of the research design used 
for this thesis. The objectives (OBJ1-OBJ6) are also indicated on the ‘Research Design 
Framework’. 
For each stage of this study the various methods tools and techniques are discussed in detail 
in this chapter. The first stages: I & II comprise the theoretical analysis of the principles 
associated with the development of ontology languages.  The I. Preliminary Stage’ focuses 
on obtaining initial knowledge of the domain by looking at current ontologies in use, 
consulting experts and contemplating parts of the domain by drawing initial sketches. The II 
Ontology Stage begins by defining the hierarchy and extracting classes, properties and 
relationships then implements and evaluates the ontology. The ‘III. Clustering Stage’ was the 
next logical step as data has formerly been prepared: here clustering techniques are analysed, 
and the chosen technique is used to perform the Cluster Analysis and evaluate the results. 
The last stage is the ‘IV. PMP Framework and Testing Stage’: here the most appropriate 
devices are surveyed for defined criteria required and testing on the patients takes place. The 
framework is also developed at this stage and finally put to test in simulated epilepsy 
scenarios. There is a considerable ethical scrutiny process adhered to for the testing to take 
place, this is undertaken at various phases throughout the study. 
 
3.2 Research Design 
In selecting appropriate research methods several factors were considered: the research 
question, ethics, and time are all major considerations. This sequential approach to research 
for this study involves the use of mixed research methods to achieve the aims and objectives. 
Mixed methods research is found to be one of the three major research paradigms including  
quantitative and qualitative research [98]. 
This study uses a sequential strategy which incorporates the mixed methods mentioned 
above. This is represented in the ‘research design framework’ seen in Figure 3.1. The research 
approach model was influenced by earlier findings in the literature during analysis of 
methodologies for ontology development whereby the generic steps and variations that are 
involved in the development of an ontology in a heterogeneous domain such as controlled 
vocabulary is key to ontology development.  
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3.2.1 Research Approach for Ontology 
This research approach was selected to address the research question by taking into account 
the following findings from the literature (Chapter 2): 
• Use a Sequential Framework. i.e. Sampalli in 2011 [95] uses a generic 
framework for the development of an ontology and is divided into three 
important phases: a specification phase, a conceptualization phase, and an 
implementation phase. 
• Adapt Stages of a Methodology. i.e. The methodology can be modified and 
tailored to its purpose and even built from scratch if necessary [96]. 
• Use a Manual Curation Approach. i.e. Findings indicate that when extracting 
terminology for an ontology: it is still commonly documented that ‘manual 
curation’ is the most reliable method for ontology development. 
Furthermore, as the information to be captured in this research depended 
critically on a combination of the domain and specific focus on capturing 
key terms for the domain, it was therefore crucial to select an approach which 
was all encompassing in order to exploit this knowledge. As observed such 
a sequential all-encompassing methodology can be modified to suit its 
purposes [96]. 
Understanding the parameters of a given individual ‘patient profile’ was imperative and the 
chosen framework served to depict this knowledge base. Once the ontology was created then 
data from the ontology can be at any time extracted from the place where it will be stored in 
the system in RDF or OWL and subsequently published on the Web. In this way, the ontology 
can be used by other users and systems based on the Semantic Web. This chosen design 
approach for the ontology development can be visualised implemented within a broad 











I. Preliminary Stage 
The methods selected for the Preliminary stage (A1:A3) are discussed below: 
A1.  Obtain Knowledge 
As part of the knowledge discovery process 3 knowledge pools are selected: 
➢ A1.1 Existing Epilepsy Ontologies  
➢ A1.2 The ILAE (International League Against Epilepsy) 
➢ A1.3 Knowledge from clinicians.  
 
A1.1 Existing Epilepsy Ontologies 
It was significant at this stage to see if there were any other existing ontologies, and to find 
if these ontologies were still in use or out-dated. Even if the existing ontologies were large 
scale it was the intention to see if any segments of them could be useful for the creation of 
ESO (Epilepsy Seizure Ontology) in this study. The ontologies were studied to see if they 
contained any epilepsy syndromes, seizure types, classes or data elements associated with 
them, which could be re-used for the ESO. Another element crucial to obtaining knowledge 
of the domain was to understand how experts or in this instance clinicians understood 
seizures. Classifications and categories that could be used to inform the ESO were 
investigated. 
 
A1.2 The ILAE (International League Against Epilepsy) 
The initial stage of this research work investigated any current taxonomies or ontologies for 
seizure types/classifications. In 2017, the ILAE released a new classification of seizure types, 
largely based upon the existing classification formulated in 1981. To depict routinely used 
terms in the patient profile domain and discover if any current standardisation for epilepsy 
ontologies or taxonomies existed, the most recent classifications and terminologies were 
investigated and updated to adhere to the ILAE (International League Against Epilepsy) [99]. 
The ILAE strives to provide definitions for key concepts and classification schemes that will 
help the world epilepsy community in developing a common language to communicate 
effectively regarding the many facets of epilepsy. The clear terminology, based on available 
evidence, was used to inform the development of a language named (for the purpose of this 
thesis): ‘PPDL’ (Patient Profile Description Language). At this stage the correct medical 
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terminologies were collected so that they could be embedded into the new ontology language: 
PPDL.  
 
A1.3 Knowledge from clinicians.  
To understand how experts or clinicians understand seizures, it was significant to gather and 
discover as much knowledge of the domain as conceivable.  
 
A2. Specification Phase  
In the specification phase knowledge of the domain is obtained. The two methods used in this 
phase are: 
➢ A2.1 Compile a list of routinely used terms 
➢ A2.2 Collect and analyse patient medical records 
 
A2.1 Categorise routinely used terms  
During this stage the intention is to further discover if there are any additional terminologies 
or classifications to be adhered to, this is to ensure that the ontology is reflected in the latest 
terminology.  
 
A2.2 Collect and analyse patient medical records 
In this specification phase knowledge of the domains in question, which were the actual 
‘patient profiles’ were acquired, this was done by accumulating and reviewing patient 
medical records and most significantly collecting the anonymous patient profiles.  
 
A3. Initial Sketch and Hierarchy 
At this stage initial sketches were drawn so that initial requirements could be looked at. Parts 
of the domain scope were considered, and core classes, properties or initial design patterns 
were contemplated. These initial sketches were not intended to cover all the requirements but 
instead the purpose here was to look at a minimum core set of concepts. The next step was to 




II. Ontology Stage 
The methods used for the Ontology stage (B1:B3) are discussed below: 
 
B1. Conceptualisation Phase  
This stage focuses on the collected vocabulary and uses the procedures defined below (B1.1-
B1.7) to convert it into the ontology to add deeper semantics.  
➢ B1.1 Defining the Scope 
➢ B1.2 Extract Classes & Attributes/Properties 
➢ B1.3 Define the classes and the class hierarchy 
➢ B1.4 Define the ‘object properties’, ‘data properties’ an ‘individuals’ 
➢ B1.5 Domains and Ranges   
➢ B1.6 Define Data Types and Data Values 
➢ B1.7 Disjoints 
 
B1.1 Defining the Scope 
The definition of ontology goal and scope is considered the first step in the ontology creation. 
The scope limits the ontology, specifying what must be included and what must not [100]. 
It is an important step for curtailing the amount of data and concepts to be analysed [100] 
especially for the extent and complexity of the ESO.  
In defining this common vocabulary for this specific domain or ‘sector’ of epilepsy 
information can be shared. The set of data is defined at this stage, and its structure will be 
available for other programs to use. Problem-solving methods, domain-independent 
applications, and software agents use ontologies and knowledge bases built from ontologies 
as data [101]. Making very clear domain assumptions [102] underlying an implementation 
makes it possible to change these assumptions easily if our knowledge about the domain 
changes. Hard-coding assumptions about the world in programming-language code makes 
these assumptions not only hard to find and understand but also hard to change, in particular 
for someone without programming expertise. In addition, explicit specifications of domain 
knowledge are useful for new users who must learn what terms in the domain mean [103]. 
Here the hierarchy is defined to depict a structured set of terms to describe the ‘patient profile 




B1.2 Extract Classes & Attributes/Properties 
The collected vocabulary at this stage is converted into the ontology to add deeper semantics. 
Prior to extracting the classes and attributes for the ESO important terms in the ontology were 
enumerated, similar to writing pseudocode before writing a computer program, useful lists of 
terms were recorded of which can be used either to make statements about or to convey 
information to the user of the ontology [102] i.e. What are the terms we would like to talk 
about? What properties do those terms have? What would we like to say about those terms? 
Much of this initial thinking is mined from the Preliminary Stage. 
To develop the class hierarchy and define the properties of concepts the process begins by 
creating a few definitions of the concepts, and an initial list of key terms in the hierarchy and 
then continued by describing properties of these concepts and so on.  
 
B1.3 Define the classes and the class hierarchy 
A ‘top-down’ approach is selected to develop the class hierarchy. Several other approaches 
are considered [104] such as a ‘bottom-up’ approach and a ‘combination development’ 
method. The ‘top-down’ approach is used since it started with the definition of the most 
general concepts in the domain and subsequent specialisation of the concepts.  The ‘bottom-
up’ approach is more suited to a larger ontology since it focuses on more detailed levels of 
grouping and used more sub-classes.  The ‘combination’ development process which is a 
combination of the top-down and bottom-up approaches is again suited to larger ontologies 
and leans more to those using several middle level concepts. None of these three methods is 
inherently better than any of the others. According to Rosch the approach to take depends 
strongly on the personal view of the domain [105] therefore demonstrating that the curator’s 
opinion is key to this decision. 
 
B1.4 Define the ‘object properties’, ‘data properties’ and ‘individuals’ 
Next the internal structure of concepts is defined. As the classes are already selected, are most 
of the collected remaining terms to be properties of these classes? These terms included, for 
example, a seizures type, symptom, frequency, patient ID etc. It becomes clear that the next 
3 concepts to be identified are: ‘object properties’, ‘data properties’ and ‘individuals.’ 
Initially it is confusing as to what should a property, what should be an individual and which 
are object properties? 
A property has a domain, which can be interpreted as the class of individuals to which this 
property can be applied whereas a range is the class of individuals that a property can have 
as its value [106]. As in OWL; object properties, are relationships between individuals and 
datatype properties, that is, relationships between individuals and basic types, e.g. numerical 
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or string [107]. Therefore, relationships are defined: “has a”: a patient “has” a seizure type a 
patient “has a” seizure type.  
Data properties specify relationships between individuals (or instances) and data values 
[108].  Therefore, for the class ‘seizure type’ has a certain name or code, or ‘patient’ has 
“profile ID”. Whereas ‘Individuals’ are instances of classes, and properties may be used to 
relate one individual to another. For example, an individual may be described as an instance 
of the class Person and the property ‘hasemployer’ may be used to express this relationship 
of the individual [109]. 
The next step is to identify the individuals. Individuals represent the instances from the 
classes. 
Individuals (instances) are the basic, ground level components of an ontology. Individuals 
are specific instances of the concepts or objects [110]. The individuals help to bring the 
ontology to life and visually the developer can use different individuals to ‘try out’ the 
ontology. The ESO used 30 individuals. 
 
B1.5 Domains and Ranges  
At this stage domains and ranges are defined. Properties may have a domain and a range 
specified. Properties link individuals from the domain to individuals from the range[111]. 
Simplistically, the domain and range properties are used to provide an insight into the way 
that the property links a domain to an object. 
It is important to observe the domains and ranges as they are used as ‘axioms’ in reasoning, 
as witnessed in this example from Horrage; 
“if the property hastopping has the domain set as Pizza and we then applied the 
hastopping property to icecream (individuals that are members of the class 
icecream), this would generally not result in an error. It would be used to infer that 
the class icecream must be a subclass of Pizza!” [111] 
 
B1.6 Define Data Types and Data Values 
According to Leipzig an ontology usually includes some kinds of entities that are classes, 
relations, instances, data types and data values [112]. Therefore, the next stage specifies the 
data types and data values of the ESO.  Datatypes are important in the Semantic Web 
ontologies and applications, because most of which need to represent, in some way, various 
real world properties such as true/false, left/right or yes/no, therefore whether a string, 
Boolean, integer and so on. These aforementioned datatypes and data values are created and 
depicted in this section. Various Web ontology languages, such as RDF(S), OIL, 
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DAML+OIL1 and OWL2, have witnessed the importance of datatypes in the Semantic Web. 
All of them support datatypes [113]. 
 
B1.7 Make classes disjoint of each other to avoid multiple inheritance  
In preparation for the ‘Implementation Phase’ (using Protégé) it is important to make classes 
disjoint of each other to avoid multiple inheritance, so that there will only be an instance of 
one class. 
Hierarchies in which all types have only a single parent are referred to as single inheritance 
hierarchies, whereas hierarchies in which types can have more than one parent are referred 
to as multiple inheritance hierarchies. The problem with using multiple modes of 
classification and with allowing multiple inheritance is that the meaning of the ‘is_a’ relation 
becomes uncertain, resulting in errors on the part of both maintainers and users of an ontology 
[114] and the inability to use the hierarchy for automated reasoning.  While in practice it can 
be difficult to avoid multiple inheritance, even within a single mode of classification, multiple 
modes of classification (and therefore multiple meanings for is_a) should be avoided by using 
the corresponding specific relations (e.g. Has_location). The benefits are not only an ontology 
that has fewer errors, is easier to maintain, and can be used for automated reasoning, but also 
a reduced loss of information by using the more specific representation [115]. 
 
B2. Implementation Phase  
The next stage in the process is to build the ontology with Protégé [116]. The methods 
selected at this phase are divided and discussed in the following sections: 
➢ B2.1 Specify IRI 
➢ B2.2 Implement the Ontology 
➢ B2.3 Publish the Ontology 
➢ B2.4 Visualisation Tools 
➢ B2.5 Exporting to Web Ontology Language (OWL) 
  
B2.1 Specify IRI 




B2.2 Implement the Ontology 
Protégé 5 is used to implement the ontology (ESO). Protégé is an ontology development tool 
that is used to build and edit the ontology. The Stanford-created, Java-based program Protégé 
is chosen as the implementation mechanism for ESO. The Protégé software provides a 
development environment for the creation of an ontology through GUIs. Protégé has become 
a widely accepted program used for implementing ontologies into a computational 
environment and was chosen as a free, open-source software. Apart from Protégé there are 
more leading ontology editors including Ontoedit, Oiled, Chimaera. Yet Protégé has greater 
community support and deploys visual tools which lend itself appropriately to academia and 
for the purposes of ESO.  
 
B2.3 Publish the Ontology 
The ontology is published online so that it can be accessible for Evaluation Tool use later. 
 
B2.4 Visualisation Tools 
Protégé provides excellent extensions for ontology visualisation. In order to comprehend the 
structure of the ESO, graph visualisation was used. Ontograph provided useful support for 
interactively navigating the relationships of the ESO ontology; there are various layouts that 
Ontograph supports which automatically organise the structure of the ontology. It also 
supports different relationships and each subclass, individual, domain/range object 
properties, and equivalence. The developer can filter relationships and node types which aid 
to create desirable views [117]. Findings also identify that there is a high demand for further 
assessment and analysis of the ontology and these tools which graphically visualise 
ontologies are being used to aid this [118] therefore the OWLviz plugin is used in addition, 
to allow the asserted and inferred classification hierarchies to be visualised. 
 
B2.5 Exporting to Web Ontology Language (OWL) 
The next step is to export the ontology into the Web Ontology Language (OWL) and to 
transform it to a semantic ontology. The Web Ontology Language OWL extends RDF and 
RDFS. Its primary aim is to bring the expressive and reasoning power of description logic to 
the semantic web [109]. The semantic web is a set of standards and best practices for sharing 
data over the web for use by applications not for human beings. RDF is the standard for 
semantic web (not a language but a data model). OWL builds on RDF; the reason OWL is 




Protégé fully supports the latest OWL 2 Web Ontology Language and RDF specifications 
from the World Wide Web Consortium [119]. The OWL Plugin is a Semantic Web extension 
of the Protégé ontology development platform. The OWL Plugin can be used to edit 
ontologies in the Web Ontology Language (OWL), to access description logic reasoners, and 
to acquire instances for semantic mark-up.  
Embracing the semantic web is an important consideration for the future of PPDL, whereby 
web languages used by the semantic web can become IoT enabled and better enable objects, 
devices and people to work in co-operation [87]. The initiative by Tim Berners Lees’ 
semantic web can link knowledge-based systems such as PPDL.  
 
B3. Ontology Evaluation Phase 
In this phase the methods selected to debug the ontology and remove errors are demonstrated. 
Finally, to evaluate the ontology a review by domain experts for accuracy and completeness 
of the knowledge represented in the ontologies is undertaken. 
The steps are divided and discussed in the following sections: 
➢ B3.1 Reasoners in Protégé 
➢ B3.2 Protégé Debugger 
➢ B3.3 Evaluation Tools 
➢ B3.4 Review by Experts 
 
B3.1 Reasoners in Protégé 
To ensure the quality of the ESO ontology, and to deal with any inconsistency and uncertainty 
for use in other applications reasoners in Protégé are used. The quality and correctness of 
ontologies play a vital role in semantic representation and knowledge sharing [120]. DL 
reasoners verify whether there are any logical contradictions in the ontology axioms [121]. 
An inconsistent ontology means that an error or a conflict exist in an ontology, as a result 
some concepts in the ontology cannot be interpreted correctly. The inconsistency will result 
in false semantic understanding and knowledge representation. An uncertain ontology means 
that the correctness of the ontology is probabilistic. Ontology reasoning reduces the 
redundancy of information in knowledge base and finds the conflicts in knowledge content 
[121]. 
Reasoner is a software that is used to derive new facts from the existing ontologies. Some of 
the popular reasoners developed in the last few years are: Pellet, RACER, FACT++, 
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Snorocket, Hermit, and others. A reasoner is a program that infers logical consequences from 
a set of explicitly asserted facts or axioms and typically provides automated support for 
reasoning tasks such as classification, debugging and querying [122].  
Protégé 5 has two reasoner options, FACT++, and Hermit 1.3.8. FACT ++. FACT ++ is the 
reasoner chosen for the ESO, even though hermit is a reasoner based on Description Logic 
(DL) it is more suited to larger and more complex ontologies [123]. 
An updated version of fact is FACT ++. This reasoner uses the same algorithm as in fact, but 
with a different internal structure. It is implemented in C++. The first version of the FACT 
++ was only supporting the reasoning in SHOIQ, OWLDL. However, the latest version of 
FACT ++ supports OWL and is based on the description logic SROIQ. FACT ++ implements 
a tableau-based decision procedure for general tboxes and incomplete support for aboxes 
[124]. The quality and correctness of ontologies plays vital role in semantic representation 
and knowledge sharing [120]. 
After an ontology is developed, it is used, reused, and related to other ontologies, and also 
needs to be maintained. These tasks may be easier when an ontology is designed with these 
tasks in mind. For example, building ontology on a shared upper ontology and using a 
modular design usually means easier use and maintenance.  
  
B3.2 Protégé Debugger 
The debugger in Protégé is also used to check if ESO is coherent and consistent. 
 
B3.3 Evaluation Tools 
There are numerous theoretical models and metrics for evaluating an ontology, but still there 
is a problem for evaluating ontologies as some anomalies can appear in developed ontologies 
since ontologists should handle diverse difficulties [125]. Therefore, in any ontology 
development project it is vital to perform the ontology evaluation activity since this activity 
checks the technical quality of an ontology against a frame of reference [126]. 
The vision of the Semantic Web originally proposed by Berners-Lee et al. [126] has promoted 
the continued growth of dataset published as well as the publication of ontologies used to 
model and enrich semantically these data. In this scenario, as important of the quality of the 
data published should be the quality and validation of the ontologies bringing semantic to 
such data. These ontologies should be published according to LD principles, but they also 
must be evaluated at different stages, both during their development and their publication. 
Thus, the evaluation of those ontologies has become a significant challenge. Ontologies 
developed following a particular methodology (e.g., NeOn Methodology [127] or 
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Ontoknowledge [128] have normally higher quality than those built without using 
methodological guidelines. However, to apply methodologies for building ontologies do not 
guarantee to have final products completely free of errors.  In order to produce a list of 
evaluation results, the Ontology Pitfall Scanner [129] takes as its input the ontology to be 
analysed. The system is accessible to humans by means of a web user interface and to 
machines throughout a web restful service that will be detailed in Section 3 and Section 4 
respectively. The input ontology could be entered by its URI or the OWL code 2, which 
describes the ontology to be analysed.  
Once the ontology is parsed using the Jena API3, the Pitfall Scanner module inspects the 
declared ontology looking for pitfalls among those available in the catalogue. During this 
scanning phase, the ontology elements prone to potential errors are detected, whereas some 
modelling suggestions are generated by the Suggestion Scanner module. Then, the evaluation 
results are provided including the list of pitfalls detected, if any, and the ontology elements 
affected, as well as explanations describing the findings. The system allows not only 
analysing all the automated pitfalls, but also choosing specific pitfalls or predefined groups 
according to the pitfall classification. Finally, a conformance badge is provided to the user 
together with the HTML code for including it within the ontology documentation website 
[129]. 
 
B3.4 Review by Experts 
Review by domain experts for accuracy and completeness of the knowledge represented in 
the ontologies. The experts will be asked to complete an evaluation form and answer 
evaluation questions to clarify any ambiguities throughout the development of the ontology.  
 
III. Clustering Stage 
The methods used for the Clustering stage (C1:C2) are discussed below: 
 
C1. Clustering Analysis  
Prior to performing clustering, this stage carries out an analysis on clustering tools. Discussed 
in section C1.1. 
C1.1 Clustering Analysis Overview 
This section investigates the concept of clustering in general. Beginning by looking at its 
theory and background it further discusses its use in society and how clustering essentially 
models data. It was important to see what role clustering plays in other applications and if it 
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has achieved any success. Finally, it was imperative to see how it will be applicable/beneficial 
to this research. 
By looking at the concept of clustering, it was valuable to see what it tries to achieve, this 
was done and discussed by looking at examples. The techniques and algorithms available for 
clustering were analysed and discussed with the goal of determining the best approach to take 
for this study.  
Accuracy is important in the clustering environment and factors which affect this are 
flexibility and scalability. This is considered when deciding upon a partitioning or 
hierarchical type of clustering, this is discussed in this section. Euclidean Distance 
Calculation (EDC) used  to achieve efficiency was also discussed in this section. 
After analysing and discussing clustering analysis and techniques finally the chosen 
clustering method was selected which will be described in detail in the ‘Clustering’ Chapter 
5.  
 
C2. Perform Clustering  
The next stage outlines the methods used to performing Clustering with the chosen clustering 
method. Dataset preparation and pre-processing methods are used and discussed at this stage. 
Further Analysis on the dataset used in the ‘Ontology Stage’ is performed to ensure it is ready 
for OBJ.3 
Then follows ‘Data Cleaning’ whereby categorical attributes are converted to numeric values 
to be used for K-means. This stage then uses the Pre-Processing tool in WEKA to [130] 
remove any noise or redundant data. 
There are many processes addressed and carried out to perform K-means Clustering on the 
pre-processed dataset. When performing the K-means algorithm in WEKA properties need 
to be measured and moulded to fit the needs of the outcome. These properties are, ‘Percentage 
Split’, ‘Choosing the Seed’ and ‘Choosing the Optimal Number of Clusters’. The 
aforementioned methods are carried out and discussed in Chapter 5 ‘Clustering’. Once the 
clustering is performed the K-means Results are evaluated and findings are discoursed, 
together with a discussion about how ‘Sum of Squared Errors’ is used to validate the cluster 
results. Finally, tools in WEKA are used for visualising the results, which provide a further 
analysis of the results. 
Sections are divided accordingly into the following sections below and discussed in detail in 
Chapter 5. 
C2.1 Dataset Preparation & Pre-processing 
C2.2 Data Cleaning 
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C2.3 Clustering Considerations 
C2.4 Percentage Split 
C2.5 Choosing the Seed 
C2.6 Choosing the optimal Number of Clusters 
C2.7 Evaluating K-means Results 
C2.8 Sum of Squared Errors 
C2.9 Visualising Results 
 
IV. PMP Framework & Testing stage 
The methods used for the PMP & Testing stage (D1:D3) are discussed below: 
 
D1. Experiment Procedures  
This section discussed the experiment procedures and carried out methods such as an analysis 
of possible IoT sensor-based devices and positions, experiment description and objectives, 
together with pilot study methods and finally the experimental results. 
Central to the study was the investigation to discover possible IoT sensor-based devices, in 
order to identify and obtain the IoT sensor-based device information methods are proposed 
here for collection and analysis. 
Additionally, the retrieval of this data from the devices also requires the researcher to 
understand and utilise techniques to analyse and visualise information collected from the 
device. This characteristic is also sought, and all are discussed in Chapter 6. 
The methods selected are outlined below. This mixed methods approach is selected because 
often a combination of techniques that gathers both quantitative and qualitative information 
will yield the most comprehensive results [131]. Furthermore, using a combination of 
methods, (see list below) whilst time consuming, has the advantage of gaining a 
comprehensive insight ensuring a full range and depth [131]: 
➢        Literature Review 
➢ Forum Discussions 
➢ Data Extraction Tests 
➢ Experiments with Apps 
➢ Observations and Surveys 
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➢ Information Gathering:  
o Discussions with Commercial companies 
o Contacting Researchers at other Universities 
• Exploring Data 
• Exploring all capable and available sensors 
• Discovering techniques to visualise extracted data 
Correct sensors had to be discovered in order to analyse and discover if there is any change 
in a patients behaviour through assessing an IoT sensor-based device performance during a 
seizure: hence to see if the patients known time of seizure matched the sensor behavior on 
the device.  
This section also analysed ‘sensor positions’ i.e. Can an individual patients profile indicate 
which part of the body the sensor should be positioned?  
This experiment focused on the theory (study hypothesis) of the ‘personalised approach’ to 
see if it worked in practice, hence: could the individual epilepsy patient profile make a 
difference in which device to wear? The experiment objectives, eligibility criteria and data 
collection and analysis are discussed here, (see Chapter 6). 
These experiments will be carried out by consenting NHS patients wearing the IoT sensor-
based device containing a custom-made APP which will ascertain the time of seizure from 
the accelerometer and heart-rate sensor. 
To carry out testing upon hospital patients, a vigorous NHS application process was 
undertaken using ‘The Integrated Research Application System’ (IRAS). The IRAS is a 
single system for applying for the permissions and approvals for health and social care / 
community care research in the UK.  The methodology for this study and the protocol is 
discussed later in Chapter 6. 
Once the IoT Sensor-based device was chosen a pilot study was undertaken. Preliminary 
Experiments with the selected sensor-based device are performed, and simulated data from 
the sensors is collected. 
Results and findings from experiments on epilepsy patients and volunteers are discussed and 
analysed in this section. 
 
D2. Develop PMP Framework 
This section discusses the development of the PMP framework. The framework was designed 
with components which will support the PMP (Personalised Monitoring Plan), this is 
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presented in Chapter 7 . The components are discussed at this stage, the two main features 
are ‘Personalisation’ and ‘Monitoring and Management’. At this stage only the 
‘Personalisation’ components are implemented.  It is not intention of this thesis to implement 
a fully operational system but instead a sequential framework which represents components 
of the system. To produce the PMP framework this research has chosen a sequential method 
and offers a conceptual framework for understanding and approaching the decisions and 
obstacles that arise in monitoring epilepsy. As observed by Mcgaghie Et Al: when presenting 
the particular research question the conceptual framework sets the scene that drives the 
investigation being reported based on the problem described [132]. 
 
D3. Testing and Validation 
This section discussed the testing and validation of the PMP framework. Here the PMP 
frameworks’ personalised approach capabilities are tested so that the research hypothesis can 
be validated. 
In Chapter 7 the PMP framework is tested in two epilepsy scenarios through a Use Case 
Evaluation ( see 7.6 Use Case Evaluation) and the results determine how effective the 
developed framework can be used as a tool for recommending the IoT device to an epilepsy 
individual patient. Therefore, significant evidence will be presented from the epilepsy 
scenarios and ensure that it is a dependable and useful tool.  
The testing will be conducted by healthcare professionals in simulated epilepsy scenarios 
whereby random anonymous individual patient profiles will be input to the PMP framework.  
 
3.3 Summary 
This chapter explained in detail the research design and methods selected to carry out the 
research this thesis.  The sequential ‘Research Design Framework’ shown in  Figure 3.1. 
Research Design Framework) demonstrated a novel way to approach the research 







 Ontology for PPDL 
 
4.1 Introduction 
This chapter presents the steps taken to gather the knowledge to inform the outcome which 
is the PPDL (Patient Profile Description Language). In gathering this knowledge, the ESO 
‘Epilepsy Seizure Ontology’ is developed. 
To begin there is the knowledge discovery process with a clear focus on the dependable 
attributes for a ‘patient profile’ showing how they are discovered and fed into the ESO to 
develop the PPDL. This chapter discusses the implementation of the ontology and presents 
the authentication of the ESO in line with the present vocabularies used in current hospital 
settings demonstrating how they will be useful to create a PMP (Personalised Monitoring 
Plan). 
Focusing upon ‘I. Preliminary Stage’ and ‘II. ‘Ontology Stage’ of the Research Design 
Methodology, (see Figure 4.1) presented in Chapter 3, stages A1:B3 are discussed. Beginning 
with where the knowledge is obtained, right through to the Ontology Evaluation this chapter 
will demonstrate (using the stages of Research Design) the outcomes at each stage and 












 Figure 4.1. Preliminary and Ontology Stage 
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4.2 Preliminary Stage (I) 
The Preliminary stage consists of three activities (A1-A3) 
 
A1.  Obtain Knowledge 
As part of the knowledge discovery process 3 knowledge pools are selected: 
A1.1 Existing Epilepsy Ontologies  
A1.2 The ILAE (International League Against Epilepsy) 
A1.3 Knowledge from clinicians.  
 
A1.1 Existing Epilepsy Ontologies 
At present, there are more than 300 biomedical ontologies listed at the NIH-funded National 
Center for Biomedical Ontologies (NCBO) [133], at the time of writing this thesis only 3 
epilepsy ontologies are found in this database, see Figure 4.2. Epilepsy Ontologies [133]. 
These 3 existing epilepsy ontologies are large scale. One widespread and prevalent ontology 
is EPSO (The Epilepsy and Seizure Ontology) this being the largest with 1357 classes. EPSO 
is the most all-encompassing ontology, whereas another epilepsy ontology; ‘EPILONT’, 
although based on the diagnosis proposed by the International League Against Epilepsy 
(ILAE) is focused specifically upon Eletroencefalogia which is apparatus for epilepsy. ESSO 
(2015) a more recent ontology contains epilepsy syndromes, seizure types, and data elements 
associated with them, this is useful, and classes can be re-used for the ESO but it is not 
updated to ILAE 2017. As identified by Berg et al; since epilepsy is known to have inherent 
complexity and a diverse stakeholder community this in turn affects the task of the 
classification of epilepsy, making it a complex and controversial undertaking” [134]. 
 




A1.2 The ILAE (International League Against Epilepsy) 
The most recent classifications and terminologies are followed from the ILAE . The clear 
terminology, based on available evidence, is used to inform the development of the PPDL 
(Patient Profile Description Language). The ILAE classifications are large scale but 
nevertheless the correct medical terminologies are adhered to by updating the old terms to 
the new terms and noting and abbreviations, for each seizure type, symptom and sign. These 
are embedded into the ontology. A snapshot of this process is shown below Table 4.1. ILAE 
Classification’s. 




































A1.3 Knowledge from clinicians.   
Another element crucial to obtaining knowledge of the domain is to understand how experts 
or in this instance clinicians understand seizures. It is discovered within literature [99] that 
clinicians generally classify seizures by “Symptoms”, “Signs” and “Seizure Type”. These 3 
classifications are used to inform the PPDL 
It is also found that the current practices (within the hospital settings) collect seizure type 
information upon patient appointment and during monitoring. Each patient has their own 
‘medical record’ which is completed and updated during these times. Discussions with 
clinicians revealed: 
• There is no current catalogue of any patients attributes i.e. A database which 
lists symptoms such as, ‘metallic taste’ or ‘déjà vu’ or ‘finger rubbing’. 
Likewise, there is no specific list for ‘Seizure Types’. Instead seizure type 
information is presented sporadically within the patient records i.e. Within 
descriptive paragraphs. Indeed all 3 classifications are mentioned, together 
with their associated attributes but these classifications are not easy to extract. 
• In addition to the 3 classifications other information that is revealed by 
clinicians during discussion is: 
o The way in which a symptom and sign is interpreted during practice: 
a symptom is something the patient reports. A sign is what the doctor 
observes. For example, an aura (the feeling the patient has before a 
seizure) could be a symptom of a seizure (as the patient is reporting 
it). However, if the patient is seen stiff and shaking that would be a 
sign. The combination of symptoms and signs results in the diagnosis 
of epilepsy.  
o Patients are identified in 2 categories: ‘Observed Patients’ and those 
that are ‘Appointment Patients’ and self-monitored (seen every 3/6 
months). The ‘Observed Patients’ are only the patients who are having 
frequent episodes considered more than 2-3 per week. The observed 
patients are monitored by video telemetry & EEG and are in hospital 
for 5 days. 
o When analysing the observed data from the video telemetry & EEG 
there are no techniques used to learn from the data, the lab technicians 
basically look and can identify with the naked eye when a seizure 
occurs. 
In summary of these findings the overall observations reveal that there is indeed a gap 
highlighting a need for patient seizure type information to be organized and categorised. The 
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3 classifications found in literature are strictly used within hospital settings, and the 
interpretation of ‘signs’ and ‘symptoms’ has also been understood. Interestingly patients with 
frequent episodes are considered 2-3 per week and need to be observed by the hospital. Lastly 
the datasets from each patient when being monitored are used ‘only’ to detect the seizure in 
real-time and the data does not appear to be used for any analysis after the seizure event, 
illustrating an opportunity for utilising this data in the future. 
 
A2. Specification Phase  
In the ‘specification phase’ knowledge of the domain is obtained. The 2 goals in this phase 
are: 
A2.1 Compile a list of routinely used terms 
A2.2 Collect and analyse patient medical records 
 
A2.1 Compile a list of routinely used terms 
During this stage the intention is to further discover if there are any additional terminologies 
or classifications to be adhered to, this is to ensure that the ontology is reflected in the latest 
terminology. It is discovered in 2017 that in the study by Fisher et al [99] a way of 
categorising the main routinely used terms related to seizures, is identified see Figure 4.3. 
Categorising Routinely used Terms. 
These additional categorisations aid to individualise the patient profile and are embedded in 




Figure 4.3. Categorising Routinely used Terms 
A2.2 Collect and analyse patient medical records 
100 anonymous patient medical records are collected. Once the data is gathered it is analysed 
to discover if values for each of the attributes are different for each patient, and to address the 
research question derived from RQ 1b. “How can an understanding of typical seizure patient 
profiles be achieved?” To do this the key considerations during this process, are listed below 
and then a discussion follows:  
• ‘Are there any further categories to note and embed?’ 
• ‘Are there any commonalities found between seizure type patients?’ 
•  ‘What are the main symptoms discovered?’ and ‘are the seizures 
diurnal or nocturnal?  
Upon analysing the 100 patient medical records further categories are observed and 
embedded to support individualising the patient profile, i.e. ‘diurnal (daytime) or nocturnal 
(nigh time)’ and ‘frequency’ (to ascertain how often the seizures occur). 
The data collected demonstrates that values for each of the attributes are different for each 
patient, a snapshot of this data is shown in Table.4.2, ‘Personalisation Measures’. This table 
presents a diverse selection of patient profiles to demonstrate personalisation  measures. The 
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patient medical dataset displayed in this table was originally derived from unstructured data 
found in patient medical records which had no pre-defined organisation. Therefore, to make 
it easier to analyse potential personalisation measures the data was organised into categories 
under the headings: profile id, seizure type, alert for patient, typical actions during seizure, 
occurs from sleep and frequency. These initial categories discovered from the patient records 
were considered one of the crucial steps in determining the individual patient. The colouring 
scheme used in Table 4.2 is referred to in the next paragraphs and further emphasised in a  
key provided at the end of the table.   
Not one patient is the same as the other; every patient’s values are unique. Based upon the 
first 50 records, there are 13/50 patient profiles whose seizures are one or more daily, this is 
‘high frequency’, indicated in red in Table 4.2. Personalisation Measure’s.  
Commonalities found between these seizure type patients are that the patients mainly have 
the ‘seizure type’ known as GTC (General Tonic Clonic Seizures), indicated in purple, but 
the seizure occurrence is either diurnal (daytime) or nocturnal (night time), yet often ‘both’ 
(in yellow) and the ’signs’ are anything from stress, metallic taste, tingling hands, confused, 
dizzy or none at all. 
One of the main symptoms found for “Symptoms” during the seizure is shaking (or other 
times described as jerking or whole body shaking), known as ‘clonus’, shown in green. 








Table 4.2. Personalisation Measure’s 
 
Profile Seizure Type Alert for patient Typical Actions During seizure  Occurs from Sleep Frequency 
Profile 1 
(384362) 






palpitations, unable to 
catch breadth 
Full jerking of body or 
Can just be arms or legs (no tongue 
biting) 
Hip and leg twitching 
Yes (both: day & 
night) 









odd feeling in head 
then appears vacant 
Possible lip smacking occasionally 
LOC, convulsions. (during recording: 
3 times the patient raised the right 
arm, & shaking movements were 
observed with some repetitive rubbing 
of fingers) 
Yes (both: day & 
night) 
1-2 per month 
Profile 3 
(164396) 
• Partial seizure  
• GTC 
Suddenly switches off: 
does not seem real 
Partial seizure then GTC  1 every 2 days 





• Blank Spells 
(Absences) 
• GTC 
Metallic Taste for 
absences 
No warning for GTC 
Body Stiffening & shakes, foaming at 
mouth, tongue biting, 
Yes (both: day & 
night) 
1 every 2 days 




• Visual Auras 
Visual Disturbance: 
flickering coloured 
lights in right eye that 
spread to left then loss 
of vision 
GTC, tongue biting, occ. Urinary 
incontinence 
Yes (both: day & 
night) 
Weekly Aura 







Aura of dizziness, 
fuzzy head, raising 
sensation 
Bursts of Seizure, LOC, Confused 
behaviour, tongue Biting 
Both Day and night Daily 
Gelastic (10 a day) 
GTC : 3 per month 
CPS: 1 per week 
Profile 21 
 
• GTC When stressed, more 
frequent 
Jerking of limbs, occasional 
incontinence 
Night 1 or 2 a week 
Profile 22 
 
• GTC  
Déjà vu, head rush 
Shaking, tongue biting, incontinence, 
confused 
Daytime Every 4 to 5 days. Up to 10 per 








No warning Appears vacant, picking at cloths, lip 
smacking 










Daytime Absences: 1 per day 
GTC: Every 2-3 months 
Profile 25 
 
• Drop Seizure No warning LOC, falling asleep without warning, 
twitching 





No warning then 
Collapse, LOC 
Collapse, LOC,  
During GTCS: Intermittent shaking of 
right arm (lasting over an hour) 
Many similar events of right hand/arm 
shaking 
Yes (both: day & 
night) 
2-3 times per week 
 
 








A3.  Initial Sketch and Hierarchy 
The initial sketches for the ontology facilitated initial requirements and at this juncture parts 
of domain are contemplated.  When developing an ontology next step is to identify the core 
classes of the domain, this initial step addresses organisation  and introduces structure to the 
terms[135]. The core classes identified are the ‘Patient’ and ‘Seizure’, additionally the 
associated entities considered significant are ‘Seizure Frequency’ and ‘Seizure Indicator’. 
The ‘type’ of seizure is also important i.e. ‘Focal’, ‘GTA’, ‘Partial’, it is envisaged that these 
are the ‘properties’ of the core classes. Sketching some initial diagrams helps to begin the 
thought process in terms of ‘hierarchy’ and the driving questions are: 
• How can each individual patient profile (1-100) be  represented? 
• Should the seizure indicator be a sub-class of seizure or patient? 
• How can the frequency of the seizure be categorised? 
It is apparent during this stage how the ontology development is going to be an iterative 
process; nouns and verbs from the knowledge source are used to sketch an concept of the 
overall structure and it is envisaged that later stages will go through multiple iterations to 
refine the structure, [136] see Figure 4.4. Initial Sketch & Hierarchy.  
(Where the figure demonstrates the rough idea that a seizure ‘may’ occur from ‘sleep/not 
sleep’ simply demonstrates ‘either/or’ and for clarification purposes there is no foreseen plan 
within the scope of this thesis at this stage to capture stochastic information.) 
These initial sketches are not intended to cover all the requirements but instead the purpose 
here is to look at a minimum core set of concepts. At this stage only a minimum core set of 




Figure 4.4. Initial Sketch & Hierarchy 
 
4.3 II. Ontology Stage 
The Ontology stage (B1:B3) is discussed below: 
 
B1. Conceptualisation Phase  
The collected vocabulary is at this stage converted into the ontology to add deeper semantics. 
Any relationships in existing concepts are identified. This is discussed below; first the scope 
is defined then the classes, properties and attributes are extracted and defined. 
B1.1 Defining the Scope 
B1.2 Extract Classes & Attributes/Properties 
B1.3 Define the classes and the class hierarchy 
B1.4 Define the ‘object properties’, ‘data properties’ and ‘individuals’ 
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B1.5. Domains and Ranges   
B1.6. Define Data Types and Data Values 
B1.7. Make classes disjoint of each other to avoid multiple inheritance 
B1.1 Defining the Scope 
The definition of the ontology goal and scope is now considered, this is the first step in the 
ontology creation. The scope limits the ontology, specifying what must be included and what 
must not. It is an important step for minimizing the amount of data and concepts to be 
analysed, especially for the extent and complexity of the ESO. This ontology only considers 
the needs for creating an ‘individual’ patient profile with concepts related to the patient’s 
‘seizure’ and characteristics specific to their seizure. It does not consider the concepts related 
to other areas such as the patient’s personal details, i.e. weight, height or any other area such 
as EEG results or other treatments. It only includes concepts related to the actual seizure 
either before or during with the aim of demonstrating that it is the individual seizure type 
patient that makes a difference. This is because there is evidence amongst other studies 
discovered in the literature review (Chapter 2) that whilst recognising the importance of 
achieving more accurate seizure counts there is also a strong necessity to better distinguish 
seizure types i.e. between patients exhibiting generalised and partial seizure types [71], also 
identified  is that there is minimal information on which bio-signal or bio-signals combination 
is best for the individual seizure types and for each individual patient [72]. 
To demonstrate how the above data is defined Table 4.3. Defining the Scope of the ESO 
Ontology shows how only the relevant data is selected, the decisions on ‘what to include’ and 
what ‘not to include’ are informed based upon the aforementioned philosophy discussed i.e. 













Table 4.3. Defining the Scope of the ESO Ontology 
 
What must be 
included? 
Notes What must not be 
included? 
Notes 
Patient The patient and the patient 
profile ID must be represented 
as the ‘individual’ 
Patient weight, height, 
medication etc. 
The ontology will not define any 
personal characteristics only those 
specific to the patient’s ‘seizure’. 
Seizure_Type The type of seizure is 
imperative to the individual. 
Sometimes the patient has 
more than one seizure type. 
Seizure History The history of the patient’s seizure 
is irrelevant since only its current 
occurrence is needed. 
Seizure_Sign The seizure sign depicts the 
‘start’ of the seizure and is 
significant as an alert to the 
sensor. 
Seizure Location The location of the seizure is useful 
to alert carers but the ESO does not 
need this to individualise. 
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Seizure_Symptoms The seizure symptoms are 
what occurs during the seizure 
and will often also alert the 
sensor when there is no sign or 
alert: i.e. ‘right arm shaking’. 
Seizure Reason Sometimes patients begin having 
seizures due to illness or accidents, 
again this is not useful to the ESO 
as it does not depict the individual 
seizure type. 
Seizure_Occurances How often the seizures occur is 
significant to the individual. 
This characteristic is specific 
to the individual. 
Seizure EEG results. Many seizure EEG datasets exist 
yet the emphasis of this study is to 
look at remote monitoring as an 
‘alternative’ to the gold standard 
EEG. 
Dominant_Side The dominant side, either left 
or right will determine which 
side the sensor will be worn. 
Sleep related disorder 
data 
Sometime sleep related disorders 
can produce symptoms of epileptic 
seizures so it was important to 
discount this data from patient 
records. 
Diurnal_Nocturnal Diurnal or nocturnal is whether 
the seizures occur at day or 
night. This is another 
characteristic specific to the 
individual. Sometimes this can 
be both. 
Seizure ‘duration’ The duration of the seizure was 
considered, yet its length is 
insignificant to the creation of the 
ESO as it does not specifically 
individualise the patient since the 




In defining this common vocabulary for this specific domain or ‘sector’ of epilepsy 
information can be shared. This initial set of data was defined as above, as discussed in the 
methodology chapter; the clear specifications of domain knowledge are beneficial for new 
users who must learn the meaning of the terms in the domain [75]. 
During part of an established step-by-step methodology (Domain Knowledge Acquisition 
Process: DKAP) [138] when developing an ontology, it is identified that the hierarchy should 
be defined to represent a structured set of terms; hence in this case to describe the patient 
seizure type domain which is used as the foundation for a knowledge base [138]. The 
knowledge in this domain will still evolve among domain experts, therefore ‘Epilepsy 
Specialists’ (doctors and nurses) are consulted and several discussions took place together 
with constant reference to the ILAE guidelines. 
The classes, attributes and relations are next developed and guided by the knowledge from 
the anonymous Patient Profiles (1-100) collected, the ILAE and by adhering to any existing 
relevant classes and attributes found in other ontologies. This process begins by extracting 
classes & attributes to inform the ontology. Following which the relations between these 
concepts are established, see ‘Object Properties’ in Table 4.4. Elements of  the ESO 
Ontology. Further details of how this conceptualisation phase is carried out is described 
below. 
 
B1.2 Extract Classes & Attributes/Properties 
Prior to extracting the classes and attributes for the ESO important terms in the ontology are 
enumerated, similar to writing pseudocode before writing a computer program, useful lists of 
terms are recorded of which can be used either to make statements about or to convey 
information to the user of the ontology [75] i.e. What are the terms we would like to talk 
about? What properties do those terms have? What would we like to say about those terms? 
Much of this initial thinking is mined from the Preliminary Stage. See, Figure 4.5. Initial list 





Figure 4.5. Initial list of Key Terms in the Hierarchy 
 
B1.3 Define the classes and the class hierarchy 
As justified in the Methodology Chapter, a ‘top-down’ approach is used to develop the class 
hierarchy [104]. The process starts with creating classes for the general concepts of the 
patient and seizure. Then it works down the hierarchy and focuses upon the ‘seizure class’ 
and considers any subclasses, if the subclass adds no new information it can be removed, and 
consequently the slot (class) already indirectly contains it [75]. Therefore the ‘Patient-Profile’ 
seen as a subclass of Patient in Figure 4.5. Initial list of Key Terms in the Hierarchy’ can be 
removed since Patient represents ‘Patient-Profile’. Yet a different thinking can apply with 
the subclass ‘S_Nausea’ of ‘Seizure_Sign’ since:  
“If a list of classes defining a range or a domain of a slot contains all subclasses 
of a class A, but not the class A itself, the range should contain only the class A 
and not the subclasses” [75] 
Moreover, ‘S_Nausea’, should be treated as an ‘Individual’ (also known as an instance) not 
a sub-class, as: 
“Deciding where classes end, and individual instances begin starts with deciding 
what is the lowest level of granularity in the representation [75]. 
Subsequently it is evident that there are no sub-classes in the ontology since it is not 
concerned with the extension or specific details of i.e. S_Nausea or other signs and symptoms 
and these elements are the lowest level of granularity therefore they are ‘individuals.’ These 
individuals can be seen embedded in Table 4.4. Elements of  the ESO Ontology. From Figure 
Classes Possible Sub-Classes Relationships 
Patient Patient Profile Patient ‘has a’ Patient_Profile 
Patient_Profile ‘has a’ Profile_ID  
 











Patient   ‘Reveals’       ‘Seizure 
Symptom’ 
 
Seizure Type FAS 
 




Once a Day  
Dominant Side Dominant_Left 
Dominant_Right 
Patient ‘displays’ Dominant Side 
 






4.5 created in the previous step terms are selected that describe objects having independent 
existence rather than terms that describe these objects.  
 
B1.4 Define the ‘object properties’, ‘data properties’ and ‘individuals’ 
Next the internal structure of concepts is defined. The classes have already been selected. 
Then the ‘object properties’, ‘data properties’ and ‘individuals’ are chosen as in Table 4.4. 
Elements of  the ESO Ontology. The full list of individuals for ‘Seizure Type and 
‘Occurrences are shown in Table 4.5. Full List of Individual.  Again, this theory is explained 
in the Methodology Chapter 3. The chosen object properties (also known as relationships or 
axioms) are defined here (and embedded in Table 4.4): 
 
Relationships (axioms) 
Patient ‘has a’ Patient_Profile 
Patient_Profile ‘has a’ Profile_ID  
Patient ‘exhibits’ a ‘Seizure Sign’ 
Patient ‘will have’ Seizure Type’ 
Patient ‘reveals’  ‘Seizure Symptom’ 
Patient ‘seizure time’ Diurnal/Nocturnal 
 
B1.5  Domains and Ranges   
Properties may have a domain and a range specified. Properties link individuals from the 
domain to individuals from the range [111]. Simplistically, the domain and range properties 
are there to provide an insight into the way that the property links a domain to an object. 
To demonstrate this in the ESO ontology, the property ‘Has_Sign’ links the individual 
‘Seizure_Sign’ belonging to the class Patient. In this case the domain of the ‘Has_Sign’ 
property is Patient and the range is ‘Siezure_Sign’. This is depicted in Figure 4.6. Domains 
and Ranges for ESO which shows the Domains and Ranges for the entire ontology together 
with the Classes, Object Properties and Individuals.  
Domains and ranges should not be understood as actual constraints, but as axioms to be used 
by reasoners [139]. In general, domain for a property is the range for its inverse and the range 
for a property is the domain of its inverse. As observed to help ensure the coherency of an 
ontology the use of domains and ranges are vital [140] confirming coherency testing for the 





Figure 4.6. Domains and Ranges for ESO 
 
B1.6 Define Data Types and Data Values 
The next stage specifies the data types and data values of the ESO. The datatypes and data 



















Data Properties Datatype Individuals 
(examples) 





Patient N/A  Profile_ID Integer 1,2,3 No 1 
Seizure_Sign N/A Patient ‘Has_Sign’ a ‘Seizure 
Sign’ 
Seizure_Sign String S_Nausea 
(Etc.) 
Yes True/False 
Seizure_Symptom N/A Patient  ‘Has_Symptom’       
‘Seizure Symptom’ 
Seizure_Symptom String Sy_Awareness 
(Etc.) 
Yes True/False 




String 1 = FMS 
(full list in 
Table.4.5) 
Yes True/False 
Seizure_Occurances N/A Patient 
‘Has_Seizure_Frequency’ of 
Seizure Occurrences 





















(full list in 
Table.4.5) 
Dominant_Side N/A Patient 
‘Has_Dominant_Side’ 
Dominant Side 
Left_Or_Right String Dominant_Left 
Dominant_Right 
No Yes/No 










Table 4.5. Full List of Individuals 
B1.7 Make classes disjoint of each other to avoid multiple inheritance 
In preparation for the ‘Implementation Phase’ the next step is to make classes disjoint of each 
other to avoid multiple inheritance, so that then there will only be an instance of ‘one’ class. 
As discussed in the Methodology Chapter the benefits of avoiding multiple inheritance 
Seizure Type Individuals Occurrences Individuals 
1 = FMS 
2 = FBTCS 
3 = GTCS 
4 = MTC 
5 = FSIA 
6 = NMA 
7 = unclassified 
8 = Gelastic 
9 = GA 
10 = FAS 
11 = Multiple: GTCS/NMA 
12 = Multiple: GTCS/FBTCS 
13 = Multiple: GTCS/FSIA 
14 = Multiple: GTCS/FBTCS 
15 = Multiple: GTCS/FAS 
16 = Multiple: MTC/GA 
17 = Multiple: Gelastic/GTCS/FSIA 
18 = Multiple: GTCS/FBTCS 
19 = Multiple: GTCS/NMA/FSIA 
20 = Multiple: GTCS/NMA/GA 
21 = Multiple: GTCS/NMA/FAS 
22 = Multiple: GTCS/NMA/GELASTIC 
23 = Multiple: GTCS/EE 
1 = once daily/nightly 
2 = multiple daily( up to 5) 
3 = multiple daily( over 5) 
4 = once weekly 
5 = multiple weekly (up to 5) 
6 = multiple weekly (over 5) 
7 = once monthly 
8 = multiple monthly (up to 5) 
9 = multiple monthly (over 5) 
10 = once yearly 
11 = multiple yearly (up to 5) 
12 = multiple yearly (over 5) 





deliver a reduced loss of information by using a more precise representation and provide an 
ontology that has less errors, that can be used for automated reasoning and is easier to 
maintain [115]. Consequently, the collected ontology concepts are inspected, and classes are 
made ‘disjoint’ of one another, see Table 4.6. 
Table 4.6. Disjoints 
Class Disjoints With 
Patient √ Seizure_Sign, Seizure_Symptoms, 
Seizure_Type, Seizure_Occurances, 
Dominant_Side, Diurnal_Nocturnal 
Seizure_Sign √ Patient, Seizure_Symptoms, 
Seizure_Type, Seizure_Occurances, 
Dominant_Side, Diurnal_Nocturnal 
Seizure_Symptom √ Patient, Seizure_Sign, Seizure_Type, 
Seizure_Occurances, Dominant_Side, 
Diurnal_Nocturnal 




Seizure_Occurances √ Patient, Seizure_Sign, 
Seizure_Symptoms, Seizure_Type, 
Dominant_Side, Diurnal_Nocturnal 
Dominant_Side √ Patient, Seizure_Sign, 
Seizure_Symptoms, Seizure_Type, 
Seizure_Occurances, Diurnal_Nocturnal 






B2. Implementation Phase  
Protégé 5 is used to implement the ontology. It includes the concepts and properties that 
characterize the data extracted from the analysis of the 100 anonymous patient records carried 
out in the previous stages. Protégé is an ontology development tool (discussed in 
Methodology Chapter) and is used to build and edit the ontology.  
Now that the design of the ontology has been decided, the next stage in the process is to build 
the ontology with Protégé 5. This sequential process can be seen in Figure 4.7. Protégé 
Implementation Steps. Using Table 4.4. Elements of  the ESO Ontology to guide the 
development the steps in Figure 4.7 are carried out. The steps are divided and discussed in 
the following sections: 
B2.1 Specify IRI 
B2.2 Implement the Ontology 
B2.3 Visualisation Tools 
B2.4 Exporting to Web Ontology Language (OWL) & XML 
B2.5 Publish The ESO 
 
 
Protégé Implementation Steps 
 
1. Specify Ontology IRI (put on webspace) to store ontology there 
2. Setup classes and sub classes 
3. Make classes disjoint of each other to avoid multiple inheritance (so will only be 
an instance of one class) 
4. Create Object properties (describing relationships between 2 properties of 
individuals) 
i.e. “has a ” :a patient “has” a seizure type 
a patient “has a” seizure type 
5. Specify the domain and range for object property 
6. Next is “Data Properties” which describes relationships between instance and 
data values for example  seizure type has a certain name or code. Or Patient has 
“profile ID” 
7. Run Reasoner, check everything is working and makes sense. 
8. Next is ‘Adding Individuals’: individuals represent the instances from the classes. 
i.e. from class Lecturer -individual  would be ‘lecturer 1’ 
so for class Patient we can have :Profile_ID_2 
 
9. Next is to publish the owl file ontology online 
 
 
Figure 4.7. Protégé Implementation Steps 
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B2.1 Specify IRI 
To begin the ontology set-up first the IRI is specified. Each named ontology has a specific 
IRI (Internationalized Resource Identifier) and the Ontology IRI should be an absolute IRI. 
For the present ontology, as recommended the Ontology IRI is in fact a URL (Uniform 
Resource Locator) (http://…........) This points to the web location from where the ontology 
can be downloaded. 
Protégé allows the Ontology IRI to be viewed and edited. The Ontology IRI also has an 
Ontology Version IRI. The version IRI describes the version of the ontology and this version 
IRI is also a URL that points to the Web location where this version of the ontology will be 
published.  
 
B2.2 Implement the Ontology 
Guided by Table 4.4. Elements of  the ESO Ontology, the next steps in the ontology 
development are carried out, from step 2 to 8 (Figure 4.7). 





























Figure 4.8. Ontology Implementation Snapshot 
 
B2.3 Visualisation Tools 
The structure of the ESO, can be visualised below, using Ontograph (see Figure 4.9. 
Ontograph Visualisation below).  
The relationships are interactively navigated within the ontology. The key below the ontology 
(Arc Types) shows the different relationships; subclass, individual, domain/range object 
properties, and equivalence. In this case there are no equivalence found in that no two classes 
had the same individuals in any interpretation, due to naming convention i.e. S_Visual 
=Sign_Visual and Sy_Visual=Symptom_Visual. The Ontograph aids in this analysis: for 
object and data properties, asserting that two properties are equivalent means that their 
domains and ranges apply to both properties, and that every assertion using one property can 
be rewritten as using the other [141]. With reference to Figure 4.9: the ‘classes’ are 
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represented with the orange symbols together with their ‘individuals’ (purple diamonds). 
While the colour key in the pane beneath (Arc Types) shows the relationships between the 
‘classes’ and ‘individuals’, namely the ‘object properties’. 
 
 
Figure 4.9. Ontograph Visualisation 
The Protégé VOWL plugin is also used to provide a ‘user-oriented’ visualization of the ESO 
ontology, see Figure 4.10. VOWL Visualisation. It implements the ‘Visual Notation for OWL 
Ontologies’ (VOWL).  
The Visual Notation for OWL Ontologies (VOWL) defines a visual language for the user-
oriented representation of ontologies. It provides graphical depictions for elements of the 
Web Ontology Language (OWL) that are combined to a force-directed graph layout 
visualizing the ontology [142]. 
This visualisation clearly focuses on the ontology schema (i.e. The classes, properties and 
datatypes). Connected by lines, the circles depict the classes and the arrows represent the 
property relations. Property labels and datatypes are shown in rectangles. Information on 
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individuals and data values is either displayed in the visualization itself or in another part of 
the user interface. 
The second ingredient of VOWL is a colour scheme complementing the graphical primitives. 
It defines colours for the visual elements to allow for an easy distinction of different types of 
classes and properties. The Protégé VOWL visualisation is used to present the ESO ontology 
in a user-friendly way and helps provide an overall ‘Birdseye view’ image. 
 
 
Figure 4.10. VOWL Visualisation 
 
B2.4 Exporting as ESO OWL and XML Serialization for PPDL 
As revealed in the Methodology Chapter 3, embracing the semantic web is an important 
consideration for the future of the ESO, as further observed recently that there has been an 
interest in presenting ontologies using ontology languages such as the Web Ontology 
Language (OWL) [143]. 
Also expressed recently is the observation that the success of the Semantic Web depends 
strongly on the growing amount of ontologies. Because of this reliability upon such formal 
ontologies there is also an impact on the structure underlying data for the purpose of 
comprehensive and transportable machine understanding [144] hence demonstrating the 
important role of ontologies on the Semantic Web. 
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Today ontologies are part of the W3C standards stack for the Semantic Web, providing users 
with the necessary structure to link one piece of information to other pieces of information 
on the Web of Linked Data [122]. 
Subsequently the ESO ontology is saved as a Web Ontology Language (OWL) and is thus 
transformed to a ‘Semantic Ontology.’ The OWL format, which is synonymous with Protégé 
is in a "pure" RFD (Resource Description Framework) format, which was also discussed in 
the Methodology Chapter 3.  
Before saving the ontology into an OWL file it is a necessary requirement to run the reasoner 
(see B3 later) first and fix any errors prior to this. There are different syntaxes for OWL in 
Protégée which first prompt the user to choose the version.  The default is RDF/XML and is 
the best format to choose, since it is the most stable in Protégé [145].  To import the Ontology 
to a web ontology (OWL file) the process is straight forward: using File>Save or File>Save 
as.  
Even though an ontology is used to describe knowledge in a certain domain, nonetheless the 
key is to keep in mind the three major uses of ontologies identified, to assist in communication 
between humans, to achieve interoperability, and to facilitate communication among software 
systems [146]. 
In order to achieve this for ESO and make it useable for HCPs (Health Care Professionals) it 
needs to be in a language that is understandable by humans and machines, [147] this can be 
accomplished by XML.  
Moreover, it is important to ‘retain’ the metadata schema from the ontology, this can be done 
with RDF serialisation. In addition, the vocabulary of the concepts used in the annotation can 
be  transformed into semantic annotations. 
There are several ways Protégé achieves this serialisation. Firstly, the OWL ontology is 
mapped to a set of RDF triples [147] then the RDF can be serialised in different formats, so 
in essence the outcome is the RDF/XML serialisation of the RFD mapping of an OWL 
ontology (OWL file). These serialisations include, Turtle, N3, RDFa (RDF embedded in 
HTML) and RDF/XML. 
Hence it is common to find that the OWL files which exist online are in fact RDF/XML 
serializations of RDF mappings of OWL ontologies [148]. 
Therefore, ESO is transformed (during the saving process mentioned earlier) into RDF/XML 
serialisation. This XML becomes an outcome: namely the PPDL (Patient Profile Description 
Language).  




B2.5 Publishing the ESO 
The latest version of the ESO ontology is published with its Ontology IRI.  PPDL is freely 
available at http://www.epilepsypatient.co.uk/PPDL.owl  a snapshot is shown in Figure 4.11. 
Snapshot of Raw XML PPDL. This ontology, once evaluated, will be been submitted to the 
Bioportal site of NCBO.  
Protégé uses a hash (“#”) by default to identify the classes and properties that are declared 
in the vocabulary/ontology. A slash (“/”) for this purpose is used as well. 
 
 
Figure 4.11. Snapshot of Raw XML PPDL 
 
B3. Ontology Evaluation Phase 
In this section tools used to debug the ontology and remove errors are demonstrated. Finally, 
to evaluate the ontology a review by domain experts for accuracy and completeness of the 
knowledge represented in the ontologies is undertaken. 
The steps are divided and discussed in the following sections: 
84 
 
B3.1 Reasoners in Protégé 
B3.2 Protégé Debugger 
B3.3 Evaluation Tools 
B3.4 Review by Experts 
 
B3.1 Reasoners in Protégé 
The importance of quality and correctness of ontologies in semantic representation and 
knowledge sharing was discusses in the Methodology Chapter 3. 
To determine the effect of axioms in more expressive logics, i.e., OWL 2 DL, the fact++ 
reasoner was used to attempt to classify the ontology. This fact++  reasoner can reason about 
Web Ontology Language (OWL) and Resource Description Framework (RDF) constructors, 
deducing new facts in ontologies. 
The results of the reasoner did not reveal any additional unsatisfactory classes or new facts, 
see Figure 4.12. Reasoner Log below.   
 
 




B3.2 Protégé Debugger 
The debugger in Protégé is also used to check if the ontology is coherent and consistent, as 
evidenced in Figure 4.13. Coherent Ontology. 
 
Figure 4.13. Coherent Ontology 
 
B3.3 Evaluation Tools 
As observed in the Methodology Chapter 3 when evaluating ontologies some anomalies can 
appear. Therefore, in any ontology development project it is vital to perform the ontology 
evaluation activity since this activity checks the technical quality of an ontology against a 
frame of reference [129]. 
Evaluation tools were also previously analysed and the Ontology Pitfall Scanner (OOPS!) 
was chosen, as observed it depends on the purpose of the evaluation which approach is the 
most suitable [149]. For example, to check the consistency of the ontology, the reasoner has 
already been used, in addition the coherence of its representation according to domain 
knowledge, will be checked working closely with domain experts. For the next step: 
correctness and completeness OOPS is a useful and easy to use tool for supporting ontology 
evaluation [150]. 
Also as observed compared to OOPS  most other evaluation methods for an ontology don’t 
show any tangible ontology diagnosis output and tend only to deal with taxonomical 
knowledge, address a narrow range of ontology evaluation aspects or provide a set of 
measurements [151]. Henceforth with OOPS there is an output to work with and correct 
directly. 
 
B.3.3.1 Ontology Pitfall Scanner (OOPS!)  
 
Figure 4.14. Pitfall Scanner 
In order to produce a list of evaluation results, the Ontology Pitfall Scanner [152], see Figure 
4.14 takes as input the ontology to be analysed. The system is accessed by a web user interface 
and to machines throughout a web restful service. The input ontology can be entered by its 
URI or the OWL code 2, which describes the ontology to be analysed. Once the ontology is 
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parsed using the Jena API3, the Pitfall Scanner module inspects the declared ontology looking 
for pitfalls among those available in the catalogue [129]. 
B.3.3.2 Scanner Results and Evaluation 
At the time of writing this thesis all 41 of the 41 pitfalls defined in the catalogue are evaluated 
within the system, see Figure 4.15. Pitfalls Defined. During this scanning phase, the ontology 
elements prone to potential errors are detected. 
 
Figure 4.15. Pitfalls Defined 
The evaluation results from the Pitfall Scanner are provided from OOPs and  include a list 
of pitfalls detected, and the ontology elements affected, as well as explanations describing 
the findings. This first set of  results was obtained using the original IRI shown in the 
screenshots, this IRI has since been updated to: http://www.epilepsypatient.co.uk/PPDL.owl 
Within the first set of results 1 critical case was found, (P19) according to the pitfall scanner 
it is crucial to correct the pitfall otherwise it could affect the ontology consistency, reasoning 
and applicability. The critical case found was that more than one domain or range statements 
was defined by an Object Property. In this Critical Case the object property identified: 
‘Yes_No’ had been shared between several of the classes, ‘Seizure_Sign’, 
‘Diurnal_Nocturnal’). This Object property ‘Yes_No’ was removed, it was later discovered 
it was essentially redundant and new Object Properties where created to uniquely describe 
the relationships between classes i.e. ‘Has_Sign’, ‘Has_Time_of_Day’ etc. Hence evaluation 
results below depicted in the Pitfall Scanner, see Figure 4.16. Critical Case. 
 Results for P19: Defining multiple domains or ranges in properties.1 case | 
Critical  
The domain or range (or both) of a property (relationships and attributes) is 
defined by stating more than one rdfs:domain or rdfs:range statements. In OWL 
multiple rdfs:domain or rdfs:range axioms are allowed, but they are interpreted as 
conjunction, being, therefore, equivalent to the construct owl:intersectionOf. This 
pitfall is related to the common error that appears when defining domains and 
ranges described in [7].   
• This pitfall appears in the following elements:  
› urn:absolute:www.webdesignerchic.com/PPDL.owl#Yes_No  
 
Figure 4.16. Critical Case 
87 
 
Upon fixing the critical case the ontology was put through the scanner again and the second 
results revealed the critical case fixed with only 2 important and several minor errors see 
Figure 4.17. Results 2.  
 
Figure 4.17. Results 2 
 
The 19 cases (Minor) revealed that annotations where missing; this was fixed see Figure 
4.18. Annotations Fixed. Giving human-understandable documentation to OWL entities 
is important and non-trivial [152]. 
 
Figure 4.18. Annotations Fixed 
The next Minor Cases: P13 : “Inverse relationships not explicitly declared”.  In the 6 Object 
properties declared within the Ontology there exists no inverse relationships. All current 




Figure 4.19. No Inverse Relationships 
One of the other Minor Cases: ‘Using different naming conventions in the Ontology’ was 
related to use of delimitators i.e. As "-" or "_", in Figure 4.20. Use of Deliminators below. 
 
Figure 4.20. Use of Deliminators 
Apparent is that the entity ‘Diurnal-Nocturnal’ needed to be updated, as indicated by fix. The 
final minor case: ‘URI contains files Extension’, this pitfall occurs if file extensions such as 
".owl", ".rdf", ".ttl", ".n3" and ".rdfxml" are included in an ontology URI. Best practices 
indicated reveal that a URI should be persistent, Archer et al claim in their:’10 rules for 
persistent URIS’ that it is necessary to remove the extensions as;  
- Uris are dumb strings, i.e. They carry no meaning except to identify a 
resource. For clarity, a URI such as http://example.com/document.pdf 
does not convey that there is a PDF available at that location. It would be 
perfectly conformant, contrary to what one would expect, for this URI to 
return a CSS stylesheet.  
- Servers are smart and flexible – they can be configured to do a great deal 
more than return a static file and such configuration means that a single 
URI might de-reference to different resources in future. [153] 
Archer et al conclude that since few things change as rapidly as technology these facets of 
HTTP mean that it can be said that persistent URI’s should not include file extensions because 
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often (although not necessarily) they reveal the technology used to create the resource. Yet 
the Protégé tool used in this thesis does not allow the facility to remove a file extension, 
furthermore without the extension the OOPS scanner cannot read the ontology. Since this is 
deemed as a ‘minor case’ the extension will remain. 
Finally, the ‘Important Case’: ‘No Licence declared’, the ontology metadata omits 
information about the license that applies to the ontology. As an ontology is after all ‘content’, 
a ‘Creative Commons License’ would be appropriate. The Gene Ontology, for example, 
uses a ‘Creative Commons Attribution 4.0 Unported License [154]. It is the intention to 
acquire a licence for this ontology once the study is finalised. Consequently, to conclude the 
evaluation using the pitfall scanner, the conformance badge provided reads: “according to the 
highest importance level of pitfall found in your ontology the conformance badge suggested 
is "Important pitfalls": see Figure 4.21. Conformance Badge. 
 
Figure 4.21. Conformance Badge 
B3.4 Review by Experts 
Four experts in the field of Epilepsy are consulted to review the final ontology. Working 
closely with ‘The Walton Centre Neurosurgery Department’ provided valuable assurance and 
helped to clarify any ambiguities throughout the development of the ontology. This close 
collaboration helped to build a data model fit for real-world adoption inside hospital settings.  
The ontology reviewed by the above four domain experts, can be seen in Table 4.7. Epilepsy 
Expert Review together with the ontology questions. 
The answers to the 4 sets of evaluation questions were 100% with yes: positive, indicating 
that indeed ESO is a sound and useable ontology. Conversations occurred regarding the ESO 
prior to the clinicians completing the form, these are also recorded in Table 4.7. Epilepsy 
Expert Review under ‘Verbal Feedback’. In general, the initial reactions from clinicians were 
of pleasant surprise and genuine appreciation in the fact that the terminology was familiar 
and useful to them. The clinicians also expressed how the ESO could be added to in the future 
and how some of the updated ILAE abbreviations were important as the epilepsy terminology 
evolves. 
Overall the evaluation forms together with the verbal feedback indicated the ontology model 




Table 4.7. Epilepsy Expert Review  
Evaluation Questions 
 
Reviewed by Domain 
Experts 
Q1. Can the knowledge 
depicted in the ontology 
determine if an individual 





The attributes represent the 
terms we are familiar with. 
They are recognisable from 
the patient medical records: 
information we read every 
day. 
Q2. Can the knowledge 
depicted in the ontology 
determine the feasibility 




The way that the terms have 
been categorised is a good 
way to view the data. 
Q3. Can the concepts 
presented in the Ontology 
easily evolve in the 




It is possible to add further 
categories if required. 
Q4. Do the classes 
represent a sound and 
accurate depiction of a 
‘Patient Profile’? 
Yes 
There is nothing extra that 
should be included. 
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Q5. Do the updated 
abbreviations and 
terminology conform to 
ILAE and are they clearly 
understood? 
Yes 
Some of the abbreviations are 
being used but not all.  
 
4.4 Summary 
This chapter discussed the implementation of the ESO (Epilepsy Seizure Ontology) and 
demonstrated its use to inform the PPDL Language in XML. From the initial ‘obtaining 
knowledge’ stage through to its evaluation the PPDL has presented a strong component to be 
























This chapter begins by discussing the reasoning behind clustering the patient profiles to fulfil 
Objective 3: ‘Perform a Clustering technique to discover distinct groups of patients that share 
similar characteristics.’ The rest of this chapter discusses the methods outlined in the 
Methodology Chapter for the Clustering Stage: (C1-C2) by discussing a selection of 
clustering methods and algorithms (C1) then it continues to the next step: (C2) whereby 
Clustering is performed. 
5.2 Clustering Stage (III) 
The Clustering stage consists of 2 activities (C1-C2) 
C1. Clustering Analysis 
This stage carries out an analysis on the concept of clustering, together with tools, techniques 
and algorithms used. 
 
C1.1 Clustering Analysis overview 
Clustering methods have been used in many similar scenarios whereby a diversity of patent 
characteristics have endeavoured to be understood: i.e. Irritable bowel syndrome [155] 
diabetes [156] and asthma [157] but so far little is known about any associations for epilepsy 
patient profiles that share multiple characteristics in sub-groups to achieve a more 
personalised care. 
This section identifies systematic patterns of perceptions using cluster analysis, and 
investigates associations among epilepsy patient profile clusters, for example patients who 
have the seizure type ‘GA’ will frequently fall into the category of having seizures that occur 
daily. 
The ESO (Epilepsy Seizure Ontology) dataset developed in Chapter 4 uncovered a variety of 
patient profiles showing similarities. However, clustering techniques provide a replicable 
methodology for grouping the patient’s profiles. Using clustering techniques, grouping 
becomes feasible and replicable, shifting from a “one size fits all” [158] to a more individual, 
patient-tailored approach and thus improve health outcomes [158]. 
C1.2 Clustering Techniques 
Prior to performing Clustering, next is an analysis of relevant clustering techniques. In 1967 
P.E Green alleged ‘Clustering Analysis’ is a set of techniques used to identify “similar” 
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entities from characteristics (categorical or measured) possessed by the entities [159]. Today 
clustering analysis is still very much in use and is ‘one of the most common exploratory data 
analysis technique used to get an intuition about the structure of the data’ [160] and can be 
defined as the task of identifying subgroups in the data such that data points in the same 
subgroup (cluster) are very similar while data points in different clusters are very different.  
It is important for a HCP to diagnose the symptoms of a patient correctly so that they are 
handled specifically, therefore the patient should be placed within the correct group. For 
example, patients sharing the same symptoms from a particular disease can be put in a 
labelled group and those without these symptoms can be placed in another group, this way a 
degree of similarity can be identified. 
To draw inferences the rational grouping of objects is required for various purposes not just 
in healthcare but in other areas for example marketing, biology, image segmentation and 
engineering, some of these application areas are discussed later. 
Approaches to clustering vastly vary, a multitude of techniques have been proposed over the 
years and one of the reasons for this is that there is no such precise definition to the notion of 
“cluster” [161]                   
Clustering approaches can be divided into two different groups: hierarchical and partitioning 
techniques. Yet Han and Kamber [162]suggest further categories for applying clustering 
techniques: density-based methods, model-based methods and grid-based methods. Another 
categorisation based on the induction principle of different clustering approaches is presented 
in Castro et al [163]. More recently, according to Afrida [164], these conventional clustering 
approaches are not very effective in dealing with clusters which have ‘overlapping regions’ 
and propose three-way clustering (3WC) as being an effective and promising approach. 
Alternatively, many researchers of late take a ‘combined methods’ approach such as in image 
segmentation for example where a hybrid image segmentation method is used, this is based 
on a clustering algorithm and black hole algorithm [165]. Other approaches such as 
‘Multiobjective clustering’ have emerged where multiple objective functions are 
simultaneously optimised and deemed as a robust alternative in such situations [166]. 
One of the biggest problems in the clustering community is deciding the optimal number of 
clusters, (discussed later in this Chapter) this means that prior to the clustering process the 
number of clusters into which available dataset is to be divided must be decided upon. This 
is carefully decided by the users, and approached differently by using methods such as 
heuristic, trial and error or evolutionary. High accuracy is the aim judged by intra-cluster 
distance, if of course the user decides an appropriate number. A good overview of the most 




Figure 5.1 Clustering Techniques  
Clustering analysis uses ‘similarity measures’ such as Euclidean-based distance or 
Correlation-based distance. These measures try to find homogeneous subgroups within the 
data such that data points in each cluster are as similar as possible. The decision on which 
‘similarity measure’ to use is usually ‘application-specific’ [160]. 
Clustering is a division of data into groups of similar objects. Representing the data by fewer 
clusters necessarily loses certain fine details but achieves simplification. It models data by its 
clusters. Data modelling puts clustering in a historical perspective rooted in mathematics, 
statistics, and numerical analysis. From a machine learning perspective clusters correspond 
to hidden patterns, the search for clusters is unsupervised learning, and the resulting system 
represents a data concept. From a practical perspective clustering plays an outstanding role 
in data mining applications such as scientific data exploration, information retrieval and text 
mining, spatial database applications, Web analysis, CRM, marketing, medical diagnostics, 
computational biology, and many others [168]. 
As mentioned earlier traditionally clustering techniques are generally divided in hierarchical 
and partitioning  [160]. Hierarchical clustering is further subdivided into agglomerative and 
divisive. The basics of hierarchical clustering include Lancewilliams formula, idea of 
conceptual clustering, now classic algorithms SLINK, COBWEB, as well as newer 
algorithms CURE and CHAMELEON [169]. 
While hierarchical algorithms build clusters gradually (as clusters are grown), partitioning 
algorithms learn clusters directly [170]. One such partitioning algorithm is K-means 
Clustering, which tries to discover clusters by iteratively relocating points between subsets 
or tries to identify clusters as areas highly populated with data.  K-means clustering is also 
an unsupervised learning method which is a type of machine learning algorithm used to draw 




In 2015 Gulati et al [172] did a large study surveying different clustering algorithms, snapshot 
is in Table 5.1. Analysis on Clustering [172]  they concluded that when the clusters are of 
convex shape having similar size and the number of clusters can be identified prior Partitional 
clustering algorithms are the most useful. Yet sometimes due to the incapacity in foreseeing 
the number of clusters in advance Hierarchical clustering algorithms should be used. 
Although since Hierarchical clustering algorithms divide the dataset into several levels of 
partitioning called dendrograms, the cost of development of dendrograms is very high for 
bigger datasets. Also, observed is that when mining large datasets Density based clustering 
techniques are very useful [172]. The table identifies the type of dataset considered suitable 
for each algorithm, notably K-means suitability for numerical data whereas PFCM 
(Possibilistic Fuzzy C-Means) is best for Fuzzy and homogeneous data. Advantages and 
disadvantages for each algorithm assess various factors such as privacy and security and some 
such as K-means Parallel are noted for lack of support for heterogeneous (or diverse)  datasets 
or MDCA (Multi-Hop Data Communication Algorithm) recognised as being useful in a non 
uniform schema.  
According to Shreyansh Gokhru [173] the one and the most basic difference regarding where 
to use K-means (Partitioning) and Hierarchical clustering is on the basis of ‘scalability’ and 
‘flexibility’. Hierarchical is flexible but cannot be used on large data. K-means is scalable but 
cannot use for flexible data. 
This is further evidenced as weakness in the fact that; agglomerative clustering methods do 
not scale well [174], also unfortunately with hierarchical clustering once a step (merge or 
split) is done, it can never be undone [175]. 
Yet observed in favour of the ‘Hierarchical’ algorithm it allows less assumptions about the 
distribution of data and it will provide a hierarchy, this structure being more informative than 
the unstructured flat clusters provided by K-means [176]. 
On the other hand, accuracy indicators often lead to the conclusion that K-means is more 
accurate than Hierarchical, for example in one study on an iris dataset it was found that the 










Table 5.1. Analysis on Clustering [172] 
 
Authors Algorithm     Clustering 
Category 
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C1.3 Clustering Application Areas and Selecting Clustering Approach 
Clustering analysis has been successfully executed in various fields, its use has been well 
documented and the different clustering techniques available have been carefully selected to 
apply to each problem situation. One such field is ‘urban development’ whereby decisions 
on how to place stations for setting up of industrial towns and economic hubs along highways 
[178] where made, here K-means clustering based on Ant Clustering Method was known to 
play a decisive role. The GFDBSCAN Clustering algorithm [179] was used to aid geographic 
positions for setting up amenities such as banks and schools. K-means was also implemented 
to  identify patterns in online cable-discharge monitoring [180]. 
 
Clustering techniques have been performed extensively in the areas of computer security. It 
has been evidenced that using data from clustering can restrict cyber-criminals and thus 
enhance privacy protection. By partitioning data into clusters and providing a just a single 
relevant cluster to any information seeker responsible data sharing can be attained. This can 
be done using k-means algorithm [181] and distributed clustering [182]. 
 
In studying various aspects of human anatomy with the aim to understand the effects caused 
by a certain ailment, medical imaging has played a major role in medical science to treat 
patients. For example ‘mean shift clustering’ has been used in blood oxygen level dependent 
functional MRI activation detection [183]. Brain image segmentation has been done using 
semisupervised clustering [184] inhomogeneous medical image segmentation has been 
executed successfully using a hybrid method based on fuzzy clustering [185]. 
 
Additional fields where clustering has been utilised can be seen in a study by Ghosal, Nandy 
et al [186] in Table 5.2 Areas of Application and Algorithm used, this comprehensive table 
also identifies the clustering algorithm used in each sector and demonstrates the sheer 
diversity of techniques and how different domains have optimised a technique based on its 
helpfulness. Certain parameters are used to help evaluate and decide which technique to use. 
Some users require only an unsupervised grouping of objects into a number of clusters, where 
they can manually define the K, so for this proper alignment then only choosing the value of 
k matters. This decision can be made based upon how accurate the intra-cluster objects (or 
patterns) by virtue of distance is expected from the user [187] and choosing k can be heuristic 








Table 5.2 Areas of Application and Algorithm used [186] 
Area of Application Algorithm Used 
1. In Banking: 
• Anti Money Laundering 
Regulatory System 
DBSCAN 
• Broadcasting warning messages 
against bank frauds 
K-means, K-means++ 
• Installing ATMs and e-corners at 
strategic locations 
DBSCAN 
• Long-term bank failure 
prediction 
Fuzzy Refinement domain 
adaptation 
• Profit maximization and 





2. In segmentation engines and recommendation 
engines: 
• Market analysis K-means 
• Tourist market segmentation Fuzzy C-medoids 
• Education K-means and Hierarchical 
clustering 
• Crime domain documentation K-means, k-means++ 
• Drawing patterns in social media 
usage handling all the side-
information and metadata within 
any document working of web 
search engines 
k-means, fuzzy C-means and 
hierarchical clustering algorithms 
3. In Health Care: 
• Detection of 
neurovascularization in retinal 
images 
Multivariate m-Medoids based 
classifier 
• Detection of tumors K-means 
• Blood oxygen level dependent 
functional MRI activation 
detection 
Mean shift algorithm 
• Brain image segmentation Spectral clustering 
• Inhomogeneous medical image 
segmentation 
Fuzzy clustering 
• Medical image analysis Spectral clustering 
4. In Urban Development: 
• Positioning of towns, building 
efficient power supplies 
K-means clustering based on Ant 
Clustering Method 
• Setting up amenities such as 
banks, schools etc 
DBSCAN 
• Transformer fault diagnosis k-medoids 
• Identifying patterns in online 
cable-discharge 
 
• Transformer fault diagnosis k-medoids 
• Identifying patterns in online 
cable-discharge Monitoring 
k-means 




Despite the ‘choosing k’ challenge k-means clustering dominates and is still the most popular 
clustering method. In addition to Table 5.1. Analysis on Clustering [172] which previously 
identified useful factors to help a user choose an algorithm, a few other researchers have 
performed studies undertaking the task of deciding a clustering method, for example Fraley 
[167] describe a clustering methodology based on multivariate normal mixture models and 
showed it can give much better performance than existing methods, but Saxena et al. [187] 
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found many limitations with this such that computational methods for hierarchical clustering 
cannot be directly applied to large data sets since they have storage and time requirements 
that grow at a faster than linear rate relative to the size of the initial partition.  Bensmail et al.  
[188] showed that exact Bayesian inference via Gibbs sampling, with calculations of Bayes 
factors using the Laplace–Metropolis estimator, works well in several real and simulated 
examples [167]. 
Further parameters used to evaluate a clustering techniques merit or usefulness depending on 
a user’s purpose are presented in Table 5.3 Parameters to Evaluate Clustering Techniques. 
For example, for large data sets, CURE method is advisable unlike ROCK but with less time 
complexity although scalability is high to that obtained by CURE. This table is a useful source 
measuring each technique by parameters such as time complexity, scalability, large scale data 
suitability, high dimensional data suitability and noise sensitivity. 
 
Table 5.3 Parameters to Evaluate Clustering Techniques 
 
 
The application of clustering is wide, the strengths and limitations of each technique are 
available within the vast amount of literature. Deciding which technique to use can be 
determined by evaluating parameters and keeping in mind the user’s overall purpose. 
Objectively this section has presented a rationale to demonstrate it is not feasible to agree on 
one recommended clustering technique. A user’s objective and strategy will be different, and 








C1.4 Selected Technique K-means 
Since finding the maximum similarity among epilepsy patient profile groups is the goal a 
clustering technique principally to measure similarity of objects within a cluster, would be 
the most appropriate technique to use.  
Due to the aim of accuracy in results and the fact that the size of the ESO dataset is expected 
to grow to large, the K-means method is chosen for this study. Also, since K-means clustering 
has commonly known use in medical fields and is one of the simplest clustering technique. 
[189]. Some of the other available techniques such as PFCM (Possibilistic Fuzzy C-Means) 
although good for complex data have shown overlapping clusters due to usage of membership 
function and since the number of clusters are not to be defined prior [172] limits control. 
Saleability for K-means technique is judged as ‘middle’, whereas the CLARA technique is 
‘high’ (according to Table 5.3 Parameters to Evaluate Clustering Techniques) this is apt at 
this stage since it will be a fair applicability to large datasets and performance is expected to  
decrease linearly with data size increase. 
K-means uses unsupervised learning method to solve known clustering issues. Another 
reason that K-means is chosen is that it works well with heterogeneous datasets, such as the 
dataset used for ESO in this study, since it contains many attributes, this will be useful as 
observed by Trevino, in identifying unknown groups in complex data sets [190]. 
Moreover, since there is no prior knowledge of groups with the ESO patient profile dataset it 
is decided to use this ‘Unsupervised method’ for this study, as presently the dataset only 
contains features and instances so K-means will be used to group them. The basic step of K-
means clustering is simple. In the beginning, the number of cluster K is determined and the 
centroid or center of these clusters is assumed, see Figure 5.2. K-means Clustering Process 
[142]. 
Any of the random objects as the initial centroids is taken or the first K objects can also serve 
as the initial centroids. Then the K-means algorithm will do the three steps below until 
convergence. Iterate until stable (= no object move group):  
1. Determine the centroid coordinate  
2. Determine the distance of each object to the centroids  




Figure 5.2. K-means Clustering Process 
The K-means method uses Euclidean Distance, which is the most common distance 
measurement used in clustering. Furthermore this is deemed as one of the most apparent ways 
to represent distance between two points [191]. 
Euclidean distance or simply 'distance' examines the root of square differences between 
coordinates of a pair of objects [192] In basic terms this distance measure calculates 
the distance between two points [193]. The formula below shows the square root of the sum 
of the distance (d) of the points from each other, squared. It can also be described as a distance 
measure between a pair of points x and y in an n-dimensional feature space (or variables) with 
case i. Therefore given 2 n-dimensional variable’s x and y: 
- 𝑥 = (𝑥1, 𝑥2, . . 𝑥𝑛)  
- 𝑦 = (𝑦1, 𝑦2, . . 𝑦𝑛)  
Euclidean distance d(x, y) is defined as the formula [194] in Equation 1. ED Formula below: 
 
𝑑(𝑥, 𝑦) = √∑  
𝑛
𝑖=1
(𝑥𝑖 − 𝑦𝑖) 
2
 
Equation 1. ED Formula 
 
For example: Point x has coordinate (3, 0, 1) and point y has coordinate (5, 2, 0). 
I.e.            X = (3,0,1)      y = (5,2,0) 
The Euclidean Distance between point x and y is: (see Equation 2. ED ’[194] below) equating 




- D(x, y) = √(3 − 5)2 + (0 − 2)2 +  (1 − 0)2 = 3  
Equation 2. ED Answer  
To demonstrate simply Euclidean distance formula can be used to calculate the distance 
between two data points in a plane, see Figure 5.3. Euclidean Distance [194] 
 
Figure 5.3. Euclidean Distance  
Euclidean Distance is one of many similarity distance measures, Manhattan Distance being 
another popular measure. Since this study is looking for attributes that are similar (so being 
in the same space or neighbourhood) then Euclidean distance is the most suitable. Other 
similarity measures exist such as Correlation-based distance, which is widely used for gene 
expression data analyses [195] but these focus on things that go up and down together, 
regardless of their range. From a good distance measure, it is expected that there is a high 
degree of accuracy and robustness. Euclidean Distance has its criticisms but is widely 
endorsed and commonly used by several other authors in similar studies whereby its function 
can produce significant robustness [196] and a study in transportation services measuring the 
accuracy of EDC confirmed that Euclidean distance helped them to achieve an excellent level 
of accuracy [197]. 
 
 
C2. Perform Clustering 
The next stage outlines the methods used to performing Clustering using the K-means 
algorithm. The following sections includes data preparation and pre-processing and data 
cleaning. 
 
C2.1 Dataset Preparation & Pre-processing 
One of the important steps of data mining process is data pre-processing. Data pre-processing 
is used in identifying the missing values, noisy data and irrelevant and redundant information 
from dataset [198]. At this stage the data set is prepared.  
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The dataset was prepared in the Ontology Stage. Yet some re-arranging and further 
analysis/editing is needed in to ensure it is correct and worthy for the intended OBJ 3: 
‘Perform a Clustering technique to discover distinct groups of patients that share similar 
characteristics.’ 
It is discovered that the original dataset is wide-ranging and has 60 signs and symptoms 
collected from the patient medical records, a snapshot is shown below in Table 5.4:   
























Vomit Head deviation 
According to Robert Fisher [150] the Key Signs and Symptoms for seizures can be put into 
the following categories listed, together with their updated ‘Medical Term’ in Table 5.5: 
 
Table 5.5. Key Signs and Symptoms 
Symptoms Medical 
Term 
Automatic behaviors Automatisms 
Emotions or appearance of 
emotions  
Emotions 
Extension or flexion postures Tonic 
Flushing/sweating/piloerection Autonomic 
Jerking arrhythmically Myoclonus 
Jerking rhythmically Clonus 
Language or thinking 
problems, Deja vu 
Cognitive 




Numb/tingling, sounds, smells, 
tastes visions, vertigo 
Sensations 




Trunk flexion Spasm 
 
In addition to Table 5.5 it is identified in the Ontology Chapter in “Categorising Routinely 
Used Terms” that other signs and symptoms can be put under the following categories shown 
in Table 5.6. 














































































Adjudicating from the occurrences of signs and symptoms in the patient medical records it is 
apparent that those in Table 5.6 are indeed less common than those identified in Table 5.5. 
This is a good way to organise and re-arrange the dataset in preparation for clustering, by 
narrowing and refining the data, whereby signs and symptoms are mapped to new categories, 
a snapshot is shown in Figure 5.4. Curating Epilepsy Terms,  (the colouring scheme shown 
in Figure 5.4 is described below).  
The new categories are named ‘Key Signs and Symptoms’ are shown in green  and ‘Common 
Signs and Symptoms’ in pink. During further analysis ‘New Categories’ (shown in blue) are 
discovered and added to ‘Key Signs and Symptoms.’ These other prominent Key Signs and 
Symptoms that frequently occur throughout the patient medical records are: 
• LOC (Loss of Consciousness) 
• Bilateral_Tonic (Both Left & Right side) 
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• Bilateral_Clonus (Both Left & Right side) 
• Bilateral_Shaking (Both Left & Right side) 
• Urinary/Incontinence 
Some of the categories from Key Signs and Symptoms found in Table 5.5. Key Signs and 
Symptoms were also found in Table 5.6. Categorising Routinely used Terms. Therefore, these 
categories were deemed as redundant so where either removed or moved (see in grey in  
Figure 5.4). 
From the 100 patient medical records it is also observed that often the patient would have a 
trigger such as ‘Menstrual Cycle’ just before the seizure occurred, this way the patient would 
know that a seizure was imminent. Other common triggers where observed from the records 
including: ‘Sleep deprivation’, ‘Stress’ and ‘Eating’. Therefore, these categories were added 
to the new dataset in preparation for Clustering. See in yellow in Figure 5.4 
 
Figure 5.4. Curating Epilepsy Terms  
Clinicians can advise the position on the body of the monitoring sensor, this can be 
determined by where the seizure begins on the patient (left arm/leg, right arm/leg) or which 
side the seizure mainly occurs. It is evident from the patient medical records that notes were 
recorded from observations about the ‘dominant side’ and ‘limb factors’ as witnessed  in 
some profiles in Table 5.7. Seizure Initiation Factors. Therefore, the categories ‘Arm’ and 
‘Leg’ are added together with ‘Dominant Left’ and ‘Dominant Right’ to the new dataset in 







Table 5.7. Seizure Initiation Factors 
 Dominant Side 
Profile 
95 
GTC Stress, sleep dep,  Right arm extends & 
clenches & right leg 





NMA Feels Hot LOC, shaking, eyes open 
(up to 30secs) 
Profile 
97 
GTC Illness, constipation, 
asking for bed 
Vocalisation, left arm 
extends, (stiffens), 




NMA Distorted perception 
of environment 
Feeling like on a ship 








Change in mood, 
sleepy, excitement, 
constipation, ill health 
Left arm & left leg 
extension &shaking, 
grunting, grabbing at 
people & objects, talking 
then LOC (3 mins) 
 
C2.2 Data Cleaning 
Most implementations of K-means only allow numerical values for attributes. To create 
meaningful clustering, all the non-numerical attributes are converted to the numeric attributes 
(without affecting the meaning of those attributes while deciding the cluster), as discovered  
K-means cannot handle categorical variable directly and uses distance computation at core 
of its algorithm [150].  
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Therefore, a Boolean value ‘0,1’ or ‘True or False’ is assigned as in Fig.45. Data Cleaning 
Sample. To begin the raw data is analysed and converted to binary: ‘0.1’ then it is again 
converted to Boolean: ‘True/False’. This way all categorical attributes are converted to binary 
values, and then K-means is performed as if these were numeric values. 
As witnessed by Mobasher [199] it was found that it may also be required to normalise the 
values of attributes that are measured on significantly different scales (e.g., "age" and 
"income").  Therefore, upon analysing the dataset used in this study it is observed that some 
categories are on different scales compared to others; ‘Seizure Types’ and ‘Seizure 
Occurrences’. Therefore coding/labelling systems are used to aid the process (see Figure 5.5. 
Data Cleaning Sample). 
Raw Data Converted to Binary 
 
 




Figure 5.5. Data Cleaning Sample 
Next the pre-processing is performed. The figure below demonstrates that some filtering was 
needed because the class attribute ‘id’ is providing an invalid signal that is overlapping the 
valid data creating redundant data as can be seen in ‘Figure 5.6. With ‘id’ Attribute’, whereby 
110 
 
1 count (attribute) for each of the 100 patient profile is visible, which does not reveal 




Patient Profiles 1-100 
Figure 5.6. With ‘id’ Attribute 
The correct types and values associated with the attributes are automatically determined as 
observed during further pre-processing, here 29 attributes and 100 instances are established 
from the dataset. When (for example) the ‘DOMINANT LEFT’ (Figure 5.7. Dominant Left) 
is selected some information about this attribute can be visualised. For example, 82/100 have 
the seizure occurring on the ‘left’ side and 18/100 do not. These two distinct values (true and 
false) are derived from the values in the dataset. 
Whereas when ‘Seizure Type’ is selected (Figure 5.8. Seizure Type) there is a slightly 
different view as the values for this attribute are numeric, 7% are unique which means they 
cannot match with each other. This demonstrates, (from the 23 seizure types) how seizure 
types 1-4 are the most common with 41. These Seizure types are FMS, FBTCS, GTCS and 
MTC. 
 






Seizure Types (1-23) 
 
Figure 5.8. Seizure Type 
 
C2.3 Clustering Considerations 
The K-means is chosen as the clustering method from a list of clusters. The chosen 
numclusters is 6. This chosen number of clusters is discussed later in 5.5.3. 
The seed number is next chosen (discussed below). Then the various cluster modes are 
considered i.e.: Use training set, Supplied test set, Percentage split or Classes to cluster 
evaluation. Percentage spilt is chosen as 66% then the clustering process begins. 
 
C2.4 Percentage Split 
The ‘Percentage split ’option will train the classifier on the indicated percentage of the data 
and test it on the rest. As observed Browmlee [200] that a common split value is 66% to 34% 
for train and test sets respectively, but this should not to be used to make decisions, unless 
working with a very large dataset and it has been tested [200]. Yet, do the splits sufficiently 
describe the problem? A good reason why the percentage split should be used is witnessed 
by Cohen [201] whereby he ascertains that a percentage split should be used to avoid a 
problem called “over-fitting”, whereby trends are learnt in training data that might not exist 
in the real world. 
The percentage split (66%) for training and 34% for testing is used for the evaluation mode 
in this study as it would not be good to learn a very specific set that occurs by chance in 
the training data, because it would not really reveal anything about the pattern, since the 
pattern might not be observed in other data. It is best to test on data that hasn’t been seen 
before so that it’s possible to simulate having real-world data to test the pattern on, rather 




C2.5 Choosing the Seed 
The data is shuffled randomly based on the random number seed. The seed can be altered 
from 1-10. This is done using the ‘Fisher-Yates’ shuffle in WEKA [130]. 
When the seed is altered different results are produced. K-means always uses random 
numbers, if the same seed always remains the same, the same random numbers will always 
be returned. Which means, if K-means is run over the same data twice, and if both times the 
same seed is used, the result will be the same. Whereas if same seed is not used, results will 
vary every time K-means is run [202]. 
Seed numbers are numbers only due to the way random number generators are implemented. 
Also observed is that different seeds produce slightly different error rates, the seed number 
used in this study is number 10, since this produced a low number of SSE (Sum of squared 
Errors), but further justification for this seed number is discussed in section 5.5.5. 
 
C2.6 Choosing the Optimal Number of Clusters 
As identified in the earlier sections of this chapter determining the initial number of clusters 
when performing unsupervised clustering is a complicated problem and can be heuristic or 
stochastic. There are various methods available for deciding the optimal value for "k" in K-
means algorithm including thumb-Rule, elbow method and silhouette method etc. Yet the 
ideal number of clusters is subjective [203]. As observed by Vincent Granville [204] upon 
questioning what the ideal number of clusters is, he conveyed that no one can tell with 
certainty, not AI, not a human being, not an algorithm.  Even today people are still doing 
research. Consequently a heuristic approach is taken and the number of optimal clusters 
chosen for this study is 6 since this number of groups demonstrates a good sample/range to 
showcase what is achieved with clustering seizure-type patient profiles and henceforth there 
is no concrete agreement that would justify the search of the ideal number of clusters [205]. 
 
C2.7 Evaluating K-means Results  
The Cluster results show the centroid of each cluster, thus, centroids can be used to 
characterize the clusters, the results show the statistics on the number and percentage of 
instances assigned to different clusters, each dimension value in the centroid represents the 
mean value for that dimension in the cluster. For example, the centroid for cluster group 2 
shows that this segment of patients represents seizure type 5 seizure Type 10 = FAS (Focal 
Aware Seizure, previously termed ‘Auras’) also the Key Signs & Symptoms ‘Sensation’ and 
‘Automatisms’ are ‘TRUE’, this group also only has seizures during ‘Diurnal’ (day-time), 
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and seizures occur both on the ‘Dominant Right’ and ‘Dominant Left’. Furthermore, this 
group has Seizure Occurrences ‘6’ which is ‘multiple weekly (over 5)’, and no triggers 
recorded for their seizures.  
Extracted from the Cluster Output the cluster groups 0-5 are displayed in Table 5.8. Cluster 
Groups. The 6 cluster groups reveal six completely different categories of patients each with 
their distinct seizure related information. ‘Cluster Group 1’ although reveals an ‘unclassified’ 
seizure type, this is just as relevant as those with identified seizure types since they reflect a 
‘real world’ model of what one of the individual seizure type patients is like.  ‘Cluster Group 
0’ has seizures which are dominant on the right side of the body, occur over 5 times a week 
and either during daytime or night-time, they will have a loss of consciousness, together with 
urinary/incontinence and some automatisms (i.e. Tongue biting, finger rubbing, lip smacking 
etc.), this group specifies the neither arm or leg meaning that seizures could begin or effect 




Table 5.8. Cluster Groups 
Attribute Cluster 
 Cluster 0 Cluster 1 Cluster 2 Cluster 3 Cluster 4 Cluster 5 
Seizure Type NMA Unclassified FAS Gelastic GTCS MTC 
Key Sign & Symptoms LOC (Loss of 
Consciousness) 





None   LOC LOC 




Automatisms Automatisms Sensory 
Cognitive 
Automatisms 
Arm/Leg Either Leg Either Either Leg Either 









Seizure Occurrences Multiple weekly (over 
5) 
  
Once Monthly Multiple weekly 
(over to 5) 
Multiple weekly 
(over to 5) 
Multiple monthly 
(up to 5) 
 
Multiple weekly 
(up to 5) 
Dominant Side Right Left and Right Left and Right Left and Right Right Left and Right 





C2.8 Sum of Squared Errors  
The SSE (Sum of squared errors) SSE is the “sum of the squared differences between each 
observation and its group's mean. It can be used as a measure of variation within a cluster. If all 
cases within a cluster are identical the SSE would then be equal to 0” [206]. There is much 
discussion about returning the Sum of Squared Errors in the cluster output and the important 
question here is: “does the lower amount of squared errors achieve a more accurate result?” It is 
easy to just pick a result with a specific seed value that has the lowest SSE, but this does not 
really hold any validation. Yet the goal of K-means is to reduce the sum of the squared error over 
all k clusters [207] [208]. One method to achieve this is if you increase the number of clusters 
you tend to get a lower SSE [209]. Again, this is easy, but a good clustering with smaller K can 
have a lower SSE than a poor clustering with higher K [160]. Therefore, this argument can link 
to ‘how to choose the initial number of ‘K’? (‘K’ known as clusters); discussed in C.2.2.4.  As 
with many algorithms the limitations are many, and as witnessed perhaps the answer appears to 
lie in some or all of the hidden patterns to ascertain whether the cluster output is actually 
meaningful [160]. Founded on this discussion the seed value 10 is chosen in this study as it 
produced the 2nd  lowest SSE: ‘188.07751’, (out of 10) and represented a good variation of seizure 
types. Seed 6 produced a slightly lower rate at: ‘182.90444’ yet the cluster group patterns for 
seed 6 did not include the most common seizure type being GTCS.  
 
C2.9 Visualising Results 
Another way of understanding the characteristics of each cluster is through visualization. The 
data just provides the centroid but with the visualisation tool deeper analysis is enabled. 
This is shown in Figure 5.9. Visualising Cluster Assignments which shows the patients in clusters 
(coloured for each cluster) on the X-Axis. The Y-Axis shows the seizure type and it is evident 
that the clusters are sharing common seizure type 3 GTCS General Tonic Clonic Seizure which 
is true to data count in the data set. Based on 60 random patient profiles the 6 cluster assignments 




Figure 5.9. Visualising Cluster Assignments 
Another visualisation seen in Figure 5.10 shows those patients with all clusters of a seizure type 
and all occurrences are showing True (red) or False (blue) for Sensory. In this example it shows 
the selected cluster (in red circle) whereby the seizure type is ‘Multiple’ with ‘Sensory’ for ‘Key 
Signs & Symptoms’ and ‘Multiple Weekly (up to 5)' as indicated on X axis. 
 
Figure 5.10. Seizure Type Clusters 
 
5.3 Summary  
In summary, this chapter has described the process followed to derive clusters groups of patients 
based on shared characteristics in their seizure symptoms and signs. The clustering algorithm used 
is the K-means algorithm in WEKA and the resulting 6 clusters show strong similarities in each 
cluster group using ‘seed 10’ and producing a mean sum of squared error of ‘188.07751’. As the 
clusters are now constructed, a list of typical seizure type patients can be produced and which 
cluster they belong to. Then a specific cluster can be taken, and the patient characteristics can be 








This chapter discusses the experiments that are performed to capture seizure data, obtained from 
sensors, which are positioned on different parts of the patient’s body. This is done to test the 
assumption that it is ‘the individual profile’ that makes the difference in which device to choose. 
This chapter corresponds to the methodology stage: ‘I.V. PMP Framework & Testing Stage’ 
shown in Figure 3.1 Research Design Framework and addresses ‘D1.Experimental Procedures’. 
The results from this experiment will be used to inform a typical model or a PMP (Personalised 
Monitoring Plan) discussed in the next chapter. This chapter will show a concise analysis of 
results from the test carried out. 
 
6.1.1 Experiment Procedures 
It is already becoming known that wearing sensors on the body is starting to be popular, as 
observed recently in a  2018 study where a great interest was highlighted in the use of wearable 
technology for epilepsy carers, this being independent of demographic and clinical factors and 
remarkably outpacing data security and technology usability concerns thus demonstrating the 
vital factor of comfortability [210]. Yet as discovered during a review to select the best sensor 
for each individual patient there was limited data on which was the best sensor for each seizure 
type, this was unfortunate despite an internationally active research effort, signifying the gap in 
knowledge, again, for understanding the individual epilepsy patient [211]. 
The actual ‘sensor’, and their ‘position’ (worn by the patient) are significant for epilepsy and the 
focus in this experiment is on how patients exhibit behaviour, rather than any actual testing of 
devices. It was therefore important to choose the most accurate sensors for monitoring epilepsy; 
these are found to be the accelerometer and heart-rate sensors, although latest studies suggest 
making use of other sensors too such as peripheral temperature, photo plethysmography (blood 
circulation), respiratory sensors [212],  and galvanic (changes in sweat gland activity) among 
others [213].  
Numerous studies have been previously been conducted with sensors and use for epilepsy [214] 
[215]. Since the ‘gold standard’ for epilepsy monitoring is video-EEG monitoring (which takes 
place within hospitals)  [216] the driving questions addressed here were:  
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➢ Can the patient be just as accurately monitored at home with an inexpensive, easily 
obtainable accelerometer and heart-rate sensor-based device? 
➢ Can the individual requirements of the patient be pinpointed? If so, is it possible 
that these sensors can be worn at home (a personalised approach) and be just as 
effective as using EEG monitoring in the hospital setting? 
From the analysis of the patient data it is clear that a patient profile based on particular 
characteristics can indicate which position the sensor is best placed on the patient’s body. 
Sample patient profiles where selected based upon criteria informed from discussions with 
clinicians. For example, Patient Profile 1 seizures begins with the right arm suddenly raising, 
therefore can the sensor be placed upon the right shoulder? Patient Profile 4 has a lot of shaking 
during their Focal Onset Seizures with shaking starting on the left arm so therefore can the sensor 
be useful attached to the left wrist? Whereas Patient Profile 5 begins their seizures with severe 
tremors on the right leg, can the sensors detect movement and heart-rate changes with sensor in 
this position? This analysis is further discussed in Chapter 7 in the ‘Sensor Advisory’(section 
7.4.1).  
During the investigation practicable devices to use in the experiment to monitor epilepsy were 
analysed. 
Table 6.1. Analysis of Practicable Devices for Experiment shows a list of possible devices, useful 
platforms or apps with their data export option and other sensors (that may be useful for future 
use) and notes (to assist decision). 
In summary the ‘Fitbit Ionic’ is chosen as the best option since both the heart-rate and 
accelerometer can be extracted. The commercial activity device has been used in other studies, 
most notably recently whereby it used data from more than 47,000 Fitbit users in five U.S. states 
and data revealed that with Fitbit use the state-wide predictions of flu outbreaks were enhanced 










Table 6.1. Analysis of Practicable Devices for Experiment  
 
 
6.2 Experiment Description and Results 
Experiments were designed to gather data from sensors. The results of these tests will be used to 
inform the development of the PMP framework in Chapter 7. 
This experiment is a, non-randomised, non-interventional study and is not intended as a device 
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√ X No Works with Fitbit device 
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performance rather the sensor compatibility with the patient so that difference in behavior can be 
analysed.   
Participants with confirmed epilepsy are recruited. The study targeted 10 epilepsy patients but 
only 6 were recruited. The data from the sensors will be collected after during a 5-day observation 
period.  




The objectives of this experiment are to assess the movement from the accelerometer sensor and 
the pulse from the heart-rate sensor in the detection of epileptic seizures 
This study evaluates: 
(1) The movement from the accelerometer sensor and the pulse from the heart-
rate sensor in the detection of an epileptic seizure. Over a period of 5 days they 
will be asked to wear the device and continue recording seizures in their 
seizure diary. 
(2) Any differences in result due to the ‘position’ of the sensor on the body 
together with the patients’ acceptability & comfort  
Secondary objectives 
(3) To investigate whether this study can pin-point a patient’s individual 
requirements to improve their daily management of epilepsy 
(4) To investigate if the sensors worn are just as effective as detecting seizure data 
in the patient’s seizure diary 
 
6.2.2 Eligibility Criteria 
The patients’ medical records are used to determine their eligibility for the study.  
Additionally, pre-determining eligibility reduces the burden on patient’s time and help ensure 
only those who meet the strict inclusion criteria for the study are included. The information 
obtained, other than participant grouping, from the participants medical records is not shared 
within the research team.  
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Inclusion criteria for patients: 
(i) Patients who have a confirmed diagnosis that epileptic seizures occur 
(ii) Patients who are having frequent episodes of epileptic seizures; more than 2-3 
per week. 
(iii) Patients that are willing to record seizures in a seizure diary. 
(iv) Patients that are confident using technology. 
(v) Between the ages of 18 – 80  
 
Exclusion criteria for patients: 
(i) Patients that have non-epileptic seizures. 
(ii) Patients that have less frequent seizures; so less than 2 per week 
(iii) Patients that are not confident using technology. 
(iv) Patients that are unable or not willing to record seizures in a seizure diary 
(v) Inability to comply with the trial procedure, such as cognitive or behavioural 
problems 
(vi) Inability to give informed consent 
 
6.2.3 Wearable Sensors  
This experiment intends to monitor bio-signals using the non-invasive wrist, leg, knee or arm-
worn Fitbit Ionic containing sensors. Two sensors are used during the study: accelerometer and 
heart-rate sensor. There is one Fitbit Ionic used containing two sensors: accelerometer and heart-
rate monitor. These sensors are described below: 
• Accelerometer Sensor: sensor captured motion-based activity and can be 
used for measuring the acceleration of a moving or vibrating body 
• Heart-Rate Sensor: uses green LED lights paired with light-sensitive 
photodiodes to detect the amount of blood flowing through the wrist (or other 
body part) at any given moment. When the heart beats, the blood flow in the 
wrist and the green light absorption is greater [212]. 
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The patient is also issued with instructions. These instructions explain how to begin the 
monitoring using the device and also how to wear it in the recommended position, see example 
below: Figure 6.1 and Figure 6.2. 
 
Figure 6.1. Position on ankle 
 
Figure 6.2. Inside 
Sock 
Participants are asked to wear the Fitbit Ionic with the sensors for 1 week. They are asked to 
remove it for charging and for bathing. The device will require charging once every 5 days, the 
participants receive information and accessories to charge their sensor-based device.  
The instructions contain daily forms for the patient to complete, hence, keeping a diary of the 
times of seizure, if they do not use this method an EEG recording will be obtained from hospital 
staff. This way the actual time stamp of the patients recorded seizure can be checked against the 
server time stamp observations of the seizure, so for example if the patient records their seizure 
at 10.20am and the server readings reveal heart-rate peaks and rapid movement from the 
accelerometer also at 10.20am, then this confirms the server readings match the patients (or EEG) 
known seizure occurrence  (see Figure 6.3. Seizure Time Stamps). 
 
Figure 6.3. Seizure Time Stamps 
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6.2.4 Data Collection & Analysis 
The artefacts collected at this stage are: 
• Number of seizures recorded in patient’s seizure diary or from EEG  
• Data collected from the wearable sensors. This data will be synced daily and 
uploaded to the server. 
The captured epileptic seizures will be measured. This will be measured against the patient’s 
seizure diary or EEG confirmed recordings from the hospital.  The data produced from the sensors 
for each individual patient will be time-stamped with the seizure diary (or EEG) and data analysis 
will determine what was happening before, during and after a seizure occurs. The back-end 
monitoring process can be seen in APPENDIX A ‘Backend Monitoring’. 
6.2.5 Pilot Study 
A pilot study took place to calibrate the experiment design. Preliminary experiments with the 
Fitbit Ionic device were performed, and simulated data from the accelerometer and heart-rate 
monitor sensors were collected. 
There were certain aspects to consider and modify due to the experience during the pilot study 
such as identified in Table 6.2. Pilot Study Aspects & Modifications. 
 
Table 6.2. Pilot Study Aspects & Modifications 
Aspects Modifications  
The battery power ceased after 5 
days. 
Data collection also ceased as a 
result, although data captured up to 
that point is secure. 
The participants need to 
receive clear instructions 
on how to charge the 
device. 
 
There was no indicator that once 
the device comes back on it 
immediately starts capturing data 
and the APP is re-started.  
To test this, a “force-run-
down” on the battery was 
performed by running an 




The assurance is that the 
device begins capturing 
immediately. 
Slow reading of data prompted 
concerns about the limited memory 
space in the device and data 
handling to store further data.  
It was discovered in the 
original specifications that 
Ionic has 2.5 G.B storage 
space. Yet during data 
collection storage exceeded 
this limit and did not pose a 
problem. 
Therefore, is was possible 
to record and measure data 
every 30 seconds rather 
than every minute. 
It was found that file size 
restrictions existed within the 
device.  
 
New files after a file size 
threshold were created to 
deal with this. 
 
6.3 Experiment Results 
Six hospital patients were enrolled, but one patient excluded due to technical difficulty obtaining 
both the heartrate and accelerometer data. Two volunteers where enrolled and performed seizures 
in a simulated environment. Table 6.3 provides known patient profile characteristics and reported 
seizure types. 
Hospital patients wore the sensor-based device for 5 days during video and EEG monitoring 
within hospital settings, all observations are in APPENDIX B ‘Hospital Patient Observations’. A 
total of 24 seizures were recorded with video and EEG: 9 GTCS, 14 non-GTCS and 1 none-
epileptic event. Two volunteer patients simulated total of 8 seizures. In total 32 seizure events 
were captured by the sensor-based device. 2 events recorded by video and EEG were missed (for 
HP4) as the patient  was either not physically wearing the watch at the time of a GTCS or the 
data was skipped due to technical difficulty. The sensor-based device consequently detected 








Seizure Type  Dominant 
Side 
Key Signs & 
Symptoms 
Common Signs & 
Symptoms 




2 GTCS (Generalised 





Diurnal Heart-rate data collected 
but accelerometer did not 
work. 
The patient used the 
paper-based diary to 
record seizures. 
Cluster Group 4 
Patient 1 
(HP1) 
14 FAS (Focal Aware 
Seizure) also known 
as CPS 
 
FSIA (Focal seizures 
with impaired or loss 
of awareness.) 
Seizures 
begin on the 
Right. 
 
LOC Automatisms Diurnal Continues to have seizures 
despite surgery.  
 
Seizures usually lasting 
10-20 seconds. 
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and Right  
LOC 
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Automatisms Diurnal Also, but (rare) secondary 
GTCS. R temporal 
cavernoma (small vascular 
malformation) but 
surprisingly the EEG 




Tonic Clonic Seizure) 
 
 
changes during seizures 
(ictal onset zone) was over 







Tonic Clonic Seizure) 
 
FSIA (Focal seizures 














No seizures captured 
despite patient reporting 
frequent seizures at home. 
Cluster Group 4 
Patient 4 
(HP4) 
9 GTCS (Generalised 
Tonic Clonic Seizure) 
 
FSIA (Focal seizures 














Nocturnal Video EEG captured 
secondary generalised. All 
seizures from sleep.  







Left Bilateral Clonus Cognitive Diurnal No epileptic seizures but 
one non epileptic shaking 
event recorded. 
Cluster Group 1 
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Seizure Type  Dominant 
Side 
Key Signs & 
Symptoms 
Common Signs & 
Symptoms 





4 GTCS (Generalised 
Tonic Clonic Seizure) 
Right  Bilateral Clonus  Diurnal & 
Nocturnal 
 




4 GTCS Left  Bilateral Clonus  Diurnal   Cluster Group 4 
129 
 
All seizure events detected by the sensor-based device recorded the correct date and time of the 
seizure, matching the time-stamp of the EEG video recording and not the ‘patient diary’. Six out 
of 32 seizures occurred during sleep while, 26/32 seizures occurred during the day or night-time 
while the participants were awake. The durations of the events detected by the sensor-based 
device were visually captured in charts showing periods of 2-4 minutes (with the exact time of 
the event indicated): this time-scale varied from 2-4 minutes for each participant due to available 
data queried at the time from the server. The average duration for the seizure captured by the 
sensor-based device was 1 minute. Seizure event data was uploaded to the server and to the online 
database in 32/34 (94.18%) of the seizures.  
Non-seizure durations were also charted for each participant, in some cases false positives events 
occurred this due to any non-epileptic activity from tossing and turning in bed, cleaning teeth, 
stirring a drink or general daily activity.  
None of the seizure events, except for the excluded patient, were recorded on the paper diary 
provided during the study.  
 
6.3.1 Findings and Discussion  
The heart-rate and accelerometer sensors used to detect characteristics of seizure events can 
successfully record seizure data, without need for participant cooperation beyond wearing the 
sensor-based device, even recharging the battery (battery life is 5 days when fully charged) was 
not required by the participants. Both the sensors detected the ‘shaking’ seizures correctly as seen 
from 2 observations below from HP4 in ‘Figure 6.4’ and ‘Figure 6.5’. 
 





Figure 6.5. Observation b HP4 
The effectiveness was also verified by “Non-seizure times” which are more easily recognised in 
sleep due to inactivity demonstrating that the sensors worked properly: see below random time 
periods whereby seizures did not occur for HP4 in Figure 6.6 and Figure 6.7. 
 
Figure 6.6. Observation k HP4 
 
Figure 6.7. Observation i HP4 
Both accelerometer and heart-rate sensors have been used to detect seizures in numerous previous 
studies [212] but in this study it was found that when used together in one device they did not 
always work in sync “together”. This is because when the sensors are worn on the non-dominant 
side and seizure occurs only heart-rate change indicated: accelerometer shows no change. Yet 
when in correct position on the body they work in union as an excellent detection method. 
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Therefore, demonstrating that body placement or position is paramount. For example, HP4s’ 
dominant side is the right arm. This means seizures are known to occur on the right. The results 
from “Observation c HP4” (Figure 6.8), can be seen below. During shaking from the right wrist 
at the recorded time: 00.23am during a GTCS seizure all 3 measurements on axis X, Y and Z 
showed sudden movements and the heart-rate increased to its highest peak at 128. Before the 
seizure the heart-rate was much lower at 80, then rising rapidly to 90 and up to 128.  This suggests 
both the sensors detected the seizure correctly. 
 
Figure 6.8. Observation c HP4 
Yet the results from “Observation a HP4”, seen below (Figure 6.9) indicate that during a GTCS 
at the recorded time ‘12.44pm’ the 3 measurements on axis X, Y and Z did not show any sudden 
movement, in fact barely any movement at all, yet the heart-rate increased to its highest peak at 
124, in keeping with typical heart-rate increase measurement during a GTCS for HP4. Since the 
accelerometer was positioned on the left wrist this reveals the sensor did not detect movement 
therefore demonstrating the sensor was positioned in the wrong position. 
 
Figure 6.9. Observation a HP4 
Knowing the individual characteristics of the patient profile prior to sensor-based device 
recommendation is key, for example the HP1 with FAS (Focal Aware Seizures) and FSIA (Focal 
Seizures with Impaired Awareness): the question here was “did the 2 sensors work in union to 
detect the Focal seizures?” Some heart-rate increase was detected but the accelerometer was 
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primarily redundant, for example in ‘Observation 10’ (Figure 6.10) a seizure occurs with sensor 
positioned on right wrist at the observed time: 09.44am, in this observation the heart-rate sensor 
detects some change over a 2 minute period i.e. The heart-rate begins at 87 increases to 90 then 
back to 87 then declines to 86 then steadily back to 90. At 09.45am the heart-rate does show 
increase to 95 and goes back down to 85. Heart-rate range is 87 -95, with some sudden movement 
from accelerometer at time of increased heart-rate. 
 
Figure 6.10. Observation 10 
Yet, during ‘Observation 11’, seen below in Figure 6.11 for HP1 with the seizure observed at 
20.36pm the heart-rate range is 81-84 with little sudden movement. Likewise, in ‘Observation 
12’ (Figure 6.12) : the seizure occurrence at 21.06pm demonstrates the heart-rate range: 81-86 
and little sudden movement. 
 





Figure 6.12. Observation 12 
 
A pattern emerges for HP1 in other observations whereby the heart-rate decreases, for example 
in ‘Observation a HP1’ (in Figure 6.13 below) at the time of the seizure ‘09.55am’ the heart-rate 
decreases from 90 to 84, and likewise in ‘Observation f HP1’ (Figure 6.14) with heart-rate 
decrease from 104 to 79 during the observed time of seizure at 11.01am and in ‘Observation g 
HP1’ (Figure 6.15) with heart-rate decrease from 100 to 84 during the observed time of seizure 
at 20.44pm. 
 
Figure 6.13. Observation a HP1 
 





Figure 6.15. Observation g HP1 
In ‘Observation g HP1’ the accelerometer indicates movement from all 3 X,Y and Z axis on the 
accelerometer at the time of the seizure. This is further observed in ‘Observation e HP1’ (in 
Figure 6.16) whereby there is sudden change in the accelerometer, but this is ‘21.01pm’ ‘after’ 
the time of seizure at ‘21.00’ where in fact again the heart-rate shows decrease. 
 
Figure 6.16. Observation e HP1 
Only 1/14 seizures observed for HP1 demonstrate significant movement for the accelerometer 
during seizures. Therefore, the accelerometer sensor is not useful for detecting these non-shaking 
seizures, although some patients’ profiles (found earlier in the collection of the ‘anonymous 
patient profiles’) reveal absence seizures can evolve to convulsive generalized tonic clonic 
movements. Therefore, it is endorsed that Focal seizures alone, go undetected without HR 
changes [3]. 
Predominantly during non-seizure time periods for HP1 there is no significant variance in 
accelerometer measurements when compared to ‘seizure occurrence’ time periods. For example, 
“Observation 16” (in Figure 6.17) shows a 4-minute snap-shot when HP1 has no seizure: the 3 
axis X, Y and Z move similarly in “Observation 12” (in Figure 6.18). This is further evidenced 




Figure 6.17. Observation 16 
 
 
Figure 6.18. Observation 12 
Ultimately there is some evidence demonstrated here that heart-rate ‘change’ occurs during the 
seizures for HP1 (increase and decrease). Yet since the seizures for HP1 occur for such a short 
time (20 seconds) heart-rate fluctuations can be missed or miss-interpreted as ‘false alarms’ 
perhaps due to agitation before or after the seizure.  
The key and common signs and symptoms are ‘LOC’ (Loss of Consciousness) and 
‘Automatisms’ for a patient such as HP1. Automatisms reveal themselves in a multitude of forms 
including repetitive movements, such as, lip smacking, chewing or swallowing, picking at clothes 
or skin or even staring [218] and these are difficult to detect with any sensor. 
Hence, these repetitive movements deemed as other behavioural components of seizures which 
include non-motor components and post-ictal phenomena cannot be detected  by the 
accelerometer [219] in line with the theory that seizures that are typical to the dominant body 
area not wearing the sensor-based device will not be detected. 
Some patients exhibit automatisms such as sudden sweating events [220], and since sweating is 
associated with Focal Seizures a more appropriate sensor for a patient with FAS and FSIA seizure 
types would be Galvanic Skin Response Sensor (GSR), which refers to changes in sweat gland 
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activity [57] as evidenced in other studies performed to detect seizures this galvanic skin response 
(GSR) sensor has been used in multi-modal platforms [220]. 
Empaticas’ ‘Embrace Plus’ smart watch [57] can be useful for Focal seizures as it has other 
sensors in addition to Galvanic Skin Response (GSR), for example EDA sensor and peripheral 
temperature, are just one of many sensors available in this device for researchers [221]. The 
Electro Dermal Activity (EDA )  represents the electrical changes on the surface of the skin (not 
just for sweat). Although witnessed in some studies finding that EDA increases during GTCS 
were greater than during CPS (Complex Partial Seizure, now: focal seizure with loss of 
consciousness) nonetheless it is a useful sensor for this type of seizure [221]. 
The peripheral temperature sensor also has evidence for use in detection in non-convulsive 
seizure’s (CPS) (focal) [221]. 
Although the Fitbit Ionic used in this study is not a conventional device for monitoring epilepsy, 
it can be adapted to detect seizures as demonstrated. It is a less expensive everyday ‘patient 
friendly’ option as opposed to EEG monitoring whereby the patient wears electrodes that are not 
comfortable: this is because the EEG-electrodes must be attached to the scalp which hampers the 
patient's movement making long-term home monitoring not feasible.  
In this sense this less expensive, comfortable alternative to EEG monitoring can be especially 
useful for patients with non-epileptic events. During early analysis in this thesis many patient 
profiles (found in the collected ‘anonymous patient profiles’) where identified as having non-
epileptic events and were categorised under “Non-Classified”. Although no confirmed ‘epilepsy’ 
these patients are still suffering with seizure signs and symptoms: as observed below in ‘HP5. 
Observation 1’(Figure 6.19). This patient has a non-epileptic shaking event at 23:03pm, the 
observation indicates heart-rate increase from 80 up to 109, the accelerometer also indicates rapid 




Figure 6.19. HP5. Observation 1 
The non-epileptic patient HP5 can be compared with HP2 and HP3 whom have confirmed 
epilepsy yet HP2 and HP3 had no seizures during the observation time in this study, as seen 
below in ‘Observation c HP2’(Figure 6.20) and ‘Observation a HP3’ (Figure 6.21). 
 
Figure 6.20. Observation c HP2 
 
Figure 6.21. Observation a HP3 
It is revealing how the accelerometer sensor behaves when there is no seizure (or rapid activity) 
compared to the movements witnessed in ‘HP5. Observation 1’ in Figure 6.19 above, hence the 
X, Y and X axis are much smoother. This smoothness is further evidenced when HP2 is sleeping 




Figure 6.22. Observation a HP2 
 
6.4 Personalising Patient Profiles 
In principle different types of seizures are suitable for different sensor-based devices, for example  
S. Tiwari et al disclose that the beginning step towards choosing an appropriate seizure detection 
sensor device should be to find the main legitimate component character of the seizure [222]. 
Such parameters identified in this thesis are defined under the classes discovered in the Epilepsy 
Seizure Ontology (ESO): these components are used to evaluate an individual patients’ profile. 
Once identified the Patients profile characteristics can be implanted into a “Cluster Group”.  
The ‘Cluster Group’ most corresponding to HP4 is ‘Cluster Group 4’ as identified in ‘Table 5.8. 
Cluster Groups’ Chapter 5 of this thesis.  The predominant seizure type for HP4 is GTCS this is 
associated with ‘shaking’ (clonus) and in the case of HP4 other signs and symptoms are LOC, 
and automatisms associated with the other seizure type (FAS) accompanying HP4. Since the 
patient has LOC this lends itself to the use of an ‘automatic detection’ device as patient is unable 
to record their own seizure. The heart-rate and accelerometer sensor-based device is an 
appropriate recommendation for HP4 but also for GTCS seizure types, this is because there can 
be interruption to breathing indicating that cerebral oxygen saturation sensors could be useful 
monitoring tools and adopted as automatic prediction devices [3]. 
The ‘Cluster Group’ most corresponding to HP1 is ‘Cluster Group 2’ as identified in ‘Table 5.8. 
Cluster Groups’ in Chapter 5 of this thesis.  This is because HP1 has FAS seizures, during the 
day-time only (diurnal), and seizures that occur ‘multiple weekly: over 5’. This patient also has 
automatisms and sensations associated with FAS seizures and the dominant side is ‘right’. The 
recommended sensor would be heart-rate as well as GSR to detect sweating during automatisms. 
As HP1 has a known history of ‘Diurnal’ seizures, dominantly on the right the sensors need only 
be worn during the day-time only and positioned upon the right of the body.   
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The patients HP2 and HP3 both have the same seizure types, which are GTCS and FSIA. Both 
these seizure types correspond to Cluster Groups 2 and 4. It was common during earlier analysis 
in this study to find patients having more than one seizure type, and due to this the patient will 
reveal more complex characteristics, both patients have the key signs and symptoms: LOC (Loss 
of consciousness) and clonus (shaking) and the common signs and symptoms: automatisms.  Both 
the patients have seizures which occur multiple weekly (over 5) and occur on both the left and 
right side of the body. The only specific difference in the characteristics of HP2 and HP3 is that 
HP2 has seizures that are ‘Nocturnal’ only (occur from sleep) whereas HP3 has both ‘Nocturnal’ 
and ‘Diurnal’ seizures. Based on this latter distinction the patients can be treated differently and 
hence ‘personalisation’ is realised.  
The final patient: HP5 corresponds to ‘Cluster Group 1’ with ‘Unclassified’ as seizure type. 
Distinct in their diagnosis compared to other confirmed epilepsy patients HP5 can be however 
recommended a sensor-based device since they are having multiple weekly (over 5) events. A 
key sign and symptom is ‘clonus’ (shaking) from the ‘left’ therefore the accelerometer sensor-
based device positioned on the left of the body could be helpful to detect these events. 
Furthermore, since these patients’ only other symptoms are ‘cognitive’ (i.e. Memory impairment, 
déjà vu) other sensors would not be recommended.  
 
6.5 Volunteer Observations 
Prior to this experiment upon hospital patients, this study was conducted with 2 non-epileptic 
volunteers who were asked to undergo the testing and perform ‘simulated seizures’ in a controlled 
environment with the sensor-based device positioned on different parts of the body at different 
times of the day. This was to calibrate the main hospital patient experiments. The findings are 
discussed below. The full list of Volunteer Observations is in APPENDIX C, together with the 
simulated individual profile characteristics and criteria used for observations. 
As can be seen from ‘V1.Observation 1’ in Figure 6.23 below, the first volunteer, with seizures 
occurring on the dominant right side of the body simulated a GTCS shaking from the right arm 
at the recorded time: 20.38pm. The sensor-based device was worn on the right wrist. The 3 
measurements on axis X, Y and Z showed sudden movement and the heart-rate increased to its 
highest peak at 100. Before the seizure the heart-rate was steadier at 78-81, then after the seizure 





Figure 6.23. V1.Observation 1 
When V1 simulated a seizure again from the right arm they placed the sensor-based device on 
the left wrist at the event time: 10.10am. As identified in ‘V1. Observation 3’ (Figure 6.24) the 
heart-rate shows an increase (78 to 123) yet the accelerometer axis is smooth. Similarly, in ‘V1. 
Observation 4’ (shown below in Figure 6.25) the volunteer placed the device on the ‘non-
dominant’ left leg and again the heart-rate increased dramatically but the acceleration generally 
smooth, although some movement on all 3 axis at the time: 09.47am of the event. Since ‘some 
movement’ was detected here a further test was performed with the device on the dominant right 
leg and here the difference is apparent, seen in V1. Observation 5 in Figure 6.26. This confirms 
the theory identified in earlier hospital patient observations that the sensor-based device position 
is paramount. 
 








Figure 6.26. V1. Observation 5 
 
For V2 the dominant side is left. It is evident when V2 placed the sensor-based device on the left 
leg during a simulated seizure at 22.14pm both the heart-rate and accelerometer sensors are 




Figure 6.27. V2.Observation 1 
 
Similar to V1 when V2 places the sensor-based device on the ‘non-dominant’ side (right leg) 
during a simulated seizure only the heart-rate sensor reacts, seen below in ‘V2.Observation 
1a’(Figure 6.28) again fuelling the theory that ‘position’ of the sensor-based device is paramount. 
 
Figure 6.28. V2.Observation 1a 
 
6.6 Summary  
Detection of seizures using an everyday sensor-based device and data transfer to online database 
was successful. This presented evidence that remote monitoring of specific epilepsy patients’ 
profiles with known characteristics can be improved. The comfortable sensor-based device with 
heart-rate and accelerometer provided accurate data and is a more dependable method than a 
patient’s paper diary. 
Difference was observed due to ‘position’ on the body of the sensor-based device, demonstrating 
that because of the known patient specific characteristics a personalised approach is achieved. 
Furthermore, it was discovered that the ‘type’ of sensor used is principal in its correspondence 
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with a patients’ particular ‘seizure type’ together with the particular associated signs or 
symptoms. 
The sensors and techniques used in this experiment enable some assurance in long term remote 
monitoring. The use of such sensor-based device used in this experiment can reduce the 
frequency of visits to hospitals and improve daily management of epilepsy thus, these sensing 
techniques have shown that results can be achieved in the measurement of specific epileptic 
seizures based on observations. 
As established through these experiments’ timely detection along with known patient 



















 Framework for Personalised 
Monitoring Plan   
 
7.1 Introduction 
This chapter discusses the development of the Personalised Monitoring Plan framework (PMP). 
In the previous Chapter 6 experiments were performed to capture seizure data, obtained from 
sensors, which are positioned on different parts of the patient’s body. This chapter discusses how 
results from this experiment are used to inform a PMP (Personalised Monitoring Plan) which 
recommends which sensor-based device to use based on those very individual, personal 
characteristics of a given patient. This chapter also corresponds to the methodology stage: ‘I.V. 
PMP Framework & Testing Stage’ shown in Figure 3.1 Research Design Framework and 
addresses ‘D2. Develop PMP Framework’ and ‘D3. Testing and Validation’. 
The framework is made up of various components including all the data, resources, devices, tools 
(data analysis) and ontology used together. This proposed framework is a model for which 
doctors and healthcare professionals (HCP’s) can use to assist in identifying which device they 
should recommend to the individual patient for remote monitoring. 
This chapter also presents the testing of the PMP framework to ascertain its impact and 
effectiveness. It will focus on ensuring that the framework meets the requirements and fulfils the 
original study objectives. It will be evaluated using an epilepsy scenario and demonstrate that a 
‘personalised approach’ is possible and ensure that it is a dependable and useful tool. A proposal 
for an IoT Epilepsy paradigm is also introduced in this chapter and as part of the solution further 
sensors are explored. 
 
7.2 Framework Philosophy and IoT  
In epilepsy, the most common and time-consuming patients to deal with correspond to individual 
strands of epilepsy, those patients that require long term monitoring assistance provided by 
doctors and caregivers. These highly varied kind of patient should be monitored specifically 
according to their symptoms, hence specific characteristics of each patient should be identified 
and medical treatment tailored accordingly [223] consequently paradigms are needed to 
personalise the information being described by both the condition of these patients each with 
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their individual strand of epilepsy: (signs and symptoms etc.), and from the patient record held 
for these patients.  
The PMP framework can employ aspects of the recent introduction of IoT technology which is 
available to aid epilepsy patients. An IoT-based model, namely the ‘IoT Epilepsy Paradigm’ is 
proposed and discussed in section 7.7. 
Included in the PMP frameworks is the ESO ontology which was developed to organise the terms 
used to describe seizure type patients of which the output is the PPDL, (discussed in Chapter 4). 
This is used as a knowledge base for the personalisation of seizure type patients together with 
their signs and symptoms. The K-means Clustering Analysis result builds upon the ESO ontology 
and PPDL using its singular entities and in essence categorising them. This second 
personalisation process uses the personalised ontology of a patient and automatically transforms 
it into a seizure type category. 
Consequently, the PMP framework integrates these two types of ‘personalisation’s’: 
➢ The patient as the individual (the ESO ontology) 
➢ Patients in a category (K-means Clustering method) 
The third tool of the PMP framework supports the decisions surrounding recommending the 
correct IoT sensor-based devices. The main purpose is to help HCP’s decide which IoT Sensors 
to recommend for monitoring and which position on the patient’s body.  
The PMP framework ultimately allows users to provide a description of the ‘seizure condition’ 
of a single patient or a patient type, and to automatically obtain a PMP adjusted to the patient 
requirements. It can be difficult for a HCP to know how to use an ontology confidently since 
ontologies are rarely used beyond academic institutions [224] with this in mind the PMP 
framework was constructed to allow ease of use. 
 
7.3 PMP Framework 
The proposed framework consists of two features: the first being ‘Personalisation’ (based on this 
study) and the second is the anticipated ‘Monitoring and Management’, shown in pink and blue 
respectively in Figure 7.1. PMP Framework. 
In this research, a patient record contains all the current medical information about the patient 
that may affect the immediate and short-term management of that patient.  
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In order to provide a Personalised Monitoring Plan (PMP) described in this study only the 
‘seizure related’ information of the patient is considered. This information is primarily composed 
of the patients’ seizure types, signs and symptoms. 
 
The ‘seizure profiler’ data and the ‘cluster classifier’ data plans are mutually related, and they 
define the knowledge base on which two knowledge personalisation procedures and one decision 
support process (Sensor Advisory) are implemented. 
Therefore, given the condition of an epilepsy patient (or a seizure type patient), the PMP is used 
to personalise the medical knowledge available for that patient, discarding all the knowledge that 
is not related to that patient condition.  
For example, in the PMP framework, the information from the patient record for how to deal with 
a patient profile is transformed and described instead with a single unified PMP (Personalised 
Monitoring Plan) whose information is more ‘seizure’ specific. The components in the 









7.4  Framework Components 
The framework is divided into 2 parts: ‘Personalisation’ and ‘Remote Monitoring’ both are 
discussed below together with the components contained in each. 
➢ Personalisation 
Beginning with a patient record, this first step explores the PPDL repository to find possible 
feasible seizure types, signs and symptoms that have been observed by the HCP as ‘key 
terms’ in the patient record.   
The knowledge about each single patient is personalised after a process of filtering upon entry 
to the Seizure Profiler component this is done to provide an evidence-based integrated 
description of the patient’s particular seizure condition. To determine as much as possible the 
HCP’s directly involved in the care of the patient, will incorporate the PPDL in within the 
record of the patient, and produce a new knowledge structure that can be incorporated later 
during in the ‘Sensor Advisory’ process in order to advise upon the patient’s best sensor-
based device and position. 
The HCP will input these key terms to the ‘Seizure Profiler’ component. 
This first personalisation process adapts the contents of the PPDL to the characteristics 
observed in the record of a given patient, automatically providing personalised seizure related 
data (through the Seizure Profiler component). 
Knowledge from the PPDL repository is fetched founded on the user input i.e. a ‘drop-down’ 
list. Any new terms are mapped and added to the PPDL repository and updated. 
The ‘Seizure Profiler Data’ is passed to the ‘Cluster Classifier’ component. The ‘key terms’ 
from the Seizure Related Profile Data are matched to the correct ‘Cluster Group’.  
The Cluster Classifier data is passed to the ‘Sensor Advisory’.  
 
7.4.1 Sensor Advisory 
The clear purpose is to recommend a sensor-based device to an individual patient profile, to 
do this several factors had to be considered. Informed from discussions with clinicians and 
findings from experiments it was apparent that a complex set of profile combinations existed 






7.4.1.1 Clinician Advisory Factors 
As observed in “Clinician Advisory Factors” the number of seizure types considered to be 
the most common was ‘5’, as demonstrated in  Figure 7.2 below. These 5 random sample 
patient profiles that were developed during preliminary discussions with clinicians were 
chosen because they were patients which were considered to have ‘the most common’ type 
of seizure and it was agreed that 5 represented a good range.  
The 3 other factors that were considered aspects when influencing the decision for the 
recommended sensor-based device per patient profile from the clinicians are listed below and 
shown in Figure 7.2 
• dominant side 
• limb indicator 
• signs and symptoms 
 
 
Figure 7.2. Clinician Advisory Factors 
However, the ultimate factor proposed from the clinicians to make the decision was the 
“seizure type”. Informed from discussions this proposal can be observed in Table 7.1. 
Matching Aspect whereby each of the main seizure types are matched with a useful sensor-
based device, these matches were confirmed accurate and realistic as witnessed in the 
experiments conducted in the previous Chapter. Furthermore, influenced by discoveries 
highlighted during analysis of the conducted experiments seizure type ‘A’ (which is GTCS) 
has additional sensors assigned: ‘heart-rate’ & ‘oxygen’ sensor. 
Table 7.1. Matching Aspect 
Seizure 
Type 





and or/ Heart-rate 
and oxygen 









Matching the seizure type to the device based on the ‘Matching Aspect’ table is an easy way 
to recommend a device to a patient, however all the other factors and variants must be 
considered. 
Firstly the “dominant side” and “limb indicator” factors were considered. When applying 
these factors to patient profiles per ‘seizure type’ a wide variety of alternative combinations 
are revealed. These factor infused profiles are shown below in Table 7.2. 
Table 7.2. Dominant Side and Limb Factors 
As observed (in Table 7.2) 30 different combination profiles exist demonstrating the range 
and high number of variants when the dominant side and limb indicator are applied to the 
seizure type. If the ‘signs and symptoms’ factors are also added, it is implicit that the amount 
of patient profiles grows even further. Consequently, the driving questions here are:  
“how can all these profile combinations be represented with their matching device and 
positions?”  
“what mechanism can be put in place to assist HCPs in making the decision on which device 
and position to recommend to an individual patient profile.?” 
These decisions are made by using the findings in this study and henceforth discussed. One 
approach is to form a data flow chart using a linear process yet this could not capture all the 
profile combinations with their multi-variants.  Figure 7.3. Linear Process Limitations shows 
an example of decisions in a flow chart that can be made at the point of a recommendation 
assessment for a given patient profile that has a known ‘seizure type’ (demonstrated by 
rectangle process box) . This linear process reveals limitations, one such being the fact that 
seizure ‘symptoms’ are not carefully considered and also lacks the injection of the new 
knowledge found in this research about cluster groups. Whilst straight forward decisions can 
be made about matching the correct device with a given seizure type (those represented by 
the diamond symbol) and likewise the dominant side and limb factor, the process is too 
shallow. The next sections address these limitations and seek to output such a result that 
would reveal truly all-embracing recommendations. 
 
Seizure Type A 
with 6 variants 
Seizure Type B 
with 6  variants 
Seizure Type C 
with 6  variants 
Seizure Type D 
with 6  variants 
Seizure Type E 
with 6  variants 
A right arm B right arm C right arm D right arm E right arm 
A right leg B right leg C right leg D right leg E right leg 
A left arm B left arm C left arm D left arm E left arm 
A right leg B left leg C left leg D left leg E left leg 
A both sides B both sides C both sides D both sides E both sides 








7.4.1.2 Matching the Correct Device to the Cluster Groups 
Whilst addressing the question of matching the correct device with each of the 6 cluster 
groups identified in Chapter 5 several issues came to light. The theory derived from the 
clinicians previously discussed was to simply match the seizure type to the device, as seen 
previously in Table 7.1. Matching Aspect. 
Yet if a given patient profile has seizure type B (FMS) does this mean they should 
automatically be assigned ‘Device 2’ (heart-rate sensor)? If this is the case, then other factors 
(shown in green below) have no bearing and become irrelevant. A snapshot in Figure 7.4 
(Cluster Group and Device Analysis 1) below demonstrates the problem thus providing an 
overview of the challenge to match the correct seizure type with the correct device and 
include ‘dominant side’ and ‘limb factors’ and ‘signs and symptoms’: Each of the 6 cluster 
groups are indicated by colour, i.e. Cluster 0: blue line, Cluster 1:orange line etc. 
 
 
Figure 7.4. Cluster Group and Device Analysis 1 
Yet as informed from the experiment results it was observed that it was the ‘Signs & 
Symptoms’ that had the greatest influence upon the decision for example during the 
experiments in this study the patient, namely: ‘HP1’ with ‘Focal’ seizure type was found to 
have ‘heart-rate changes’ during their seizure, this symptom reveals more about the 
individual than the actual ‘seizure type’ did since this type of seizure was not originally 
considered for the heart-rate sensor as observed in Figure 7.2. Clinician Advisory Factors, 
‘Patient Profile 3’ with a Focal type seizure. The ‘dominant side’ & ‘limb indicator’ factors 
can have no bearing upon the type of device to be recommended only the ‘position’:  yet as 
discovered during experiments: ‘position is paramount’ but nevertheless this is still not a 
factor influencing device decision. This factor instead should be treated as essential 
accompanying factor and thus as an “addon”. With this in mind this addon is removed from 




Figure 7.5. Cluster Group and Device Analysis 2 
 
Now that this factor has been removed the next focus is on how the ‘seizure type’ has bearing 
upon the decision. Upon returning to the example i.e. “a patient profile with seizure type B 
(FMS)”, the assumption is applied that this profile should automatically be assigned ‘Device 
2’ (heart-rate sensor). Yet, what if this particular patient profile has ‘sweating’ and ‘shaking’ 
too? So therefore, should they not also be assigned the ‘Galvanic Skin Response’ sensor? 
The original assumption from the clinicians that a device can be recommended based upon 
seizure type is not sound because as demonstrated “signs and symptoms” play a more superior 
part in the decision. With this in mind the “matching aspect of seizure type with device” is 
removed (as seen in Figure 7.6. Cluster Group and Device Analysis 3) and just the “signs and 
symptoms” remain as the prime factors influencing the choice of device. This makes the 
“seizure type” factor irrelevant. Removing the “seizure type” from the decision is further 
affirmed due to observations derived from the experiments on the hospital patients whereby 
there existed patient profiles that often had more than one seizure type. As this holds true 
how could ‘multi’ seizure types correspond to a device? Similarly, a patients ‘signs and 
symptoms’ can vary, especially for an “unclassified” seizure type: as witnessed during 
experiments in Chapter 6 whereby HP5 revealed ‘shaking’ symptoms’ yet another 
‘unclassified’ seizure type patient may reveal ‘palpitation’ symptoms only. Therefore, it  is 
only the ‘signs and symptoms’ that can influence the device choice, and the next step is to 
see how features of the sensor-based device correspond to particular signs and symptoms. 
Ultimately, the decision resides on what features the sensor-based device can offer, in 




Figure 7.6. Cluster Group and Device Analysis 3 
7.4.1.3 Assigning the Sensors 
Informed from the findings a method has been put in place to recommend sensors to an 
individual patient profile. The foundation for this is based upon the following logic, shown 
in Table 7.3. Assigning the Sensors’, here each of the 6 ‘Cluster Groups’  is assigned a sensor 
or ‘sensors’, (shown in blue). Then according to how the individual ‘signs and symptoms’ 
for that cluster correspond to available sensors each sign and symptom is labelled:  i.e. given 
a patient with ‘myoclonus’ (full body shaking) the sensor will be the ‘accelerometer’(labelled 
‘A’), given a patient with ‘Automatisms’ the sensor will be ‘heart-rate’ (labelled ‘B’) and so 
on. Some symptoms do not correspond to a sensor since there are not always available sensors 
for symptoms i.e. LOC (Loss of consciousness), henceforth these symptoms are labelled ‘NS’ 
(no sensor). The table below Table 7.3. Assigning the Sensors’ demonstrates this logic.  
 
Table 7.3. Assigning the Sensors 
The next step demonstrates how the decisions are ‘processed’ in the form of a decision tree, 
shown in Figure 7.7. Sensor Decision Tree. (The complete decision tree is shown at the top 
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and there is an ‘expanded view’ beneath of a random portion of the tree for added visual 
clarity, together with a key for each abbreviation used.)  
The decision tree verifies the clusters to be correct since every combination of the 5 sensors 
(for each symptom) is presented in the ‘Sensor Decision Tree’, so if each cluster runs its 
pathway through the decision tree it confirms the most suitable sensors for that particular 
cluster, as indicated in Table 7.3 above. In addition to the 6 cluster groups, every other 
outcome (or eventuality) is offered based upon the identified signs and symptoms from the 




does the patient have the symptom clonus?  
if ‘yes’  go to next question: 
does the patient have the symptom automatisms?  
if ‘no’  go to next question: 
does the patient have the symptom sensations?  
if ‘yes’  go to next question: 
does the patient have the symptom sensory?  
if ‘yes’  go to next question: 
does the patient have the symptom urinary?  
if ‘no’  go to next question: 











Figure 7.7. Sensor Decision Tree 
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Based upon the evidence that particular signs and symptoms match with a sensor, shown in 
this approach, it can be projected that future epilepsy patients displaying epilepsy symptoms 
in a similar manner will require the same sensor. In this sense a future goal is to use the 
decision tree as a training model that can be used to predict the target variable, i.e. the 
sensor, by learning simple decision rules inferred from prior training data [225]. 
The decision tree presented here is easy to understand, users can relate to its theory, its 
graphical representation is intuitive. For future data exploration it is expected more 
variables will be added such as signs/symptoms, sensors and positions, and therefore the 
decision tree can help identify the most significant variable.  
Decision trees can be used for classification and regression, and algorithms such as CART 
exist to grow the tree to predict the outcome in each leaf node the average outcome of the 
training data in this node is used [226]. Using the approach described in this thesis other 
health domain experts and researchers can take this to the next level. 
 
Generate the PMP 
The next component in the PMP framework is to generate the PMP. Now that the chosen 
sensor has been assigned together with the ‘addon’ position information, it is sent to the part 
of the framework which will generate the PMP (Personalised Monitoring Plan). 
In summary the three datasets that are passed to the ‘Generate PMP’ component during the 
process in the framework are: 
➢ Seizure Profiler Data 
➢ Cluster Classifier Data 
➢ Sensor & Position Information 












Personalised Monitoring Plan 
Patient Profile Number: 56 




Your Personlaised Monitoring Plan  
Please wear the sensors on your right leg  during night-time only at home. There is an extendible 
strap to ….etc. 




Seizure Type: GTCS 
Sign: LOC, Shaking 
all limbs 
(Bilateral Clonus) 
Symptoms: Déjà vu, 









Trigger: Sleep Dep 
Arm/Leg: Leg 







































➢ Remote Monitoring and Management 
The new knowledge gained in the PMP framework will be updated in the patient record to 
help general practitioners in their daily tasks of visiting patients, follow-up, diagnosis, 
planning of treatments and foreseeing changes. The PMP is sent with the patient to their 
home. The patient then receives the PMP together with the monitoring IoT sensor-based 
device containing the two sensors heart-rate and accelerometer as described during the 
experiment investigation and design. The patient wears the device and the monitoring data is 
then sent from the device to the mobile phone from which it's paired, and from there to the 
Health Service server.  
The proposed Health Service web server connects the data between the mobile phone, using 
JSON. The web server helps to save the data, to the MySQL database server also located in 
the hospital. The monitoring data can then be exported directly from the database.  
The app sends the ‘monitoring data’ from patient to the Health Service server to process and 
then the monitoring data is displayed shown during the experiment design, see APPENDIX 
A ‘Backend Monitoring’.  JSON (JavaScript Object Notation) is used as the data format to 
exchange information between client and server. JSON is a lightweight data-interchange 
format, JSON uses the text format which is completely independent from different 
programming languages. Furthermore, it not only supports several programming languages 
but has a satisfactory transmission and parsing speed [227] [228]. 
Finally, an HCP will receive the ‘monitoring data’ from the Health Service server for the 
given patient, this data will then be analysed. To analyse the monitoring data there will be a 
built in ‘machine learning module’ to determine seizure detection or not. This learning 
module uses training algorithms and replaces the need for humans by using a machine 
learning approach. Due to limitations in this study this module has not been built but instead 
is proposed at this stage.  
 
7.5    PMP Framework Loop and Maintenance 
With this PMP framework, the PPDL can be directly maintained (and extended) by HCP’s. 
The framework has the flexibility, (as the ontology grows with new seizure related concepts), 
to deal with the mounting diversity of seizure type patients. Therefore, the PMP framework 
is to some extent reliant on the integration of new knowledge in the PPDL. As the HCP of 
the PMP Framework confirms the recommendations, the information about the patient and 
the advice may change and this new information can cause the PMP Framework to continue 
providing new suggestions to the HCP.  
This loop stops either when the framework is not able to provide new recommendation or 
when the HCP considers that the current condition of the patient is perfectly represented by 
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the recommendation. At any point, the PMP for the patient is left to the HCP who is using 
the framework. 
Consequently both the personalised ‘seizure related data’ and the ‘cluster classifier data’ of 
a patient may evolve as the patient condition changes (i.e., when the information about the 
patient changes in the patient record of that patient) or as a result of the application of the 
PMP Framework to find out new ‘seizure type’ knowledge about the patient in question. 
These evolved datasets can be continually stored as part of the record of that patient. 
 
7.6 Use Case Evaluation 
Here the evaluation of the PMP framework in epilepsy scenarios is undertaken. Two different 
scenarios each with different patient profiles will be tested by showing their respective inputs 
and outputs. The result will help determine how effective the developed framework can be 
used as a tool for recommending the IoT device to an epilepsy individual patient. The steps 
(1-9) taken in each scenario throughout the framework are discussed and can be seen in 
‘Figure 7.1. PMP Framework’ numbered in yellow. 
 
7.6.1 Scenario 1 
Use Case Name: Scenario 1 
Use Case Description: In this scenario an HCP takes a sample patient through each of the 
steps in the PMP framework 
Actors: Patient Profile 56 (with an existing patient record) 
Triggers: The patient indicates that he/she wants to have an IoT sensor-based device to 
remotely monitor their epilepsy. 
Preconditions: The patient has known frequent seizures that have been recorded in the 
patient record. 
Post-conditions:  
i. The patient will receive a PMP (Personalised Monitoring 
Plan) 
ii. The patient will receive a recommended IoT sensor-based 
device that they will place on position on their body. 




1.   The patient will indicate that he/she wants to have an IoT sensor-based device to remotely 
monitor their epilepsy and provides consent for the HCP to access their patient record.  
2.   The HCP using the PMP framework will explore the PPDL repository (see Step ‘2’ in 
Figure 7.1. PMP Framework) to find possible feasible seizure types, signs and symptoms that 
have been observed by the HCP as ‘key terms’ in the patient record. See Figure 7.9. Patient 
Record Sample 1. 
 
Figure 7.9. Patient Record Sample 1 
The patient record is personalised after a process of filtering upon entry to the ‘Seizure 
Profiler’ component (Figure 7.10. Seizure Profiler). 
Hospital Number:### Referring 
Clinician:### 
Test Type: EEG TELEM  
CLINICAL HISTORY: 
Age/date of onset- 12 months ago. Description of 
event:(Generalised Tonic Clonic, 4 in a month, usually 
occur when lack of sleep, and when asleep, can have a 
warning during the night like increased heart-rate, 
feeling strange (happened before), visual disturbance 
unable to respond. Partner reports full body-jerking, 
mainly begins on right leg. Patient feels tired and 







Figure 7.10. Seizure Profiler 
Automatic personalised seizure related data from the Seizure Profiler is fetched. The output 
is the Seizure Profiler Data. The patient output for Patient profile 56 is revealed here: Table 
7.4. Sample Seizure Profiler Data. Keywords from the patient record have been incorporated 
and terminology updated. 
Patient Profile Seizure 
Type 
Key Signs Symptom Occurrence 





Multiple seizures (up 
to 5 per month 
Dominant Side Diurnal/Nocturnal Trigger Arm/Leg 
Right Nocturnal Sleep Dep Leg 
Table 7.4. Sample Seizure Profiler Data 56 
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3. The PMP framework passes the ‘Seizure Profiler Data’ to the ‘Cluster Classifier’ 
component. The PMP framework matches the ‘key terms’ from the ‘Seizure Related Profile 
Data’ to the correct ‘Cluster Group’ i.e. then, given the sample in Table 7.4. Sample Seizure 
Profiler Data ‘Patient profile 56’ is matched to ‘Cluster Group 1’, see Figure 7.11. Cluster 
Classifier. 
 
Figure 7.11. Cluster Classifier 
4. The PMP framework passes the Cluster Classifier data to the ‘Sensor Advisory’ 
component. Here the HCP examines the Cluster Classifier data and checks that the 
recommended sensors and position are appropriate  
The cluster group match for Patient Profile 56 (shown in Table.6.2 ) is ‘Cluster Group 4’. For 
this Cluster Group the recommended sensor/sensors are the Accelerometer Sensor and Audio 
sensor to be positioned on the right leg. This is because this type of patient has a seizure 
symptoms which predominantly reveals itself on the right side of the body and begin in the 




5. The PMP framework passes the three datasets to the ‘Generate PMP’ component: Seizure 
Profiler Data, Cluster Classifier Data and Sensor & Position Information. These three datasets 
form the PMP for Patient Profile 56, see Figure. 7.12. PMP (Profile 56). 
Figure. 7.12. PMP (Profile 56) 
6. The patient receives their PMP  
Personalised Monitoring Plan 
Patient Profile Number: 56 




Your Personalised Monitoring Plan  
Please wear the sensors on your right leg at home at night-time only.  There 
is an extendible strap to ….etc. 
Seizure Type: GTCS 
Sign: LOC, Shaking 
all limbs 
(Bilateral Clonus) 
Symptoms: Déjà vu, 









Trigger: Sleep Dep 
Arm/Leg: Leg 




Seizure Type: GTCS 





























7. The patient receives instructions and wears the IoT sensor-based device on the 
recommended body position. The patient completes a daily form and keeps a diary of the 
times of their known seizures.  
8. The PMP frameworks sends the patients ‘monitoring data’ to the Health Service server. 
9. The patient data is then analysed at the ‘Hospital Analysis’ stage of the PMP Framework 
using the ‘Machine Learning Module’ (as described in the ‘Framework Components’ 
section).  
 
7.6.2 Scenario 2 
Use Case Name: Scenario 2 
Use Case Description: In this scenario an HCP takes a sample patient through each of the 
steps in the PMP framework 
Actors: Patient Profile 57 (with an existing patient record) 
Triggers: The patient indicates that he/she wants to have an IoT sensor-based device to 
remotely monitor their epilepsy. 
Preconditions: The patient has known frequent seizures that have been recorded in the 
patient record. 
Post-conditions:  
i. The patient will receive a PMP (Personalised Monitoring Plan) 
ii. The patient will receive a recommended IoT sensor-based device 
that they will place on position on their body. 
iii. The patient’s seizures will be monitored by the NHS. 
Normal Flow: 
1.   The patient will indicate that he/she wants to have an IoT sensor-based device to remotely 
monitor their epilepsy and provides consent for the HCP to access their patient record.  
2.   The HCP using the PMP framework will explore the PPDL repository (see Step ‘2’ in 
Figure 7.1. PMP Framework) to find possible feasible seizure types, signs and symptoms that 
have been observed by the HCP as ‘key terms’ in the patient record. See Figure 7.13. Patient 




Hospital Number:### Referring 
Clinician:### 
Test Type: EEG TELEM  
CLINICAL HISTORY: 
Age/date of onset- 3 years old. Description 
of event: (Myoclonic tonic clonic), 3 in a 
week, will occur when stressed after work, 
during afternoons, can have full body-
jerking, on all sides of body but upper limbs 




Figure 7.13. Patient Record Sample 57 
The patient record is personalised after a process of filtering upon entry to the ‘Seizure 
Profiler’ component (Figure 7.14. Seizure Profiler). 
  
Figure 7.14. Seizure Profiler 
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Automatic personalised seizure related data from the Seizure Profiler is fetched. The output 
is the Seizure Profiler Data. The patient output for Patient profile 57 is revealed here in Table 
7.5. Keywords from the patient record have been incorporated and terminology updated. 


















Diurnal/Nocturnal Trigger Arm/Leg 
Either Diurnal Stress Arms 
 
3. The PMP framework passes the ‘Seizure Profiler Data’ to the ‘Cluster Classifier’ 
component. The PMP framework matches the ‘key terms’ from the ‘Seizure Related Profile 
Data’ to the correct ‘Cluster Group’ i.e. the sample in ‘Patient profile 57’ is matched to 




Figure 7.15. Cluster Classifier Profile 57 
4. The PMP framework passes the Cluster Classifier data to the ‘Sensor Advisory’ 
component. The HCP examines the Cluster Classifier data and checks that the recommended 
sensors and position are appropriate.  
The cluster group match for Patient Profile 57 shown in Table.6.2 is ‘Cluster Group 5.’ For 
this Cluster Group the recommended sensor/sensors are the Accelerometer Sensor and Heart-
rate sensor to be positioned on the right wrist. This is because this type of patient has a seizure 
type which reveals itself on both sides of the body and begins in the upper limbs. As the 
patient has Diurnal seizures, they are asked to wear the sensors during the daytime only. 
5. The PMP framework passes the three datasets to the ‘Generate PMP’ component: Seizure 
Profiler Data, Cluster Classifier Data and Sensor & Position Information. These three datasets 





Personalised Monitoring Plan 
Patient Profile Number: 57 




Your Personalised Monitoring Plan  
Please wear the sensors on your right wrist during the day-time only at home. There is an 
extendible strap to ….etc. 
Figure 7.16. PMP Sample 57 
6. The patient receives their PMP  
7. The patient receives instructions and wears the IoT sensor-based device on the 
recommended body position. The patient completes a daily form and keeps a diary of the 
times of their known seizures.  
Seizure Type: MTC 







  3 per week 
Dominant Side: 


















(up to 5) 
Dominant Side: 
























8. The PMP frameworks sends the patients ‘monitoring data’ to the NHS server. 
9. The patient data is then analysed at the ‘Hospital Analysis’ stage of the PMP Framework 
using the ‘Machine Learning Module’ (as described in the ‘Framework Components’ 
section).  
 
7.7 Proposed IoT for Epilepsy Paradigm 
To achieve the type of monitoring described in the PMP framework, several IoT 
components can be deployed to retrieve sensor data from the epilepsy patient to be accessed 
remotely. These components include the integration of the personalisation components 
described in the PMP framework, those of an internet connection and protocols which form 
the ‘network layer’, a cloud platform to manage the data analysis and fundamentally the 
sensor-based devices forming the sensor layer. These components make the ingredients of 
an IoT solution, proposed in the IoT Epilepsy Paradigm. 
The purpose of the IoT Epilepsy Paradigm is to support the PMP framework in collecting 
data from a variety of potential epilepsy device sensors and also provide optimal analysis 
tools to utilise the sensor data thus supporting clinicians to monitor epilepsy patients. 
 
7.7.1 Sensor Layer 
The sensor layer has the task of acquiring and sending the data from the different epilepsy 
devices involved in capturing seizure data, to the proposed cloud platform. 
The sensors previously used in the experiment, the heart-rate and accelerometer sensors 
were demonstrated within the PMP framework discussed in this chapter. Yet there are other 
sensors too that can work within the context of this research. These potential sensors found 
in other devices are explored and proposed below. 
 
7.7.1.1 Sensors for Epilepsy 
Despite the expense, multi-modal sensor based devices are the ultimate desire to monitor an 
epilepsy patients seizures since multiple sensors are embedded in one device and make 
comfortability for the patient and all-in-one solutions for the manager of the device, 
furthermore epilepsy patients have revealed their preference for devices capable of 
monitoring several parameters [229].  Section 2.3 in Chapter 2 uncovered some of the 
epilepsy detection devices and monitoring systems, whilst Chapter 6 demonstrated the use of 
an inexpensive device with heart-rate and accelerometer sensor (justified for experimental 
purposes), and simultaneously identified other useful sensors for epilepsy. These other 
sensors which exist in devices, those that go beyond heart and movement sensing, and beyond 
fitness devices, are amongst a vast amount. Consequently, many studies have analysed the 
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performance and limitations of each sensor based device, one critical evaluation by Peake 
[230] found many devices where not yet fully validated or tested for reliability, therefore this 
examination will aim only to propose validated devices for use in the IoT Epilepsy paradigm. 
 
Recently in 2020, Abreu, Fred et al [231] did a significant exploration on, wearables and 
related devices, that can be utilised for epilepsy prediction, the findings are produced in tables 
shown in Table 7.7 Wearable Sensor Exploration [231] which presents devices, some with 
multiple sensors, characterised with respect to their applicability to research, validation 
status, form factor or body positioning, battery duration, method to access the data, measured 
signals and, their applicability to epilepsy prediction (EP) [231]. 
This is a useful table since the devices have already been validated, and connectivity options 
identified, and since they are beneficial for epilepsy they can be proposed in the IoT Epilepsy 
Paradigm.  
These devices and their sensors, identified as applicable for epilepsy prediction contain some 
of the sensors that were observed in the sensor advisory section (7.4.1) and shown Figure 7.7, 
i.e. accelerometer, heart-rate and GSR, but the audio and bladder sensors are not included. In 
this case the audio and bladder are added to Table 7.6 Selected Sensors for IoT Epilepsy 
Paradigm, together with their connectivity options. 
The ‘IoT Epilepsy Paradigm’ proposal in Figure 7.17 shows areas on the body where 
parameters are measured, each area is indicated with a colour matching the parameter. The 
chosen devices have been proposed based upon the factors in Table 7.7 Wearable Sensor 
Exploration [231] for the best battery life, validity, and connectivity options selected for ease 
of connection to the cloud platform in the IoT Epilepsy Paradigm. Since Embrace2 device 
uses its own onboard processing it is not adaptable for the paradigm proposed in this study. 
Furthermore some of the device based sensors depicted in Table 7.7 Wearable Sensor 
Exploration [231] are multi-modal so their use can sometimes be proposed in more than one 













Table 7.6 Selected Sensors for IoT Epilepsy Paradigm 










Electrodermal Empatica E4 EDA 
or GVS 
Cloud Storage 48h 
Blood Volume Empatica E4 PPG Cloud Storage 48h 
Movement Bioharness3 ACC  BLE 
transmission 
12-24h 
Heart-Rate EQ02  ECG Bluetooth 
transmission 
48h 
Temperature EQ02 Temp Bluetooth 
transmission 
48h 















                              Table 7.7 Wearable Sensor Exploration [231] 
Product Research use Validated/ 
Reliable 
Site Battery Data Accessibility Sensor
s 
Suitability EP 
EQ02  [55] Ambulatory [56], Athletes 
Monitoring [57] 
Validation with  Holter 
[58] 
Vest 48h Bluetooth transmission ECG,  Derived  RESP, 
Temp 
√ 
E4  [59] Migraines [60], Stress  Detection 
[61] 
CE  clearance [12] Bracelet +48h Cloud  Storage EDA,  PPG, Temp √ 









Ambulatory Monitoring [67] FDA





Sports Monitoring HR  validation [69] Chest 
Strap 
12-24h BLE  transmission ECG, RESP, Temp, ACC √ 




12h         Cloud  Storage or BLE  
transmission 
ECG,  RESP, ACC √ 
Vivosmart4 
[72] 
Stress  Assessment Not  yet  validated Smartwatc
h 




Product Research use Validated/ Reliable Site Battery Data Accessibility Sensors   Suitability EP   
EP Moodmetric 
[85] 
Stress Assessment [56] Experimental comparison 
[86] 
Ring 4 days BLE  Transmission EDA x 
Embrace2 [59] Seizure  Detection FDA  and  CE  clearance Smartwatch +48h Onboard Processing EDA,  Temp, Acc, 
Gyr 
√ 
GoBe2  [87] Nutrition, Hydration, 
Emotion 
Only  for calorie  intake [88] Smartwatch 24h BLE  transmission EDA,  Acc, Gyr,  Mag √ 
MyFeel  [89] Emotion Preliminary study Wristband +24h BLE  Transmission EDA,  Temp x 










7.7.2 Cloud Platform 
The proposed cloud platform provides all the necessary services for the clinician to manage, 
process and visualise the seizure data. All the processes that involve the interaction between 
the personalisation layer and the sensor layer are carried out through the following modules: 
PMP data management, machine learning module and data analysis & visualisation. All these 
services are hosted in the cloud and clinicians are able to access them remotely from any 
location. The data analysis and visualisation module utilises the sensor data while the ‘PMP 
data management’ module pulls all the patient records from the personalisation modules and 
here the sensor data results are updated. Visualisation is a requirement for any such system 
as it is important for clinicians to be provided with user friendly GUIs so they can study the 
seizure data  from the epilepsy sensor devices. The machine learning module is also proposed, 
this is a key aspect for future development and the idea is that by using algorithms the module 
will ‘learn’ when a patient is about to have seizure and warn them in advance. 
A pre-processing hardware and a platform are needed to communicate and transmit the sensor 
data which is collected using wearable sensors positioned on a patients body. The Microsoft 
Azure IoT platform [232] is proposed , since this cloud computing server is trusted and safe 
[233]. 
 
7.7.3 Network Layer 
There are several ways the sensors can connect and send data to the cloud platform and 
since most of the sensor devices connect to a mobile phone they are served by  Bluetooth or  
Bluetooth Low Energy (BLE) and use very little power. Nevertheless each sensor based 
device is provided with its own protocol and connectivity options as noted in Table 7.6 
hence the type of  IoT connectivity is determined generally by the distance that the data 
must travel, either short-range or long-range [234]. IoT platforms such as Azure use 
gateways to connect IoT devices to the cloud. The data collected from the devices moves 
through this gateway, gets pre-processed using in build modules (Edge) and then gets sent 
to the cloud. Data is protected by an additional layer of security provided by the Azure 
Application gateway and in addition connection security is enabled as each connected IoT 
device is given a unique identity key [234]. 
 
7.7.4  Scope of IoT Epilepsy Paradigm 
An IoT approach has been proposed, this IoT epilepsy paradigm can be adopted by the PMP 
framework and has demonstrated some of the validated sensors for epilepsy monitoring. It is 
outside the scope of this thesis to develop and perform monitoring upon each of the sensor 
based devices shown in the IoT Epilepsy Paradigm, and it should be noted that there are many 
more considerations to be taken into account for an IoT ‘solution’, one such example is to 
deploy an additional component to closely monitor the function of a sensor and send an alert 














Figure 7.17 IoT Epilepsy Paradigm Proposal 
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The integration of the components and  technologies in the framework depicted in Figure 7.1. 
PMP Framework aims at providing HCP’s dealing with epilepsy patients with an integrated 
tool that helps them in recommending the correct IoT sensor and position on the patient’s 
body. 
These decisions are made at the point and time of care as an ‘aid’ in personalising the 
condition of new arriving patients, and to refine the predefined ‘patient record’ in order to 
obtain and validate a Personalised Monitoring Plan which is in addition adapted to include 
the seizure monitoring of the patient during appointments. 
The PMP Framework is designed to provide a patient-empowering support in a way that the 
available knowledge is continuously personalised to the condition of the seizure type patient. 
The IoT Epilepsy paradigm has been proposed and can be adopted by the PMP framework in 














 Conclusion and Future Work 
 
8.1 Introduction 
This final chapter seeks to conclude the thesis with a summary of its goals and contributions, 
a discussion of barriers and limitations, followed by proposed improvements and directions 
for future work. 
 
8.2 Contributions and Achievements 
The main contribution of this research set out to develop an IoT driven framework for remote 
personalised monitoring and managing of epilepsy to help HCP’s to create a ‘Personalised 
Monitoring Plan’. The research began by exploring the challenges and issues surrounding 
epilepsy and healthcare monitoring systems proposed by researchers and technologies to help 
‘detect’ seizures. The concept of Personalised Healthcare was introduced, and methods were 
observed to make epilepsy patients distinct from one another. It was discovered here how IoT 
can be utilised to support the ever growing trend of Personalised Healthcare but during this 
literature review it was found that currently, epilepsy monitoring systems and IoT platforms 
do not fully embrace a personalised approach, despite some observations in studies about the 
importance of distinguishing each ‘seizure type’.  Since ‘seizure type’ is just one of many 
parameters that can distinguish one seizure patient from another, this thesis set out to identify 
and investigate any more very individual characteristics to address the challenge to achieve 
a truly ‘personalised’ approach to managing epilepsy. 
In addition to fulfilling the aim of this thesis the following contributions were made: 
A.) Epilepsy ‘terminology’ was first investigated; existing seizure type 
classifications/categories were analysed so that an individual seizure type patient profile 
could be formed and thus an ontology was developed to model this concept, namely ESO 
‘Epilepsy Seizure Ontology’. This was a driving force for the PMP Framework and a critical 
aspect for this concept. In order to make ESO useable for HCPs (Health Care Professionals) 
the ontology was transformed into a language that is understandable by humans and 
machines, this was accomplished by XML and the outcome was PPDL (Patient Profile 
Description Language). 
B.) To see if distinct group of patients sharing similar characteristics could be identified so 
that ultimately patients could receive distinct recommendations per group Clustering 
techniques were analysed and carried out. The outcome was a set of 6 distinct ‘clustering’ 
groups, these 6 cluster groups revealed six completely different categories of patients each 
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with their distinct seizure related information. This outcome is extendable: the use of a single 
dataset means that the results should not be generalised to a wider population. For future 
work, multiple datasets should be used for further validation. 
C.) To test the assumption to see if an individual patient profile or distinct group of patients 
sharing similar characteristics can make a difference in which IoT device to use experiments 
were performed to capture seizure data, obtained from sensors, which were positioned on 
different parts of the patient’s body. The experiment outcomes revealed that difference is 
observed due to sensor ‘position’ on the body and that sensor ‘types’ are suited to different 
patient profiles. Therefore, these results were used to inform the development of the 
conceptual PMP Framework which was developed to evaluate the research. 
D.) The research design approach used in this thesis shown in Chapter 3 Figure 3.1 originated 
on findings from the literature review. However, this framework is a new and novel way to 
achieve the type of ‘personalisation’ described in this thesis. This overall design approach 
which incorporates a sequential strategy is transferrable to other studies aiming to achieve 
personalisation within alternative domains or can be applied to other healthcare conditions 
such as diabetes, asthma or a condition with many characteristics.  
 
The principal contribution in this thesis was that with the prior ‘knowledge’ of individual 
patient characteristics drawn from the PPDL repository and ‘Cluster Groups’ together with 
the supplementary ‘proof of concept’ knowledge obtained in the experiments each epilepsy 
patient can be treated distinctly and recommended an appropriate sensor-based device thus 
forming a patient specific unique PMP (Personalised Monitoring Plan). Hence 
personalisation can be achieved. 
 
8.2.1 Barriers and Limitations 
In order to carry out testing upon patients in real hospital settings a full ‘Integrated Research 
Approval System’ (IRAS) ethics application was carried out. The application was successful, 
yet it was demanding, time-consuming and vigorous. It included verbal interviews and 
seeking consent from various NHS bodies in addition to the ‘actual writing’ which required 
the author to understand new medical terminology. Despite this large-scale application and 
the proposed 20 patient recruitment, only 6 were recruited after all. 
Prior to creating this novel PMP Framework IoT sensor-based devices and their capabilities 
for epilepsy management where investigated. Finding a suitable IoT sensor-based device was 
challenging as there were many caveats to consider, such as finding just the one device which 
contained the appropriate sensors, affordability and most importantly that the device would 
allow data extraction in a raw form, so that the data could be analysed. 
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Some technical failure occurred with HP4 because the patient was either not wearing the 
watch at the time of the seizure or neither the sensor-based device nor the online server 
captured the event, as the records for 2 seizure event times were skipped during data transfer. 
Similarly, with the excluded patient, heart-rate data was recorded, however, the server 
although detecting the date and time of the seizure did not record any accelerometer data.  
All participants wearing the sensor-based device had sufficient battery power over the 5-day 
period, although clinicians reported that battery power drained quickly after this period. The 
battery life of sensor-based devices is a common problem and it is essential that the wearable 
device is powered by a reliable battery to measure everyday health indicators or specifically 
if they are used in a life-critical device [235]. There is currently work being done to use thin 
cell batteries to tackle this problem [235]. 
 
8.3 Recommendations and Future Work 
During the development of this thesis several areas have highlighted potential for future 
direction of this research, these proposals are discussed below.  
 
8.3.1 PPDL (Patient Profile Development Language) and Clustering 
The PPDL in its current form contains appropriate knowledge to answer the objectives. 
However, concepts presented in the PPDL and used in the clustering process can evolve in 
the future expanding the knowledge base. This aspect has already been catered for in the 
conceptual PMP framework design i.e. As patient’s present new signs and symptoms these 
classes can be added by the HCP, in order to maintain the real-world adoption of the PPDL. 
It is also worth mentioning that a universal acceptance of the new terminology in the ILAE 
should also be adhered to so that concepts such as PPDL and the ‘Cluster Groups’ proposed 
in this study can be more widely used. 
It is recommended in the future that further time can be spent on clustering. The next stage 
can trial some of the other available clustering techniques explored in Chapter 5. If the 
clustering technique K-means used to achieve the cluster groups in this study were to be used 
in the future there is also scope for deeper analysis upon ‘choosing the k’. 
 
8.3.2 Machine Learning and Sensor Decision Tree 
One of the most significant future directions for long-term remote monitoring of epilepsy is 
seizure detection via ‘machine learning’. By accumulating large datasets, computers can learn 
by recognising patterns in data. This automated approach (without human intervention) has 
been proposed as a ‘machine learning module’ within the PMP framework and IoT Epilepsy 
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Paradigm to determine seizure detection or not based on the patient specific profile, the idea 
being that by using algorithms the module will ‘learn’ when a patient is about to have seizure 
and warn them in advance. Due to limitations in this study this module has not been built but 
instead is proposed at this stage and recommended for the next level. Largely there is further 
work to take the PMP conceptual model and the IoT Epilepsy Paradigm (discussed below) 
into full operation. 
By using the philosophy of machine learning once again, it is a future recommendation to 
advance the sensor decision tree, (Figure 7.7. Sensor Decision Tree) shown in Chapter 7. 
This future advancement was already discussed and highlighted that a future goal is to use 
the decision tree as a training model that can be used to predict the target variable, i.e. the 
sensor, by learning simple decision rules inferred from prior training data. It is 
recommended that in future data exploration more variables will be added such as 
signs/symptoms, sensors and positions, and therefore the decision tree can help identify the 
most significant variable. This way the sensor decision tree can grow so that the outcome 
can be predicted, whereby in each leaf node the average outcome of the training data in this 
node is used. Similarly, this approach can be adopted by other health domain experts in 
other areas such as stress management, asthma or where multi sensors can treat different 
symptoms.  
8.3.3 IoT Epilepsy Paradigm and Robustness 
Section 7.7.4 in Chapter 7 identified that it is outside the scope of this thesis to develop and 
perform monitoring upon each of the sensor-based devices shown in the IoT Epilepsy 
Paradigm. This thesis demonstrated an ‘approach’ and presented an IoT ‘model’ only. 
It is recommended that the IoT Epilepsy paradigm be taken to the next level in future research. 
For the adoption of cloud computing the Microsoft Azure was proposed, yet the choice of  
a number of ready built elements that enable hardware manufacturers to connect their devices 
to the internet are vast and as such there were no less than ‘450 organisations advertising’ an 
“IoT Platform” in 2017 [236]. The tools required for IoT solutions offer everything from open 
source software SDKs and architecture design patterns to cloud-based IoT APIs and soldered 
hardware chipsets [236]. 
It is expected the number of sensor-based devices connected to the IoT Epilepsy Paradigm 
will grow over time. For the infrastructure to be effective it must be robust and that can only 
be enabled through thorough testing [237] . Chapter 7 recommended deploying an additional 
component to closely monitor the function of a sensor and send an alert to the user if a sensor 
were to malfunction, this is one of many scenarios that must be tested and it is recommended 
that simulating these scenarios during performance testing should be arranged in the future 




8.3.4 Embrace for Research platform 
During the experiments in Chapter 6 data retrieval using the light-weight Fitbit sensor-based 
device proved easy to use with adequate battery life appropriate for this research however 
other alternatives in the future should be pursued.  
One such dependable method is the ‘Embrace for Research’ platform, by Empatica, see 
Figure 8.1 below [238]. Not only are there more sensors contained in the wearable device, 
the data retrieval process is much smoother hence data-flow is seamless via a Bluetooth 
connection to the Mate app then the raw data is transmitted continuously to the Research 
Portal where researchers can review at a glance [238]. This platform was too expensive to 
use in the experiments in this study and during enquiries (at the time of experiments) it was 
alleged there were no such ‘extendible’ straps available to allow the device to be positioned 
on different parts of the body as opposed to the wrist, this being an area of potential future 
direction. 
 
Figure 8.1. Embrace for Research Platform [238] 
 
8.3.5 Long Term Uses & Applicability in other domains for the PMP Framework 
The methods used in this thesis for ontology development and clustering analysis can be 
applied to any disease whereby recognised symptoms per patient can be individualised and 
be further put into sub-groups or categories. However, to fully utilise this personalised 
approach the application of the PMP framework can be particularly applied to patients whom 
have symptoms that can be monitored with different IoT sensor-based devices and 
personalised further by wearing the device on different body positions. In the future the 
following types of patients can be handled by the proposed PMP framework: (shown below 
together with latest progressive recommended sensor-based devices). 
- Diabetes: i.e. One such recommended device could be use of ‘flash 
glucose sensing’: A device which checks blood glucose levels by scanning 
a sensor worn on their arm will be (available on the NHS for people 
with type 1 diabetes) [239]. 
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- Sick Infants: i.e. A recommended device could be use of a miniaturised, 
wireless oxygen sensor wearable device the size of a Band-Aid which 
would allow babies to be monitored from home and able to leave the 
hospital [240]. 
- Rehabilitation: i.e. The recommended device for rehabilitation could be a 
Force-based sensor which can be integrated with footwear to measure the 
interaction of the body with the ground during walking [241]. Due to the 
possibility of detecting not only physiological but also movement data 




If this research problem were to be taken now would a different approach be adopted? This 
requires a thoughtful answer. The first thoughts are driven instinctively to the research 
questions i.e. can the remote monitoring of individual patients be personalised using an IoT 
approach? In truth, yes, the research questions have been answered fittingly and the problem 
solved.  
Looking back, the approaches taken to achieve the answers were rather combined for example 
by incorporating ontology development, clustering analysis and IoT technology. Therefore, 
if the thesis had focused ‘solely’ on using one approach i.e. clustering techniques, it stands to 
reason more time would have been dedicated to it, would there have been a different/stronger 
outcome? There would have been more experiments with other clustering algorithms aside 
from K-means and more exploration in how to ‘choose the K’ but there is no certainty the 
cluster group outcomes would have been more accurate or looked any different, besides 
which the concept of clustering epilepsy patient profiles is clearly demonstrated and the 
underpinning work in place to develop this further. Moreover, without the depth of the 
ontology development approach the dataset created from the ESO which uncovered a variety 
of patient profiles, the clustering outcome would not have been so vigorous. Similarly, 
looking back, the IoT approach served to furnish the remote personalised monitoring of 
individual patients by highlighting the essential IoT sensor-based devices that can monitor 
epilepsy. The IoT approach built upon the contributions from the ontology and clustering 
approaches, capturing without human interaction how the typical seizure patient profiles can 
be represented. 
Aside from wishing that patient recruitment had begun earlier, being too ambitious about the 
amount of epilepsy patients that could be recruited for experiments, or in hindsight pursuing 
more funding to be able to afford ‘out of the box’ equipment it can be said that within the 
scope of this thesis there would not have been much done differently. 
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The premises made in this thesis put the future of personalisation in epilepsy into focus, a 
focus that shifts from a one-size fits all to a focus on the core of the epilepsy patients’ 
individual characteristics. The computer science contributions made are a ‘cog in the wheel’ 
in this arena, and these stepping stones hope to pave the way for a brighter future in epilepsy 
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Appendix A  
Backend Monitoring 
 
Raw accelerometer and heart-rate data is accessed from the Fitbit Ionic using the devices 
‘API'. A custom made ‘APP’ that runs on the watch is used for this purpose. The monitoring 
data is then sent from the device to the mobile phone which it's paired, and from there to a 
remote private server. The sensors are connected to an Android mobile phone with Bluetooth.  
The custom made ‘APP’, is named EM (Effects Monitor), shown in the image below. The 
main functions of the EM App are: 
• To capture and store data while with the user. 
• To stores the captured data while having no access to the mobile device. 
On start-up, the EM app starts to sense and capture heart-rate/heart-rate and accelerometer 
data and stores it to memory. This takes place without necessity for access to the internet. 
Once the device can gain access to the internet, it auto-uploads the data to the remote private 
server. 
 
                  
When the monitoring data is sent to the remote private server it is displayed. The program 
pulls the data from Fitbit Ionic device and displays it on the web page shown in the image 
below. 








Appendix B  
Hospital Patient Observations 
 



































Patient Profile: HP1 
Seizure Type:  
• FAS (Focal Aware Seizure) also known as 
‘aura’s 
• FSIA (Focal seizures with loss of awareness.) 
 
Dominant Side: Right  
Time of Day: Diurnal 
Trigger: Unknown 
Key Symptoms: LOC, Automatisms (seizures usually lasting 10-20 
seconds) 
Observation Criteria 
Observation 10 Seizure occurs with sensor positioned on 
right wrist (09.44am) 
Observation 11 Seizure occurs with sensor positioned on 
right wrist (20.36pm) 
Observation 12 Seizure occurs with sensor positioned on 
right wrist (21.06pm) 
Observation a HP1 Seizure occurs with sensor positioned on 
right wrist (09.55am) 
Observation b HP1 Seizure occurs with sensor positioned on 
right wrist (10.02am) 
Observation c HP1 Seizure occurs with sensor positioned on 
right wrist (19.26) 
Observation d HP1  Seizure occurs with sensor positioned on 
right wrist (20.17) 
Observation e HP1  Seizure occurs with sensor positioned on 
right wrist (21.00) 
Observation f HP1  Seizure occurs with sensor positioned on 
right wrist (11.01) 
Observation g HP1  Seizure occurs with sensor positioned on 
right wrist (20.44) 
Observation h HP1  Seizure occurs with sensor positioned on 
right wrist (20.50) 
Observation 13 No seizure occurs with sensor positioned 
on right wrist during day-time 
Observation 14 No seizure occurs with sensor positioned 
on right wrist during night-time 
Observation 15   No seizure occurs with sensor positioned 
on right wrist during night-time  
Observation 16 No seizure occurs with sensor positioned 
on right wrist during night-time  
Observation 17 No seizure occurs with sensor positioned 





Observation 10: Seizure occurs with sensor positioned on right wrist 
Observation Time: 09.43.-09-46am 
Seizure Occurrence: 09.44am 
 
 
Observation 11: Seizure occurs with sensor positioned on right wrist 
Observation Time: 20.35.-20-37pm 
Seizure Occurrence: 20.36pm 
 
Observation 12: Seizure occurs with sensor positioned on right wrist 
Observation Time: 21.05.-21-07pm 










Observation a HP1: Seizure occurs with sensor positioned on right wrist 
Observation Time: 09.54.-09.56am 
Seizure Occurrence: 09.55am 
 
 
Observation b HP1: Seizure occurs with sensor positioned on right wrist 
Observation Time: 10.01.-10.05am 
Seizure Occurrence: 10.02am 
 
 
Observation c HP1: Seizure occurs with sensor positioned on right wrist 
Observation Time: 19.25-19.29pm 











Observation d HP1: Seizure occurs with sensor positioned on right wrist 
Observation Time: 20.15-20:19pm 
Seizure Occurrence: 20.17pm 
 
 
Observation e HP1: Seizure occurs with sensor positioned on right wrist 
Observation Time: 20.58 – 21.03pm 




Observation f HP1: Seizure occurs with sensor positioned on right wrist 
Observation Time: 10.59-11.04am 










Observation g HP1: Seizure occurs with sensor positioned on right wrist 
Observation Time: 20.42-20.47pm 
Seizure Occurrence: 20.44pm 
 
 
Observation h HP1: Seizure occurs with sensor positioned on right wrist 
Observation Time: 20.48 -20.52pm 
Seizure Occurrence: 20.50pm 
 
 
Observation 13: No seizure occurs with sensor positioned on right wrist during day-time 
Observation Time: 12.52-12.54pm 











Observation 14: No seizure occurs with sensor positioned on right wrist during sleep 
Observation Time: 04.50-04.52am 
Seizure Occurrence: No seizure 
 
 
Observation 15: No seizure occurs with sensor positioned on right wrist Observation 
Time: 19.03 -19.06pm 
Seizure Occurrence: No seizure 
 
 
Observation 16: No seizure occurs with sensor positioned on right wrist Observation 
Time: 19.18 -19.22pm 










Observation 17: No seizure occurs with sensor positioned on right wrist Observation 
Time: 19.36 -19.40pm 

































➢ Hospital Patient 2 Information  
Patient Profile: HP2 
Seizure Type: • FSIA (Focal seizures with impaired of 
awareness.) 
             (main seizure type)  
Dominant Side: Left and Right 
Time of Day: Diurnal 
Trigger: Unknown 
Key Symptoms: LOC (Loss of Consciousness), Clonus, Automatisms 
 
➢ Observation Criteria 
Observation Criteria 
Observation a HP2 No seizure occurs with sensor positioned on left wrist 
(during sleep)   
Observation b HP2 No seizure occurs with sensor positioned on left wrist 
(during day-time)  
 
Observation c HP2 No seizure occurs with sensor positioned on left wrist 
(during day-time)  
 
Observation d HP2 No seizure occurs with sensor positioned on left wrist 
(during evening)  
 
Observation e HP2 No seizure occurs with sensor positioned on left wrist 





Observation a HP2: No seizure occurs with sensor positioned on left wrist during sleep  
Observation Time: 06.27 – 06.30am 












Observation b HP2: No seizure occurs with sensor positioned on left wrist during day-time  
Observation Time: 10.54.-10-56am 
Seizure Occurrence: No seizure 
 
 
Observation c HP2: No seizure occurs with sensor positioned on left wrist during day-time  
Observation Time: 15.05 – 15.07 pm 
Seizure Occurrence: No seizure 
 
 
Observation d HP2: No seizure occurs with sensor positioned on left wrist during day-time  
Observation Time: 19.39 -19.41pm 











Observation e HP2: No seizure occurs with sensor positioned on left wrist during day-time  
Observation Time: 13.54 -13.57pm 











































➢ Observation Criteria 
Observation Criteria 
Observation a HP3 No seizure occurs with sensor positioned on right wrist 
(during day-time)   
Observation b HP3 No seizure occurs with sensor positioned on right wrist 
(during sleep)  
 
Observation c HP3 No seizure occurs with sensor positioned on right wrist 
(during day-time)  
 
Observation d HP3 No seizure occurs with sensor positioned on right wrist 
(during day-time, evening)  
 
Observation e HP3 No seizure occurs with sensor positioned on right wrist 





Observation a HP3: No seizure occurs with sensor positioned on right wrist during day-time  
Observation Time: 10.10 –10.12am 







Patient Profile: HP3 
Seizure Type: • GTCS. 
• FSIA (Focal seizures with impaired of 
awareness.) 
 
Dominant Side: Left and Right 
Time of Day: Diurnal and Nocturnal 
Trigger: Unknown 
Key Symptoms: Full Body Shaking (Clonus), LOC,Automatisms 
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Observation b HP3: No seizure occurs with sensor positioned on right wrist during sleep  
Observation Time: 05.01 – 05.03am 




Observation c HP3: No seizure occurs with sensor positioned on right wrist during day-time  
Observation Time: 08.09am – 08.12am 




Observation d HP3: No seizure occurs with sensor positioned on right wrist during day-
time  
Observation Time: 13.40- 13.43pm 








Observation e HP3: No seizure occurs with sensor positioned on right wrist during day-time  
Observation Time: 19.13 -19.17am 










































➢ Observation Criteria 
Observation Criteria 
Observation a HP4 Seizure occurs with sensor positioned on right wrist (from 
sleep)   
Observation b HP4 Seizure occurs with sensor positioned on right wrist (from 
sleep)  
 
Observation c HP4 Seizure occurs with sensor positioned on right wrist (from 
sleep)  
 
Observation d HP4 Seizure occurs with sensor positioned on right wrist (from 
sleep)  
 
Observation e HP4 Seizure occurs with sensor positioned on right wrist (from 
sleep)  
 
Observation f  HP4 Seizure occurs with sensor positioned on right wrist (from 
sleep)  
 
Observation g HP4 No seizure occurs with sensor positioned on right wrist 
(during day-time)  
 
Observation h HP4 No seizure occurs with sensor positioned on right wrist 
(during day-time)  
 
Observation i HP4 No seizure occurs with sensor positioned on right wrist 
(during day-time)  
 
Observation j HP4 No seizure occurs with sensor positioned on right wrist 
(during day-time)  
 
Observation k HP4 No seizure occurs with sensor positioned on right wrist 









Patient Profile: HP4 
Seizure Type: • GTCS (Generalised Tonic Clonic Seizure) 
• FSIA (Focal seizures with impaired of 
awareness.) 
 
Dominant Side: Right Arm 
Time of Day: Nocturnal (all from sleep) 
Trigger: Unknown 






Observation a HP4: Seizure occurs with sensor positioned on right wrist during day-time 
Observation Time: 12.42 – 12.45pm 
Seizure Occurrence: 12.44pm 
 
 
Observation b HP4: Seizure occurs with sensor positioned on right wrist  
Observation Time: 00.53 -00.56am 




Observation c HP4: Seizure occurs with sensor positioned on right wrist  
Observation Time: 00.22 -00.28am 









Observation d HP4: Seizure occurs with sensor positioned on right wrist  
Observation Time: 04.41 -04.45am 




Observation e HP4: Seizure occurs with sensor positioned on right wrist  
Observation Time: 06.56 -06.59am 




Observation f HP4: Seizure occurs with sensor positioned on right wrist  
Observation Time: 10.31 -10.35am 








Observation g HP4: No seizure occurs with sensor positioned on right wrist  
Observation Time: 13.34 -13.37pm 




Observation h HP4: No seizure occurs with sensor positioned on right wrist  
Observation Time: 14.07 -14.11pm 




Observation i HP4: No seizure occurs with sensor positioned on right wrist  
Observation Time: 08.01 -08.04pm 









Observation j HP4: No seizure occurs with sensor positioned on right wrist  
Observation Time: 09.00 -09.04pm 




Observation k HP4: No seizure occurs with sensor positioned on right wrist  
Observation Time: 21.34 -21.38pm 
























➢ Observation Criteria  
Observation Criteria 
Observation a HP5 One non epileptic shaking event occurs with sensor 




Observation a HP5: Seizure occurs with sensor positioned on left wrist during evening 
Observation Time: 23:01 – 23:05pm 


















Patient Profile: HP5 
Seizure Type: Unclassified  
Dominant Side: Left 
Time of Day: Diurnal 
Trigger: Unknown 
Key Symptoms: Full Body Shaking (Bilateral Clonus) 
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Appendix C  
Volunteer 1 & 2 Observations 
 








➢ Observation Criteria Volunteer 1 
Observation Seizure  Position Time of Day (Random) 
V1. Observation 1 Yes Right Wrist Evening 
V1. Observation 2a No Right Wrist Night Time (during sleep) 
V1. Observation 2b No Right Wrist During the evening ) 
V1. Observation 2c No Right Wrist During the evening 
V1. Observation 3 Yes Left Wrist Day Time (Morning) 
V1. Observation 3a No Left Wrist Evening 
V1. Observation 3b No Left Wrist Day Time (Morning) 
V1. Observation 3c No Left Wrist Evening 
V1. Observation 4 Yes Left Leg Day Time (Morning) 
V1. Observation 4a No Left Leg Night Time (during sleep) 
V1. Observation 4b No Left Leg Morning Time (during sleep) 
V1. Observation 4c No Left Leg Evening 
V1. Observation 5 Yes Right Leg Day Time (Morning) 
V1. Observation 5a No Right Leg Evening 
V1. Observation 5b No Right Leg Evening 




V1. Observation 1: Seizure occurs with sensor positioned on right wrist 
Observation Time: 20.37-39pm 
Seizure Occurrence Time: 20.38pm 
 
 
Volunteer Profile: V1 
Seizure Type: GTCS 
Dominant Side: Right Arm 
Time of Day: Diurnal 
Trigger: Stress 






V1. Observation 2a: No seizure occurs at night (during sleep) sensor positioned on right 
wrist  
Observation Time: 02.49-51am 




V1. Observation 2b: No seizure occurs during the evening sensor positioned on right wrist  
Observation Time: 21.01-21.04 




V1. Observation 2c: No seizure occurs during the evening sensor positioned on right wrist  
Observation Time: 19.35pm – 19.37pm 







V1. Observation 3: Seizure occurs with sensor positioned on left wrist (day time) 
Observation Time: 11.09-11.11am 




V1. Observation 3a: No Seizure occurs with sensor positioned on left wrist (night time) 
Observation Time: 21.26pm – 21.28pm 





V1. Observation 3b: No Seizure occurs with sensor positioned on left wrist (morning) 
Observation Time: 11.31pm – 11.33am 








V1. Observation 3c: No Seizure occurs with sensor positioned on left wrist (evening) 
Observation Time: 19.12pm – 19.15pm 




V1. Observation 4: Seizure occurs with sensor positioned on left leg (day time) 
Observation Time: 09.46am – 09.48am 




V1. Observation 4a: No seizure occurs with sensor positioned on left leg (night time, during 
sleep) 
Observation Time: 02.15am – 02.17am 







V1. Observation 4b: No seizure occurs with sensor positioned on left leg (morning, during 
sleep) 
Observation Time: 08.10am – 08.11am 




V1. Observation 4c: No seizure occurs with sensor positioned on left leg (evening)  
Observation Time: 20.09 – 20.10pm 




V1. Observation 5: Seizure occurs with sensor positioned on right leg (day time)  
Observation Time: 11.37am – 11.40am 








V1. Observation 5a: No seizure occurs with sensor positioned on right leg (day time)  
Observation Time: 19.35pm – 19.37pm 




V1. Observation 5b: No seizure occurs with sensor positioned on right leg (evening)  
Observation Time: 20.47 – 20.48pm 





V1. Observation 5c: No seizure occurs with sensor positioned on right leg (during sleep)  
Observation Time: 04.02 – 04.04am 

















➢ Observation Criteria Volunteer 2 
Observation Seizure  Position Time of Day (Random) 
V2. Observation 1 Yes Left Leg Evening 
V2. Observation 1a Yes Right Leg Evening 
V2. Observation 1b No Right Leg During the evening  
V2. Observation 1c No Left Leg During sleep 
V2. Observation 2 Yes Right Leg Day Time (Morning) 
V2. Observation 2a No Right Leg During sleep 
V2. Observation 2b No Right Leg Evening 
V2. Observation 2c No Left Leg Evening 
V2. Observation 3 Yes Left wrist Day Time (Morning) 
V2. Observation 3a No Left wrist Evening 
V2. Observation 3b No Left wrist Afternoon 
V2. Observation 3c No Left wrist During Sleep 
V2. Observation 4 Yes Right wrist Evening 
V2. Observation 4a No Right wrist During Sleep 
V2. Observation 4b No Right wrist Evening 




V2. Observation 1: Seizure occurs with sensor positioned on left leg 
Observation Time: 22.13-17pm 






Volunteer Profile: V2 
Seizure Type: GTCS 
Dominant Side: Left side 
Time of Day: Diurnal 
Trigger: Sleep Dep 





V2. Observation 1a: Seizure occurs during evening sensor positioned on right leg 
Observation Time: 19.31-19.32pm 
Seizure Occurrence:  
 
 
V2. Observation 1b: No seizure occurs during evening sensor positioned on right leg 
Observation Time: 19.35-19.36pm 




V2. Observation 1c: No seizure occurs during sleep sensor positioned on left leg 
Observation Time: 06.23-06.24am 










V2. Observation 2: Seizure occurs (morning) sensor positioned on right leg 
Observation Time: 11.39-11.41am 




V2. Observation 2a: No seizure occurs during sleep sensor positioned on right leg 
Observation Time: 02.15-02.17am 




V2. Observation 2b: No seizure occurs during evening sensor positioned on right leg 
Observation Time: 20.20-20.21pm 








V2. Observation 2c: No seizure occurs during evening sensor positioned on left leg 
Observation Time: 20.34-20.35pm 




V2. Observation 3: Seizure occurs during on left wrist 
Observation Time: 09.03-09.04am 




V2. Observation 3a: No seizure occurs during on left wrist 
Observation Time: 20.34-20.35pm 









V2. Observation 3b: No seizure occurs during on left wrist 
Observation Time: 13.27-13.29pm 
Seizure Occurrence: No Seizure 
 
 
V2. Observation 3c: No seizure occurs during on left wrist (during sleep) 
Observation Time: 05.15-05.17am 




V2. Observation 4: Seizure occurs during on right wrist (evening) 
Observation Time: 18.45-18.47pm 










V2. Observation 4a: No seizure occurs during on right wrist (during sleep) 
Observation Time: 01.02-01.04am 




V2. Observation 4b: No seizure occurs during on right wrist (evening) 
Observation Time: 21.50-21.52pm 




V2. Observation 4c: No seizure occurs during on right wrist (morning) 
Observation Time: 10.02-10.04am 
Seizure Occurrence: No Seizure 
 
 
 
 
 
